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The autoimmune regulator (AIRE), a key player in negative selection of developing 
thymocytes, acts as a transcriptional regulator, inducing the expression of tissue 
restricted antigens (TRA) within medullary thymic epithelial cells in a process known 
as promiscuous gene expression (PGE).  Here we demonstrate how AIRE influences 
PGE through a direct impact on post-translational modifications of core histones 
which are associated with the regulation of transcription.  Through native chromatin 
immunoprecipitation on thymic epithelial cells transfected with AIRE, we show how in 
vitro, TRA are enriched in active acetylation and methylation of core histones, yet 
retain silencing modifications.  Furthermore, across a cluster of AIRE-regulated 
genes, histone modifications were deposited across the entire domain, dependent 
upon the expression profile of each gene, suggesting a role for domain-wide 
epigenetic regulation by AIRE.  Extension of these studies in vivo, utilising the 
recently developed carrier ChIP technique, allowed examination of the epigenetic 
status of TRA throughout the thymic developmental pathway.  We report how poised 
TRA are marked with combinations of active and silent modifications early in thymic 
development and that the chromatin signatures re-organise as the cells differentiate.  
The epigenetic patterning differs on a gene-by-gene basis, however their significance 
is implied upon disruption to normal development as the predictive pattern of 
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As human beings, we are under relentless attack from our environment; constantly in 
danger of infection and disease caused by pathogenic organisms.  On occasion, 
these invasions are successful, however they are dealt with swiftly and effectively by 
our immune system; a highly complex arrangement of cells and molecules, with a 
series of sophisticated mechanisms in place to identify and eradicate invaders.  
There are two major types of immune responses; innate immunity which provides an 
immediate reaction to tissue damage and infection by a wide range of potentially 
infectious agents; and adaptive immunity which is activated should innate immunity 
fail.  The adaptive immune system is organised around two basic branches; humoural 
and cell-mediated responses, carried out by B-lymphocytes (B-cells) and T-
lymphocytes (T-cells) respectively (Beck and Habicht 1996; Walker and Abbas 2002).  
It is predicted that the T-cell repertoire alone can provide protection against a vast 
number of foreign pathogens, with a capacity to recognise around 25 million antigen 
specificities (Walker and Abbas 2002).  This is achieved through a combination of 
plasticity of antigen recognition and random somatic gene mutation of the T-cell 
receptor (TCR) genes, during the development of T-cells within the thymus. 
 
1.1. T-LYMPHOCYTES: THE MAIN PLAYERS IN ADAPTIVE IMMUNITY 
 
Each day, approximately two million new T-cells are released from the thymus into 
the circulation, generated from an average of 10-100 entering haematopoietic 
precursors (Kyewski and Klein 2006; Nedjic et al. 2008).  However, these two million 
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mature T-cells are the lucky ones; for at its peak, an average of 50 million thymocytes 
are produced within the thymus from the minimal number of precursor cells, all of 
which must go through an intense selection process, ultimately resulting in the death 
of 96% of developing cells daily (Nedjic et al. 2008).  Each individual T-cell is 
encoded for a certain antigen-specificity on its TCR, thus the generation of such a 
large number of novel thymocytes requires great flexibility in TCR genes and random 
gene rearrangement.  However, this extremely stochastic process unavoidably 
results in the generation of either inert or potentially damaging T-cells.  Inert T-cells 
are simply of no use to the immune system as, although capable of recognising 
foreign antigens, they are unable to bind to them when presented via self-major 
histocompatibility complex (MHC) on the surface of antigen-presenting cells (Nedjic 
et al. 2008).  The alternative; T-cells capable of binding self-MHC, but in combination 
with self-antigens originating from our body’s own proteins, have the potential to 
cause much damage should they be released, and many autoimmune diseases 
result from a failure of the selection processes within the thymus allowing these self-
reactive T-cells to slip through the net.  Fortunately, healthy individuals are able to 
purge the system of these T-cells before they can do harm in a process known as 
tolerance, which can take place within the thymus and the periphery. 
 
1.2. T-LYMPHOCYTE DEVELOPMENT AND CENTRAL TOLERANCE 
 
The process of central tolerance is an integral part of T-cell development within the 
thymus and is therefore crucial for the generation of an effective immune system.  
The thymus represents a specialised microenvironment whose primary function is to 
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generate a repertoire of diverse but safe T-cells.  Stringent selection processes are 
orchestrated by thymic stromal cells and other accessory cells, which communicate 
with the developing T-cells as they pass through the thymus.  The thymic cells signal 
through chemokines, cytokines, selectins and transcription factors, influencing 
thymocyte migration, proliferation and differentiation during the complex stages of T-
cell development (Figure 1.1) (Rodewald 2006; Takahama 2006; Wu 2006).  In 
addition, it is not only the maturing thymocytes that benefit from these interactions as 
it has been shown that during late thymic organogenesis, the development of the 
thymic stromal cells, specifically maintenance of specialised thymic epithelial 
lineages, relies on thymocyte-derived signals in a process termed thymic crosstalk 
(Anderson et al. 1993; Anderson and Jenkinson 1995; Hollander et al. 1995; Nehls et 
al. 1996; Manley 2000; Klug et al. 2002; Jenkinson et al. 2005; Rothenberg et al. 
2008; White et al. 2008; Palmer and Naeher 2009; Shakib et al. 2009). 
 
Anatomically, the thymus can be compartmentalised into cortical and medullary 
regions, both of which are responsible for separate phases of T-cell development 
(Shakib et al. 2009).  The main processes in T-cell development can be divided into a 
number of key events, with the initial stages taking place in the outer cortex of the 
thymus following the influx of bone-marrow-derived lymphoid progenitor cells, which 
transmigrate across the cortico-medullary junction to the thymic parenchyma from the 
blood (Figure 1.1) (Takahama 2006).  These immature cells then begin the process 
of development, aided by Notch-mediated and interleukin-7 (IL-7) signals from 
cortical stromal cells (Takahama 2006).  Thymocyte progression through this stage is 
exemplified by the expression profiles of cell surface markers CD25, CD44 and c-kit 
The main stages in T-lymphocyte development. (a) Transmigration of immature 
lymphoid progenitor cells into the thymus across the cortico-medullary junction to 
the thymic parenchyma from the blood (b) development of these cells, aided by 
Notch-mediated and interleukin-7 (IL-7) signals from cortical thymic epithelial cells 
(cTECs) results in the generation of CD4-CD8- double negative (DN) thymocytes 
and then (c) CD4+CD8+ double positive (DP) thymocytes, which occurs in the 
outer cortex of the thymus.  Massive expansion of DP thymocytes occurs and 
the cells subsequently migrate to the inner cortex for (d) positive selection, a 
process brought about by cTECs and macrophages (MФ).  The DP cells then 
transfer to the medulla for negative selection, aided by signals from medullary 
thymic epithelial cells (mTECs), B-lymphocytes (B-cells) and dendritic cells (DCs), 
generating single positive (SP) CD4+ or CD8+ T-cells, which are finally (e) exported 
to the periphery as mature T-cells (Iwasaki and Akashi 2006; Rodewald 2006; Wu 
2006).  Figure adapted from (Kyewski and Klein 2006; Takahama 2006).
Figure 1.1 - The Development of T-Lymphocytes
4
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(Iwasaki and Akashi 2006; Takahama 2006; Wu 2006).  The cells alter their 
expression of these molecules as they differentiate and proliferate, passing from 
CD4-CD8-CD25-CD44+c-kit+ double negative (DN) 1 thymocytes to CD4-CD8-
CD25+CD44+c-kit+ DN2, and eventually to CD4-CD8-CD25+CD44-c-kit- DN3 
thymocytes (Iwasaki and Akashi 2006; Takahama 2006; Wu 2006). 
 
For progression along the developmental pathway, DN3 cells must successfully 
complete in-frame rearrangement of VDJ TCRβ-chain and pre-TCRα genes, thus 
allowing formation of a cell-surface pre-TCR complex (Iwasaki and Akashi 2006; 
Takahama 2006).  The thymocytes are then able to migrate through the cortex 
towards the subcapsular zone where expression of CD4 and CD8 can occur, 
generating double positive (DP) thymocytes, a process which is negatively regulated 
by high levels of transforming growth factor-β 1 (TGFβ1) (Figure 1.1) (Rubtsov and 
Rudensky 2007). 
 
It is at this point that the first blueprint of central tolerance is imprinted into the 
developing T-cell repertoire.  The first major checkpoint ensures a useful T-cell 
repertoire in a process termed positive selection (Figure 1.1).  Through presentation 
of peptide/MHC ligands on the surface of cortical thymic stromal cells and dendritic 
cells (DCs), and subsequent interactions with TCRαβ complexes on the developing 
DP thymocytes, only those capable of recognising and binding to self-MHC, receive 
positive signals to survive and continue differentiation (Kyewski and Klein 2006; 
Shakib et al. 2009). 
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For progression along the pathway of differentiation, positively-selected DP 
thymocytes must lose expression of either CD4 or CD8 to become single positive 
(SP) thymocytes.  These cells are then able to migrate towards the medulla, where 
maturation can occur, along with the final phase of tolerance induction; negative 
selection (Figure 1.1) (Takahama 2006).  Negative selection occurs mainly, although 
not exclusively, within the thymic medulla, and results in the clonal deletion of highly 
auto-reactive thymocytes, or commitment of mildly self-reactive T-cells to the 
forkhead box P3 (Foxp3)-expressing regulatory T-cell (Treg) lineage, before the 
release of mature T-cells into the circulation (Kyewski and Klein 2006; 
Aschenbrenner et al. 2007; Hamazaki et al. 2007; Rubtsov and Rudensky 2007; 
Venanzi et al. 2007; Lars-Oliver Tykocinski 2008; McCaughtry et al. 2008; Shakib et 
al. 2009). 
 
The three-dimensional meshwork of thymic epithelial cells (TECs) provide a constant 
input to all stages of T-cell development, and the impact these cells have in moulding 
the T-cell repertoire has been well documented (Anderson et al. 1993; Anderson and 
Jenkinson 1995; Hollander et al. 1995; Nehls et al. 1996; Manley 2000; Jenkinson et 
al. 2005).  This is highlighted by the fact that TEC frequency is directly proportional to 
the efficacy of thymic T-cell output and that age-related thymic atrophy leads to a 
decline in T-cell production, to the extent that by 40-50 years thymic output has fallen 
to less than 10% of its maximum potential, a process again attributed to a decline in 




1.3. PROMISCUOUS GENE EXPRESSION IN THE THYMUS AND NEGATIVE SELECTION 
 
For decades, immunologists have debated the relative importance of central versus 
peripheral tolerance, an enduring argument being that the majority of the body’s 
proteome would not be visible to developing T-cells within the sterile thymic 
microenvironment, hence central tolerance to self would be practically impossible.  
Added to this the re-emergence of the concept of T-cell subsets with regulatory 
characteristics, peripheral tolerance mechanisms have dominated the field (Walker 
and Abbas 2002; Mathis and Benoist 2004).  Within the periphery, a large number of 
systems are in place to prevent the activation of mature autoimmune T-cells and 
induce peripheral tolerance including T-cell-intrinsic mechanisms; clonal ignorance, 
anergy, phenotypic skewing and apoptosis, and T-cell-extrinsic mechanisms; which 
rely on auxiliary cells such as Treg and tolerogenic dendritic cells (Walker and Abbas 
2002; Siggs et al. 2006; Aschenbrenner et al. 2007).  Yet despite this, there was no 
denying the fact that such large numbers of immature T-cells are produced and then 
immediately deleted within the thymus.  Furthermore, the importance of TECs upon 
the prevention of self-reactive T-cell specificities is evidenced by the resulting 
development of autoimmune deficiencies when the TEC developmental pathway is 
disrupted (Shakib et al. 2009).  This challenged the classic views of a dominant role 
for peripheral tolerance mechanisms and fuelled further investigation into central 
tolerance (Mathis and Benoist 2004; Kyewski and Klein 2006).  The first major 
insight into how intra-thymic tolerance to self could realistically be achieved, 
revealed that a number of diverse tissues were represented at the RNA level in 
distinct areas of the thymus including the pancreas (insulin), and the central nervous 
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system (myelin basic protein and proteolipid protein) (Gotter et al. 2004; Mathis and 
Benoist 2004; Kyewski and Klein 2006).  Numerous reports followed in support of 
this, and with the development of a meticulous purification protocol for thymic 
stromal cell populations, the theory of intra-thymic expression of self-antigens, and 
the significance of the central tolerance concept, was again brought to the forefront, 
challenging the general rules of cell-type-specific patterns of gene expression 
(Jolicoeur et al. 1994; Klein et al. 1998; Mathis and Benoist 2004; Kyewski and Klein 
2006). 
 
Further studies into this phenomenon have built upon these findings, showing that 
essentially all organs, including genes thought to be restricted in their spatial, 
developmental, sex-dependent and temporal expression are represented in the 
thymic microenvironment (Mathis and Benoist 2009).  A predicted pool of up to 3000 
tissue-restricted antigens (TRA) are expressed; representing a significant portion of 
the genome, which include transcripts for, among others; structural proteins, 
hormones, secreted proteins and transcription factors (Anderson et al. 2002; Kyewski 
and Derbinski 2004; Kyewski and Klein 2006; Mathis and Benoist 2009).  These self-
antigens can be generated in a number of ways including; expression within bone-
marrow derived antigen presenting cells (APC) of the circulatory system (dendritic 
cells, macrophages and B-cells); import of a limited number of antigens to the thymus 
via APCs from the periphery, or directly through the bloodstream; however the 
principal way in which these TRA are produced was found to be from the proteome of 
resident thymic stromal cells (Koble and Kyewski 2009).  This process, termed 
promiscuous gene expression (PGE), was found to be predominantly restricted to a 
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very select subset of thymic epithelial cells, primarily located in the medulla and 
cortico-medullary junction; medullary thymic epithelial cells (mTECs) (Anderson and 
Jenkinson 2001; Derbinski et al. 2001; Kyewski and Derbinski 2004; Mathis and 
Benoist 2004; McCaughtry et al. 2008).  This small fraction of cells make up only 
approximately 0.005% of the whole thymus, however their role is crucial for 
preventing autoimmunity, highlighted by the fact that the majority of autoantigens, 
either known or suspected to cause specific autoimmune diseases, can be detected 
in murine mTECs including, but not limited to; thyroglobulin and thyroid peroxidise 
(TPO), causative autoantigens of Hashimoto’s thyroiditis; insulin, glutamic acid 
decarboylase-67 (GAD67) and IA-2, major autoantigens of type I diabetes; and the 
rheumatoid arthritis antigen, collagen II (Gotter et al. 2004).  In addition, mTECs 
displayed many cancer-germline group antigens such as members of the melanoma 
antigen (MAGE)-A group or NY-ESO-1, along with differentiation antigens including 
tyrosinase and MART-1 (melanoma antigen recognized by T-cells), known targets of 
circulating T-cells (Gotter et al. 2004).  Thus, PGE within mTECs acts to expose 
developing T-cells to an extensive array of TRA, imprinting them with tolerance to 
self. 
 
1.4. MOLECULAR REGULATION OF PROMISCUOUS GENE EXPRESSION BY AIRE 
 
The cellular and molecular intricacy of central tolerance, although not thoroughly 
understood, was brought one step closer to comprehension through the discovery of 
a molecular determinant of PGE, following studies into a relatively rare autoimmune 
disease.  Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy 
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(APECED), also known as Autoimmune Polyendocrinopathy Syndrome Type 1 
(APS1), is a devastating primary autoimmune disease which manifests itself as 
organ-specific autoimmunity to multiple organs due to the presence of circulating 
tissue-specific auto-antibodies, which target and attack various organs (Aaltonen et 
al. 1994; Liston 2006; Devoss and Anderson 2007; Hubert et al. 2008).  Sufferers 
classically had to present with at least two of the three characteristic features; chronic 
mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency, 
however, more recently, diagnosis extends to more atypical symptoms, following 
identification of the causal genetic lesion, including; chronic diarrhoea, keratitis, 
autoimmune hepatitis, vitiligo, alopecia, periodic rash with fever, severe constipation 
and enamel hypoplasia (Husebye et al. 2009; Mathis and Benoist 2009).  Unlike the 
majority of autoimmune diseases, APECED is curiously uncomplicated in its genetic 
cause; found in its most common form to be an autosomal-recessive disorder 
(Aaltonen et al. 1994; Nagamine et al. 1997; Heino et al. 2001; Liston et al. 2003; 
Halonen et al. 2004; Liston 2006; Devoss and Anderson 2007; Mathis and Benoist 
2009).  It was therefore possible to map the disease locus to a single chromosomal 
location; human chromosome 21q22.3 which was found to encode a novel 2027 
base pair (bp) gene; the Autoimmune Regulator (AIRE) (Aaltonen et al. 1994; 
Nagamine et al. 1997; Heino et al. 2001; Mathis and Benoist 2009). 
 
1.5. THE MANY DOMAINS OF AIRE: LINKING STRUCTURE TO FUNCTION 
 
The AIRE gene encodes a large 545 amino acid (aa) protein, with a molecular weight 
of approximately 58kDa, whose structure is characteristic of known transcription 
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factors and contains regions well-conserved across vertebrates (Figure 1.2) 
(Aaltonen et al. 1994; Nagamine et al. 1997; Uchida et al. 2004; Saltis et al. 2008; 
Mathis and Benoist 2009).  To date, more than 60 APECED-causing mutations have 
been uncovered across the AIRE gene, distributed throughout the locus and 
therefore present within all structural domains of the protein, highlighting the 
importance of each of these regions for AIRE’s function (Heino et al. 2001; Halonen 
et al. 2004; Mathis and Benoist 2009).  The most common, however, are a cytosine 
to tyrosine transition at position 769bp, and a 13bp deletion in exon 8 (967-979bp), 
with either of these two mutations occurring in approximately 95% of patients 
(Husebye et al. 2009).  The key domains of the AIRE protein, represented in Figure 
1.2 include; a SAND (Sp100, AIRE, NucP41/75, and DEAF-1) domain; found within 
many transcriptional modifiers and with predicted DNA-binding properties; two plant 
homeodomain (PHD)-zinc fingers, essential for AIRE’s function; four LXXLL motifs 
(where L is leucine and X is any amino acid), thought to mediate protein-protein 
interactions; a homogeneously staining region which has recently been identified as 
a caspase recruitment domain (CARD), the site of many mutations in APECED 
patients and a potential impetus for AIRE homo- or hetero-dimerisation, or 
alternatively interactions with other proteins with roles in transcriptional control 
(Gibson et al. 1998; Heino et al. 2001; Kumar et al. 2001; Bottomley et al. 2005; 
Goldrath and Hedrick 2005; Ferguson et al. 2007; Meloni et al. 2008; Mathis and 
Benoist 2009).  The protein also contains two functional nuclear localisation signals 
(NLS); a classical importin-α and –β pathway import signal; and a CRM1-dependent 
Schematic representation of the functional domains of the 545 amino acid (aa) 
human autoimmune regulator (AIRE) protein and their identified roles.  The 
N-terminal caspase recruitment domain (CARD) is believed to be required 
for homo-oligomerisation and for the formation of AIRE nuclear bodies.  This 
domain is known to interact with protein inhibitor of activated STAT-1 (PIAS1); a 
transcriptional co-regulator known to associate with the nuclear matrix (Ilmarinen 
et al. 2008).  AIRE has four LXXLL motifs (aa7-11, aa63-67, aa414-418 and 
aa516-520) which are putative sites for nuclear receptor binding, and a conserved 
bipartite nuclear localisation signal (NLS), present in the N-terminal, has been 
implicated in nuclear import.  AIRE’s unconfirmed DNA-binding properties are 
thought to be co-ordinated through the SAND (Sp100, AIRE, NucP41/75, and 
DEAF-1) domain (Gibson et al. 1998; Kumar et al. 2001).  DNA-dependent 
protein kinase (DNA-PK) is able to phosphorylate AIRE and aids in transcriptional 
transactivation (Liiv et al. 2008).  This interaction occurs via the first of AIRE’s 
two cysteine-rich plant homeodomain (PHD)-zinc finger domains.  PHD1 also 
displays E3-ubiquitin ligase activity in vitro, although this result in controversial 
(Uchida et al. 2004).  The CARD and SAND domain, PHD1 and 2, and the 
C-terminal region are all essential for AIRE’s ability to influence transcription, 
and mutations in any of these domains disrupt this functional property (Heino 
et al. 2001; Halonen et al. 2004).  AIRE has also demonstrated associations 
with; the transcriptional co-activator CREB-binding protein (CBP); with positive 
transcription elongation factor-b (P-TEFb), a key player in transcription elongation; 
and also with the nuclear matrix, although to date the regions required for 
these activities are not well defined (Pitkanen et al. 2000; Akiyoshi et al. 2004; 
Pitkanen et al. 2005; Ferguson et al. 2007; Oven et al. 2007; Peterson et al. 
2008).  Figure adapted from (Su and Anderson 2004; Peterson et al. 2008).
Figure 1.2 - Structure of the Autoimmune Regulator Protein
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export signal, located in the amino terminal region of AIRE (Pitkanen et al. 2001; 
Ilmarinen et al. 2006).  These features give important clues to AIRE’s molecular role, 
however there is still controversy over AIRE’s true function. 
 
The expression of AIRE is detected most prominently within the lymphoid organs, 
primarily localised to the thymic medulla and correlating significantly with the 
promiscuous expression of self-antigens within mTECs (Figure 1.3) (Nagamine et al. 
1997; Heino et al. 1999; Liston et al. 2004; Klamp et al. 2006; Mathis and Benoist 
2009).  The protein has been detected in the nucleus of mTECs, where staining with 
anti-AIRE antibodies reveals a punctate, perinuclear speckled pattern similar to 
promyelocytic leukaemia (PML) nuclear bodies, in which the AIRE homologues 
Sp100, Sp140 and Lysp100 can be found (Bjorses et al. 1999; Heino et al. 1999; 
Pitkanen et al. 2000; Halonen et al. 2001; Pitkanen et al. 2001; Akiyoshi et al. 2004; 
Cavadini et al. 2005; Hubert et al. 2008).  However, from co-immunofluorescence 
staining, it has been shown that AIRE does not co-localise with these PML 
structures, but in fact resides within unique subnuclear structures (Akiyoshi et al. 
2004).  AIRE nuclear bodies are distinct from, but located adjacent to nuclear 
speckles, in which pre-mRNA splicing components, factors required for 3` end RNA 
processing and proteins involved in transcription are found (Su et al. 2008).  The 
formation of AIRE nuclear bodies is dependent upon structurally sound AIRE protein, 
as mutations have demonstrated a block in their formation (Pitkanen et al. 2001; 
Halonen et al. 2004; Ferguson et al. 2007; Peterson et al. 2008; Su et al. 2008).  
These AIRE complexes were shown to be excluded from nucleoli and to have an 
association with the nuclear matrix, thus indicating a possible interaction with 
Diagrammatic representation of the role of autoimmune regulator (AIRE) in 
promiscuous gene expression (PGE) and central tolerance.  AIRE controls the 
expression of a catalogue of self-proteins characteristic of peripheral organs 
termed tissue-restricted antigens (TRA).  Exclusively within medullary thymic 
epithelial cells (mTECs), TRA are then processed and loaded onto cell-surface-
displayed MHC molecules for direct antigen presentation.  The rapid turnover 
rate of mTECs, upon AIRE activation, results in uptake of TRA for indirect antigen 
presentation by thymic dendritic cells (DCs) (Gray et al. 2007).  Developing CD4+ 
or CD8+ single-positive thymocytes migrate through the medulla and interactions 
between self-peptide-MHC complexes and T-cell receptors (TCRs) dictate their 
fate.  TCRs capable of recognising these TRA-MHC within a given affinity / avidity, 
would primarily be removed by clonal deletion, although an alternative suggestion 
is that some potentially auto-reactive T-cells may survive by clonal deviation to 
a more regulatory role (Walker et al. 2003; Anderson et al. 2005; Kuroda et al. 
2005).  Figure adapted from (Mathis and Benoist 2009).
Figure 1.3 - Autoimmune Regulator Protein in the Control of Promiscuous 
Gene Expression and the Induction of Central Tolerance
14
 15
transcriptional machinery (Pitkanen et al. 2001; Devoss and Anderson 2007; Hubert 
et al. 2008).  At a molecular level, the AIRE protein displays characteristics of a 
transcriptional regulator (Pitkanen et al. 2000; Meloni et al. 2008).  It is capable of 
transcriptional transactivation of numerous reporter and endogenous promoters, has 
demonstrated the potential to directly bind DNA and has been shown to co-localise 
with a number of protein partners, resulting in the integration of AIRE into large 
biological complexes greater than 650kDa in vitro (Pitkanen et al. 2000; Halonen et 
al. 2004; Pitkanen et al. 2005; Purohit et al. 2005; Oven et al. 2007; Ruan et al. 2007; 
Liiv et al. 2008; Mathis and Benoist 2009). 
 
Shortly after the identification of the AIRE gene, investigators were eager to generate 
a knockout mouse model, to further study AIRE’s function (Venanzi et al. 2004).  The 
AIRE-knockout mice displayed an autoimmune syndrome, comparable to APECED in 
humans, with auto-antibodies directed against multiple organ systems (Kyewski 
2008).  However, rather than the whole organ being targeted, it was individual and 
highly unique regions within, to which the damage was directed, for example; the 
photoreceptor layer of the retina in the eye; parietal cells of the stomach; and oocytes 
in the ovaries (Anderson et al. 2002).  Through isolation and gene expression 
profiling of mTECs from AIRE-deficient mice, it was revealed that the promiscuous 
expression of TRA genes was significantly depressed, which provided the first real 
clues as to AIRE’s role; in preventing autoimmunity (Figure 1.3) (Su and Anderson 
2004; Venanzi et al. 2004).  Studies into this phenomenon revealed the importance 
of this promiscuous gene expression with regards to autoimmune disease 
susceptibility, however, it wasn’t until more recently that the breakdown of thymic 
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expression of individual self-antigens was demonstrated to be sufficient for the 
development of selective organ-specific autoimmunity (Klein et al. 2000; Derbinski et 
al. 2001; Avichezer et al. 2003; Gotter et al. 2004; DeVoss et al. 2006; Gavanescu et 
al. 2007).  Through the use of AIRE-deficient mice, DeVoss et al (2006) found that 
spontaneous eye-specific autoimmune disease occurred as a direct result of the loss 
of expression of a highly specific eye antigen; interphotoreceptor retinoid-binding 
protein (IRBP), within the thymus, due to the absence of AIRE (DeVoss et al. 2006).  
Following this, Gavanescu et al (2007) reported an analogous result; with an 
absence of the AIRE-regulated stomach antigen mucin 6, triggering gastritis 
(Gavanescu et al. 2007).  Thus AIRE appeared to play an essential role in central 
tolerance, as a transcriptional regulator promoting the expression of TRA within 
mTECs for subsequent direct antigen presentation to developing thymocytes (Figure 
1.3).  However, given the very low numbers of AIRE-positive mTECs, in relation to 
the millions of developing thymocytes, it would seem unlikely that the entire T-cell 
repertoire could be checked for self-reactivity (Kyewski and Derbinski 2004).  Thus, 
the finding that thymocytes spend up to 5 days in the medulla and are highly motile 
may counteract this problem (Kyewski and Derbinski 2004).  Added to this, AIRE-
positive mTECs have demonstrated very high turnover rates, surviving only a few 
days after the induction of AIRE expression, which therefore may also alleviate the 
question of how so few mTECs could process and present such a massive catalogue 
of AIRE-regulated TRA (Gray et al. 2007).  Through rapid death and renewal of the 
mTEC subset, the gamut of TRAs on display to developing T-cells would be 
constantly updated, and could even be maximised through uptake of apoptotic 
mTECs by thymic dendritic cells for indirect presentation of TRA leading to the 
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deletion of self-reactive thymocytes (Figure 1.3) (Gray et al. 2007; Ferguson et al. 
2008).  An alternative mechanism is that AIRE may be involved in the positive 
selection of Treg cells, although this is not believed to be AIRE’s major role as the 
numbers of CD4+CD25+ Treg cells are comparable to wild type in AIRE-deficient mice 
(Walker et al. 2003; Anderson et al. 2005; Kuroda et al. 2005). 
 
Interestingly, AIRE’s role does not seem to be limited to central tolerance 
mechanisms as numerous groups detected AIRE mRNA within a wide range of 
peripheral tissues including kidneys, testis, ovaries, adrenal glands, pancreas and 
liver (Halonen et al. 2001; Adamson et al. 2004).  However it would appear that these 
small quantities of mRNA are not sufficient for translation to occur as 
immunofluorescence and in situ hybridisation revealed peripheral AIRE protein 
restricted to immunologically relevant sites, such as the spleen, lymph nodes and 
bone marrow, although one group, using a novel monoclonal antibody specific for 
murine AIRE, recently demonstrated the presence of AIRE+ cells in the thymic 
medulla only (Heino et al. 1999; Maarit Heino 2000; Halonen et al. 2001; Anderson et 
al. 2002; Adamson et al. 2004; Klamp et al. 2006; Lee et al. 2007).  Peripheral AIRE 
has been predicted to be required for the maintenance of tolerance, for antigen 
presentation and even for T-cell-independent B-cell responses, and indeed, the 
finding that AIRE expression is restricted to cells of the haematopoietic lineage and 
peripheral AIRE+ stromal cells certainly supports these theories (Sillanpaa et al. 
2004; Lee et al. 2007; Gardner et al. 2008; Lindh et al. 2008; Pontynen et al. 2008; 
Mathis and Benoist 2009).  An array of dendritic cell types, macrophages and 
monocytes were found to express AIRE and that loss of this expression disrupted the 
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antigen-presenting capabilities and transcriptional programmes of the cells (Sillanpaa 
et al. 2004; Pontynen et al. 2008).  However, the transcript levels of AIRE observed, 
were always at considerably lower levels than those within mTECs and the protein 
was undetectable by flow cytometry, yet it may be possible that AIRE expression in 
peripheral haematopoietic cells, could have a role to play in antigen presentation, 
particularly under inflammatory conditions (Anderson et al. 2002; Hubert et al. 2008; 
Mathis and Benoist 2009).  More recently, two groups have identified populations of 
lymph node stromal cells analogous to mTECs, able to express AIRE and a limited 
range of TRAs (Lee et al. 2007; Gardner et al. 2008).  Lee et al (2007) showed that 
CD45- cortical lymph node stromal cells which constitutively expressed certain TRAs 
were able to present these self-antigens to naive CD8+ T-cells, resulting in their 
primary activation and subsequent tolerance (Lee et al. 2007).  Gardner et al (2008) 
then went on to describe a separate population of stromal cells also capable of 
deleting auto-reactive T-cells, residing ubiquitously in lymphoid organs including the 
mesenteric lymph nodes, Peyer’s patches and tertiary lymphoid structures, which 
were CD45-MHC II+EpCAM1+ and expressed TRAs, but displayed no co-stimulatory 
molecules (CD80 or CD86) unlike mTECs (Gardner et al. 2008).  It is essential that 
self-tolerance be maintained once T-cells leave the thymus, thus the finding of AIRE 
expression outside the thymus may point to a more secondary role for AIRE-
regulated peripheral tolerance, as a back-up to central tolerance.  This hypothesis is 
strengthened by the finding that the repertoire of TRA generated by AIRE+ stromal 
cells is much more limited than those within mTECs, and that there was little overlap 
between the two expression profiles, meaning that any peripheral self-antigens not 
displayed to the developing thymocytes within the thymus could theoretically be 
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present within the lymph nodes or the spleen, ensuring deletion of any escaped auto-
reactive cells (Lee et al. 2007; Gardner et al. 2008; Kyewski 2008).  In addition, 
transplantation of AIRE-deficient thymi into wild-type recipient mice still results in 
autoimmune manifestations, highlighting the fact that AIRE and TRA expression 
within the periphery is unable to prevent autoimmune attack, although it may still play 
a role (Anderson et al. 2002; Liston et al. 2003; Kuroda et al. 2005). 
 
1.6. AIRE-REGULATED GENES: CLUSTERING ON CHROMOSOMES 
 
This work also illustrated the scope of promiscuously expressed genes under the 
control of AIRE; the fact that AIRE’s target genes extended far beyond the pool of 
autoantigens in APECED (Anderson et al. 2002; Gotter et al. 2004).  It was noted 
that these genes did not have any obvious association in terms of structure or 
function, and even more strikingly, the usual constraints of sex-specific or 
developmental-specific patterns of gene expression appeared to be over-ridden by 
AIRE (Gotter et al. 2004).  The mammary gland casein proteins, normally restricted 
to expression in late-pregnancy, along with the testis-specific antigen sperm-
associated antigen 6 (SPAG6) and the placental hormone placental lactogen (PL), 
showed equal levels of expression in male and female mTECs, which offered a 
potential explanation for the enigma of how tolerance to self-antigens, which only 
arise in adulthood, was brought about during the development of the immune system, 
when these proteins would not be visible to the developing T-cell repertoire (Gotter et 
al. 2004; Derbinski et al. 2005; Johnnidis et al. 2005).  AIRE-regulated genes showed 
a broad diversity, thus, in order to elucidate any common features regarding the 
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localisation of these genes throughout the genome, comprehensive analysis of their 
expression was undertaken, which revealed a global distribution throughout the 
genome, with no significant under- or over-representation of particular chromosomes 
(Figure 1.4) (Gotter et al. 2004; Johnnidis et al. 2005).  Instead, across individual 
chromosomes, a considerable clustering of co-regulated genes was revealed, with 53 
of 200 AIRE-regulated genes analysed occurring alongside a similarly AIRE-
activated neighbour within a region of up to 200kbp, which led to the proposal that 
AIRE could direct gene expression through a broad activity on chromatin 
conformation (Figure 1.4) (Johnnidis et al. 2005).  Gene clustering is a feature with a 
number of evolutionary advantages, including co-ordinated gene expression in single 
cells and sharing of enhancer or locus-control regions, with clustered genes generally 
switched on en masse, a highly efficient process as the transcriptional machinery 
would be able to access and induce the expression of co-expressed genes more 
easily if they were neighbours, than if they were distributed randomly across the 
chromosomes (Caron et al. 2001; Boutanaev et al. 2002; Roy et al. 2002; Gotter et 
al. 2004; Gierman et al. 2007; Soshnikova and Duboule 2009). 
 
For a number of AIRE-regulated clusters, this did in fact appear to be the case 
(Johnnidis et al. 2005).  For example, the two strict TRA salivary proteins-1 and -2, 
found on Mus musculus chromosome 15, are located within 130kbp of each other 
and both are switched on in the presence of AIRE (Johnnidis et al. 2005).  Similarly, 
gephyrin (Gphn), eukaryotic translation initiation factor 2, subunit 1α (Eif2s1) and 
arginase type II (Arg2), clustered on Mus musculus chromosome 12 are also affected 
by AIRE en masse, although instead of an increase in expression, all three genes 
Genomic distribution of gene targets of the Mus musculus autoimmune regulator 
(AIRE).  A, AIRE-regulated genes appear to distribute evenly throughout all 
chromosomes.  The top 200 AIRE-activated genes are represented in red, the top 
200 AIRE-repressed genes are in blue.  B, The impact of AIRE upon expression 
from each cluster can vary; with AIRE targets either being located adjacent to each 
other, or interspersed with AIRE-independent genes.  Certain clusters also show 
divergent regulation, with adjacent loci showing opposing levels of expression in 
the presence of AIRE.  Data taken from (Johnnidis et al. 2005).
Figure 1.4 – Chromosomal Clustering of Genes under the Transcriptional 
Control of the Autoimmune Regulator
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were shown to be negatively regulated by AIRE, suggesting that AIRE’s role as a 
transcriptional regulator is decidedly more complex (Figure 1.4) (Johnnidis et al. 
2005).  Interestingly, however, the impact of AIRE on the control of transcription 
within its target clusters was not a uniform on / off switch as a significant number of 
clusters showed a rather punctate expression profile; with the induction in expression 
of only two or three AIRE-dependent genes, while neighbouring genes in the same 
loci were not induced, or more surprisingly, their expression decreased (Figure 1.4) 
(Johnnidis et al. 2005).  The epidermal differentiation complex on Mus musculus 
chromosome 3, had previously been mapped following studies into the development 
of epidermal tissue, yet this cluster of genes was also found to be expressed in 
mTECs, under the transcriptional control of AIRE, with some loci being repressed 
including; synaptosomal-associated protein 25bp (Snap25bp); S100 calcium binding 
protein (S100) A 13; S100a3; S100a4; and S100a6, and others being activated 
(S100a8) (Johnnidis et al. 2005).  A number of clusters were also identified which 
contained members of the keratin family (Johnnidis et al. 2005).  These proteins have 
been shown to be specific to certain cortical and medullary stromal cell subsets, and 
may therefore be required for the development of the thymic architecture (Klug et al. 
1998).  The revelation that the expression of keratin 4, located on Mus musculus 
chromosome 5, increased in the presence of AIRE and that keratin 18, downstream 
of keratin 4, showed lower transcript levels in the presence of AIRE, may explain the 
differential expression patterns of these structural proteins in the thymus (Johnnidis 
et al. 2005). 
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In their thorough analysis of PGE within different subsets of thymic stromal cells 
(DCs, cTECs and mature and immature mTECs), Derbinski et al (2005) 
demonstrated four distinct pools of TRA; (i) those that show equal levels of 
expression in the TEC lineage; (ii) genes restricted to mTECs; (iii) AIRE-regulated 
genes only expressed in mature mTECs; and (iv) those that are switched on upon 
mTEC maturation, but that are in-dependent of AIRE (Derbinski et al. 2005).  This 
group chose to focus on the casein cluster on Mus musculus chromosome 5 which 
was found to house genes from a number of these different gene categories, with 
casein-β and -κ showing AIRE-independent expression; being up-regulated in mature 
mTECs in both wild-type and AIRE-deficient mice, yet all other genes in the cluster; 
casein-α, -γ and –δ, highly dependent on AIRE in mature mTECs (Figure 1.4) 
(Derbinski et al. 2005).  However, the distribution of these genes is such that AIRE-
independent and AIRE-dependent genes are interspersed along the 1Mbp cluster, 
often lying directly adjacent to each other (Derbinski et al. 2005).  Thus an alternative 
mode for AIRE’s control of promiscuous gene expression may involve two possible 
levels of regulation; a large-scale control of whole gene clusters indicative of 
epigenetic mechanisms, and a more specific targeting of individual genes (Derbinski 
et al. 2005; Johnnidis et al. 2005). 
 
1.7. PROTEIN PARTNERS OF AIRE 
 
The interaction of AIRE with other highly active proteins complements this theory, 
suggesting a role for AIRE as a co-activator in large transcriptional complexes 
(Figure 1.5).  CREB-binding protein (KAT3A/CBP), a common transcriptional co-
A model of autoimmune regulator (AIRE)-containing complexes in the control of 
promiscuous gene expression.  AIRE has been shown to interact with several 
protein partners with defined functions, suggesting a role in AIRE’s transcriptional 
regulation.  DNA-dependent protein kinase (DNA-PK), a protein involved in non-
homologous end joining, may aid in AIRE recruitment to the nucleus through 
tethering to nuclear matrix (Liiv et al. 2008).  DNA-PK is able to phosphorylate 
two sites in AIRE, which enhances AIRE’s transcriptional activity (Liiv et al. 2008). 
Protein inhibitor of activated STAT-1 (PIAS1); an inhibitor of STAT (signal transducer 
and activator of transcription)-mediated cytokine signalling, which functions as a 
transcriptional co-regulator, is also implicated in the recruitment of AIRE to the 
nuclear matrix (Ilmarinen et al. 2008).  CREB-binding protein (KAT3A/CBP), a 
common transcriptional co-activator, co-localises with AIRE in nuclear bodies 
(Pitkanen et al. 2000; Akiyoshi et al. 2004; Pitkanen et al. 2005; Ferguson et al. 
2007).  With intrinsic histone acetyltransferase activity, KAT3A/CBP may facilitate 
AIRE-mediated expression through acetylation (Ac) of histone tail residues.  AIRE 
has been found to bind positive transcription elongation factor-b (P-TEFb), a key 
player in transcription elongation (Oven et al. 2007).  P-TEFb can phosphorylate 
the serine residues of RNA polymerase II (RNA pol II), converting stalled RNA 
pol II to the elongating form, triggering active expression (Oven et al. 2007).  The 
formation of these large nuclear complexes may contribute to AIRE’s control of 
promiscuous gene expression.  Figure adapted from (Peterson et al. 2008).
Figure 1.5 – Autoimmune Regulator Binding Partners
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activator with intrinsic histone acetyltransferase activity for a wide range of 
transcription factors, has been shown to co-localise with AIRE in nuclear bodies and 
together can bring about the activation of a number of genes within cultured cells 
(Pitkanen et al. 2000; Akiyoshi et al. 2004; Pitkanen et al. 2005; Ferguson et al. 
2007).  Protein inhibitor of activated STAT-1 (PIAS1); an inhibitor of STAT (signal 
transducer and activator of transcription)-mediated cytokine signalling, functions as a 
transcriptional co-regulator and is also located in nuclear bodies and known to 
associate with the nuclear matrix (Ilmarinen et al. 2008).  However, AIRE nuclear 
bodies do not co-localise but are instead found neighbouring PIAS1, indicating that 
the binding of AIRE and PIAS1 may be through additional nuclear matrix components 
(Ilmarinen et al. 2008).  Another partner of AIRE; DNA-dependent protein kinase 
(DNA-PK) is a protein shown to be involved in non-homologous end joining and also 
to be linked to nuclear matrix (Liiv et al. 2008).  This protein has demonstrated a key 
role in AIRE’s function as it phosphorylates two sites in the AIRE protein, mutation of 
which has a negative impact on AIRE’s transcriptional activity (Liiv et al. 2008).  In 
addition, AIRE has been found to bind positive transcription elongation factor-b (P-
TEFb), a key player in transcription elongation, resulting in recruitment to RNA 
polymerase II (RNA pol II) found at the promoters of AIRE-target genes (Oven et al. 
2007; Peterson et al. 2008).  Thus it is possible that AIRE, along with its many 
protein partners may control PGE via an influence on the organisation of DNA 
indirectly; recruiting members of a transcriptional regulation complex to AIRE-
dependent gene clusters scattered throughout the genome.  Through interactions 
with the nuclear matrix, AIRE may then be able to recruit factors required for 
 26
transcriptional elongation, thus resulting in the induction of PGE (Peterson et al. 
2008). 
 
1.8. EPIGENETICS AND THE CONTROL OF GENE EXPRESSION 
 
Transcriptional regulators, including AIRE, with influence over multiple gene 
expression programmes, are all faced with a number of complexities.  Once 
transported through the nuclear envelope, these proteins encounter the initial 
problem of locating their target genes.  The nucleus is a highly heterogeneous 
structure, consisting of many sub-compartments and components, with the DNA 
molecule making up only approximately 6% of the total nuclear volume, and of this 
only 1-2% represents functional genes in humans (Lander et al. 2001).  The DNA 
itself is highly dynamic and is divided up into large functional units called 
chromosomes, the distribution of which is far from random within the nucleus, with 
particular chromosomes localising to preferred sites, referred to as chromosome 
territories, which correlate with gene activity (Kurz et al. 1996; Mahy et al. 2002; 
Parada and Misteli 2002; Simonis et al. 2006; Dostie et al. 2007; van Berkum and 
Dekker 2009).  However, the DNA within these territories is not a static structure as 
the spatial distribution of certain genes with respect to their chromosome territory has 
been shown to correlate with their activity (Kurz et al. 1996; Mahy et al. 2002; Fraser 
and Bickmore 2007; Sexton et al. 2007).  In some cases their position ensures 
maximal expression and alternatively it can result in repression (Gierman et al. 2007; 
Sexton et al. 2007). 
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In mammalian nuclei, active transcription was found to occur at meta-stable foci, 
distributed throughout the nucleus and containing high concentrations of RNA pol II, 
called transcription factories (Jackson et al. 1993; Wansink et al. 1993; Iborra et al. 
1996; Pombo et al. 1999; Osborne et al. 2004).  In contrast, silenced genes mapped 
to discrete and more dynamic nuclear sub-compartments known as Polycomb bodies 
due to the presence of Polycomb group proteins (PcG); originally shown to be 
essential for switching off the developmental homeobox (Hox) genes in Drosophila 
melanogaster (Saurin et al. 1998; Boyer et al. 2006; Grimaud et al. 2006; Lee et al. 
2006; Sexton et al. 2007).  The number of both PcG bodies and transcription 
factories within a single cell is limiting and hence silenced and active genes 
respectively are thought to share these sites, allowing co-ordinated control of multiple 
genes (Osborne et al. 2004; Schwartz et al. 2006; Osborne et al. 2007; Sexton et al. 
2007).  These transcriptions factories may in fact aid transcriptional regulators such 
as AIRE in not only locating and inducing expression of target genes, but also in co-
ordinating the expression of multiple genes, distributed throughout the genome 
across multiple chromosomes, as it has been revealed that not only genes separated 
by tens of Mbps on the same chromosome, but also those located on different 
chromosomes can associate and share these sites (Osborne et al. 2004; Osborne et 
al. 2007; Sexton et al. 2007). 
 
However, once the initial trial of locating individual target genes from the vast network 
of DNA has been overcome, regulatory proteins and transcription factors will then be 
confronted with the next challenge; gaining access to their recognition sequence, 
since all DNA in the nucleus is packaged into chromatin; a complex of proteins and 
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DNA.  It was initially believed that these proteins, referred to as histones, around 
which the DNA is tightly bound, acted as a simple, inert scaffold, there to aid in the 
compaction of DNA, however it was found that histones are subject to a plethora of 
modifications that correlated with gene activity.  This led to the idea that histones are 
dynamic players in essential DNA-based processes including DNA replication, repair, 
recombination and transcription.  In order to initiate gene expression, transcriptional 
regulators, including AIRE, will need to interact either directly or indirectly with their 
specific DNA binding sites.  However, most of these sequences will be buried inside 
the compact chromatin and therefore activation of a gene requires selective 
disruption of the folded structures and exposure of naked DNA. 
 
The principal packaging element of DNA is the nucleosome; a disc-shaped octamer 
containing two copies of each histone H2A, H2B, H3 and H4, which form four histone 
fold heterodimers of H3-H4 and H2A-H2B, around which 147bp of DNA are wrapped 
1.67 times and stabilised by linker histone H1 (Figure 1.6) (Davie 1997; Luger et al. 
1997; Barski et al. 2007; Turner 2007; Li and Shogren-Knaak 2008; Probst et al. 
2009).  Nucleosomes tend to position themselves on the DNA at fixed intervals, a 
process known as phasing, with short stretches of linker DNA (typically 30-60bp) 
connecting adjacent nucleosomes, the length of which can differ considerably 
depending on the organism and the compaction state of the DNA (Tremethick 2007; 
Bassett et al. 2009; Jiang and Pugh 2009).  The repeating nucleosomal ‘beads on a 
string’ array is however the primary structure of chromatin, which can further 
assemble into higher-order secondary and even tertiary structures of increasing 
A, The basic building block of chromatin is the nucleosome; a histone octamer 
comprising two H2A-H2B and two H3-H4 heterodimers, around which 147 base 
pairs (bp) of double-stranded DNA (dsDNA) are wrapped 1.67 times and stabilised 
by linker histone H1 (inset) (Luger et al. 1997).  Each histone is composed of a 
globular domain and amino- (NH2) and carboxyl- (COOH) terminal tails which 
are all subject to multiple post-translational modifications.  B, Compaction of 
the 10nm nucleosomal array generates a two-start double helical 30nm fibre, 
which is then looped and further compacted into heterochromatic higher order 
structures (Tremethick 2007).  These eventually form the most compact structure 
of chromatin; the mitotic chromosomes.  Figure adapted from (Schones and Zhao 
2008; Probst et al. 2009).




complexity, the extreme being condensed metaphase chromosomes (Figure 1.6) 
(Sterner and Berger 2000). 
 
In non-replicating cells, generally chromatin is compartmentalised into defined 
domains, distributed throughout the nuclear environment in more condensed regions 
(heterochromatin) and more open or decondensed regions (euchromatin) (Figure 
1.6).  Euchromatic regions of chromosomes are generally more flexible and open, 
due to irregular spacing of nucleosomes (Henikoff 2008; Schones et al. 2008; Jiang 
and Pugh 2009).  This therefore increases the accessibility for transcriptional 
regulators and DNA repair and replication complexes, meaning genes in euchromatic 
areas are generally considered active, and that these stretches of DNA are replicated 
early in S-phase (Kouzarides 2007).  In contrast, heterochromatin has few genes and 
is rich in repeating units of certain nucleotide bases.  It is frequently transcriptionally 
silent and replicates late in S-phase as regularly spaced nucleosomes decrease the 
accessibility of the DNA (Richards and Elgin 2002).  It is therefore the nucleosome 
that shapes the DNA molecule, from the atomic level; bending the DNA strand 
around the histone core, through to the large-scale influence on whole genes; 
compacting the DNA into higher-order helices (Luger et al. 1997). 
 
1.9. STRUCTURE OF THE CORE HISTONE PROTEINS 
 
Core histone proteins are one of the most highly conserved amongst eukaryotes 
(Felsenfeld and Groudine 2003).  From the determination of a high resolution crystal 
structure in 1997, Luger et al revealed in detail the numerous histone-DNA and 
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histone-histone interactions within the nucleosome (Luger et al. 1997).  Individual 
histones are composed of a structural α-helical globular domain, forming the scaffold 
for the DNA, however, each histone also possesses highly basic, flexible amino 
(NH2-) and carboxyl (COOH-) terminal tail sequences which make up approximately 
28% of their mass (Luger et al. 1997).  These histone tails contribute significantly to 
the structure and function of the nucleosome as they pass through the gyres of DNA 
into the nuclear space (Luger et al. 1997).  In particular, amino acids 16-25 of the H4 
tail interact with the exposed face of the H2A-H2B dimer of the adjacent nucleosome 
(Luger et al. 1997).  The histone tails, along with the globular core domains, are 
subject to a vast array of covalent and non-covalent post-translational modifications 
including; acetylation of lysine residues; methylation of lysines and arginines; 
phosphorylation of serines and threonines; ubiquitylation of lysines; sumoylation of 
lysines; and ADP ribosylation of glutamic acid residues, which can all influence the 
way in which the underlying DNA is controlled (Santos-Rosa et al. 2002; Kouzarides 
2007). 
 
Research into the vast range of post-translational histone modifications highlighted 
how these marks impact upon the identity of each cell in a variety of ways.  This 
diversity of modifications, coupled with the finding that several correlated with the 
expression level of the corresponding genes, indicated an enormous potential for 
these histone modifications to act as gateways, regulating access to DNA through 
complex combinations of post-translational codes, and it is for this reason that much 
work has focused on mapping of these marks, with the hope to unveil their specific 
roles in regulation of gene expression and chromatin structure. 
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1.10. POST-TRANSLATIONAL HISTONE MODIFICATIONS 
 
The first clues into a role for post-translational modification of histone side chains 
came in 1964, when Allfrey and Mirsky noted that when histones were acetylated, the 
rate of RNA synthesis increased, however, as investigation into the replication and 
transcription of DNA then took centre stage, it was not until much later that the key 
link between histone modifications and control of transcription was again brought to 
the forefront (Allfrey et al. 1964; Allfrey 1966; Fuchs et al. 2009).  Two significant 
reports; the finding that a human homologue of yeast KAT2/Gcn5 (general control 
nonderepressible 5), a well-characterised enzyme known to be involved in 
transcriptional activation, was able to acetylate histones directly; and the discovery of 
a human protein capable of removing acetylation groups from histones, linking this 
activity to transcriptional repression, provided the first real biological interpretation for 
Allfrey and Mirsky’s observations in the 1960’s (Brownell et al. 1996; Taunton et al. 
1996; Nagy and Tora 2007; Fuchs et al. 2009).  These works kick-started an 
extensive body of research, resulting in the identification of numerous post-
translational modifications occurring at specific residues both along the histone tails 
and within the globular cores (Figure 1.7), the majority of which have been found to 
exert considerable influence over the control of DNA-based processes.  Since the 
advancement of antibodies specific to individual histone marks, techniques which 
capture a snapshot of chromatin have enabled the study of the levels of these 
modifications across specific gene regions.  Chromatin immunoprecipitation (ChIP); a 
technique used to analyse the genomic location of chromatin-associated proteins or 
modified histones, has been combined with DNA microarrays (ChIP-chip), SAGE 
The four histone proteins, H2A, H2B, H3 and H4, all contain a structural globular 
core domain and flexible N- and C-terminal tail regions, which protrude through 
the gyres of DNA on the surface of the nucleosome.  A highly diverse array of 
covalent post-translational histone modifications can be deposited on specific, 
conserved residues across all histone domains.  These modifications include 
acetylation (Ac) of lysine residues, methylation (Me) of lysines and arginines and 
phosphorylation (P) of serines and threonines, ubiquitylation (Ub) of lysines and 
glutamic acid residues, along with sumoylation of lysines and ADP ribosylation 
of glutamic acid residues (not displayed).  The positions of a range of histone 
modifications are indicated across the flexible tails and globular cores of all four 
histones (Zhang and Reinberg 2001; Kouzarides 2007).  Figure adapted from 
(Cosgrove 2007).




(ChIP-SAGE), and more recently with massively parallel sequencing (ChIP-Seq), 
thus allowing the profiling of multiple global histone modifications (O'Neill and Turner 
2003; Kouzarides 2007; Schones and Zhao 2008).  The results are often varied, 
highlighting their dynamic nature and non-uniform distribution, however, certain key 
commonalities have arisen, particularly with regards to acetylation and methylation, 
the two most extensively studied modifications (Kouzarides 2007). 
 
1.11. ACETYLATION AND DEACETYLATION OF HISTONES 
 
Histone acetylation is one of the most prevalent post-translational histone 
modifications, yet it is restricted to conserved lysine (K) residues across the core 
histones (Figure 1.7).  The addition of an acetyl moiety to the ε-amino group of lysine 
from the coenzyme acetyl-CoA has a significant effect upon the amino acid chemical 
properties, neutralising the basic charge and generating ε-N-acetyllysine (Fuchs et al. 
2009).  This has been predicted to affect the structure of the nucleosome and its 
interaction with the DNA, as unmodified, positively-charged lysines bind and 
therefore stabilise negatively-charged DNA.  Disruption of the positive charge may 
directly influence the compaction of chromatin fibres through alterations to the way in 
which the DNA molecule is wrapped around the nucleosome core, making the DNA 
more accessible to ATP-dependent nucleosome remodelling factors and DNA-
binding proteins involved in transcription, DNA repair and replication (Krajewski and 
Becker 1998; Akhtar and Becker 2000; Sterner and Berger 2000; Carrozza et al. 
2003; Nagy and Tora 2007; Bassett et al. 2009).  Acetylated lysines themselves can 
also facilitate this process as many remodelling factors possess bromodomains, 
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which recognise and bind to this modification (Fuchs et al. 2009).  In addition, the 
more recent discovery that the core histone globular domains are also subject to an 
array of modifications, supports these theories.  Several of these modified residues 
are positioned on the lateral surface of the nucleosome and therefore able to disturb 
histone-DNA interactions [reviewed in Cosgrove (2007)].  One such example involves 
acetylation of lysine 56, a residue found in the globular domain of histone H3 
(H3K56ac).  As one of the key positively-charged amino acids electrostatically bound 
to the DNA, mutation of this residue to prevent acetylation results in decreased gene 
accessibility through a reduction in nucleosome mobility (Masumoto et al. 2005; 
Chen et al. 2008).  Nucleosome-nucleosome contacts are also affected greatly by 
acetylation.  Specifically, H4K16ac has been shown to impact directly on the 
formation of higher-order structures, through the disruption of the interaction between 
this residue with the acidic patch of the H2A-H2B dimer on the adjacent nucleosome 
(Luger et al. 1997; Shogren-Knaak et al. 2006).  In this regard, acetylation is 
generally considered a mark of open, active chromatin domains and in line with this, 
actively-transcribed genes are typically enriched within promoter regions and at the 
5`end of their coding regions with high levels of acetylation (Kouzarides 2007).  
However, it would appear that this cannot be explained through a bulk acetylation of 
the histone proteins, but instead by acetylation of specific lysine residues, which, on 
the N-terminal tail of H4 for example, have been shown to be acetylated preferentially 
in a defined order, with H4K16 being the first to be modified, followed by K12, K8 and 
finally K5 (Turner and Fellows 1989; Turner et al. 1989).  In a study by Roh et al, 
whole-genome mapping of histone tail modifications H3K9ac and H3K14ac in human 
T-cells revealed more than 46,000 sites across the genome which carried these 
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marks (Roh et al. 2005).  These ‘acetylation islands’ were found to correlate with 
transcriptional start sites (TSS) of active genes, CpG islands and functional 
regulatory elements, particularly within gene-rich regions and interestingly, upon T-
cell activation and TCR signalling, 4045 additional acetylation loci were induced, 
reflecting the increase in gene activation (Roh et al. 2005).  However, acetylation of 
H4K16, K12, K8 and K5 within euchromatic genes in a lymphoblastoid cell line, has 
also been shown to bear no influence on actual levels of expression, but instead 
defines chromatin states; distinguishing enriched euchromatic regions from 
depleted heterochromatin (O'Neill and Turner 1995; Johnson et al. 1998). 
 
Histone acetylation is a highly dynamic process, with a very rapid turnover rate and a 
half-life of just minutes, therefore its influence on the DNA is transient (de Ruijter et 
al. 2003; Liu et al. 2005).  The overall levels of acetylation across chromatin are 
determined by histone acetyltransferases (HATs), which catalyse the addition of 
acetyl moieties to lysine residues and histone deacetylase (HDAC) enzymes, which 
counteract this by removing the acetyl group.  Many HATs and HDACs have been 
identified to date, the majority of which have demonstrated the ability to act on 
multiple lysine residues across all four histones, and also on non-histone proteins 
(Nagy and Tora 2007; Haberland et al. 2009).  HATs can be classified into five 
families, which include; the GCN5-related N-acetyltransferases (GNATs); p300/CBP 
HATs; the MYST (MOZ, Ybf2/Sas3, Sas2 and Tip60)-related HATs; the general 
transcription factor HATs; and the nuclear hormone-related HATs (Table 1.1) (Nagy 
and Tora 2007).  Members of each of these groups have demonstrated numerous 
activities, however, the common theme that arises is of a clear and direct connection 
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Table 1.1 – Summary of Common Histone Acetyltransferase Enzymes 
HAT ORGANISM HISTONE SPECIFICITY 
GNAT SUPERFAMILY 
KAT1/HAT1 Various (yeast to humans) H4 (K5, K12) 
KAT2/GCN5 Various (yeast to humans) H3 (K9, K14, K18) / H2B 
KAT2B/PCAF Humans / Mice H3 (K9, K14, K18) / H2B 
KAT9/ELP3 Various (yeast to humans) H3 
KAT10/Hap2 Yeast H3 (K14) / H4 
P300/CBP HATS 
KAT3A/CBP Various (multicellular) H2A / H2B / H3 / H4 
KAT3B/p300 Various (multicellular) H2A / H2B / H3 / H4 
MYST-RELATED HATS 
KAT5/TIP60 Various (yeast to humans) H2A (yeast K4, K7; chicken K5, K9, K13, K15) / H4 (K5, K8, K12, K16) 
KAT6/Sas3 Yeast H3 (K14, K23) 
KAT6A/MOZ Various (yeast to humans) H3 (K14) 
KAT6B/MORF Humans H3 (K14) 
KAT7/HBO1 Various (yeast to humans) H4 (K5, K8, K12) > H3 
KAT8/HMOF Various (yeast to humans) H4 (K16) 
GENERAL TRANSCRIPTION FACTOR HATS 
KAT4/TAF Various (yeast to humans) H3 > H4 
KAT12/TFIIIC90 Humans H3 (K9, K14, K18) 
NUCLEAR HORMONE-RELATED HATS 
KAT13A/SRC1 Humans / Mice H3 / H4 
KAT13B/ACTR Humans / Mice H3 / H4 
KAT13C/P160 Humans / Mice H3 / H4 
 
 
A selection of common histone acetyltransferases (HATs), divided into their 
appropriate family, the typical organisms in which they are found, and the 
specific histone residues upon which they act.  Novel nomenclature is displayed 
prior to original names.  Devised from (Sterner and Berger 2000; Allis et al. 
2007; Kouzarides 2007). 
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between acetylation and transcriptional activation (Sterner and Berger 2000).  
Currently, 11 classical HDACs have been identified in humans (Table 1.2), which can 
be separated into four major families according to sequence similarity; class I HDACs 
(HDAC1, 2, 3, 8); class IIa (HDAC4, 5, 7, 9); class IIb (HDAC6, 10); and class IV 
(HDAC11) (Haberland et al. 2009).  In addition, a further group of non-classical NAD-
dependent HDACs, the sirtuins, are often referred to as class III HDACs (Gallinari et 
al. 2007; Haberland et al. 2009).  Consistent with the role of acetylation in 
transcriptional activation, deacetylation, particularly at gene promoter regions, is 
generally associated with gene silencing, nucleosome stabilisation and diminished 
nucleosome-remodelling (Fuchs et al. 2009; Haberland et al. 2009). 
 
1.12. HISTONE METHYLATION AND DEMETHYLATION 
 
In contrast to acetylation, methylation of histones is significantly more intricate.  
Firstly, methylation can occur both on conserved lysine residues, and arginines (R) 
across all four histone proteins, and secondly, as an added layer of complexity, up to 
three methyl moieties can be applied to the lysine ε-amino group (mono-, di- and tri-
methylation), while arginines can be mono- or di-methylated, with the latter being 
either symmetric or asymmetric in its distribution (Zhang and Reinberg 2001; Fuchs 
et al. 2009).  Each degree of methylation can potentially represent a different 
biological outcome, depending on the specific lysine or arginine methylated, and its 
location in a gene (Zhang and Reinberg 2001; Fuchs et al. 2009).  The role histone 
methylation plays in the control of DNA-based processes is extensive, however, this 
is presumably orchestrated solely through recruitment of additional regulatory factors, 
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Table 1.2 – Summary of Known Histone Deacetylase Enzymes 
HDAC LOCALISATION TISSUE DISTRIBUTION 
CLASS I 
HDAC1 Nucleus Ubiquitous 
HDAC2 Nucleus Ubiquitous 
HDAC3 Nucleus Ubiquitous 
HDAC8 Nucleus Ubiquitous?  Smooth muscle differentiation 
CLASS IIA 
HDAC4 Nucleus / Cytoplasm Heart / Skeletal Muscle / Brain 
HDAC5 Nucleus / Cytoplasm Heart / Skeletal Muscle / Brain 
HDAC7 Nucleus / Cytoplasm Heart / Placenta / Pancreas / Skeletal Muscle 
HDAC9 Nucleus / Cytoplasm Heart / Skeletal Muscle / Brain 
CLASS IIB 
HDAC6 Mostly cytoplasm Heart / Liver / Kidney /Pancreas 
HDAC10 Mostly cytoplasm Liver / Spleen /Kidney 
CLASS IV 
HDAC11 Nucleus / Cytoplasm Brain / Heart / Smooth Muscle / Kidney 
SIRTUINS (CLASS III) 
SIRT1 Nucleus ? H4K16 specific Brain / Smooth Muscle / Kidney / Heart 
SIRT2 Cytoplasm ? H4K16 specific Brain / Smooth Muscle / Kidney / Heart / Liver 
SIRT3 Mitochondria Ubiquitous 
SIRT5 Mitochondria Ubiquitous 
 
 
A representation of all histone deacetylase (HDAC) enzymes known to date, 
which can act upon multiple histone residues.  HDACs are divided into their 
appropriate class, and their typical localisation within cells and tissue 
distribution are displayed.  Devised from (Michishita et al. 2005; Haigis and 
Guarente 2006; Dokmanovic et al. 2007). 
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since methylation of lysines and arginines does not affect the charge of the residue 
and thus has no direct impact on histone-histone or histone-DNA binding (Fuchs et 
al. 2009).  Yet histone methylation is still believed to play a role in the formation and 
maintenance of higher-order chromatin structures, with a plethora of methylation 
marks being reported as essential for establishment of euchromatic or 
heterochromatic regions of the genome, for example the requirement of tri-
methylation (me3) of H3K9 in the formation of silent heterochromatin (Noma et al. 
2001; Barski et al. 2007; Kouzarides 2007). 
 
Histone methyltransferases (HMTs) are enzymes responsible for the addition of 
methyl groups to either lysine or arginine residues.  Methylation of arginines is 
catalysed by a family of protein arginine methyltransferases (PRMTs), of which at 
least 11 are known to exist in mammals, some of which show great specificity, 
however, only relatively little is known about this modification (Smith and Denu 2009; 
Wolf 2009).  PRMTs can be allocated into two main groups; those which generate 
asymmetric di-methylation (type I PRMTs), and those which bring about symmetric 
di-methylation (type II PRMTs) (Table 1.3) (Zhang and Reinberg 2001; Smith and 
Denu 2009; Wolf 2009).  In contrast, histone lysine methylation is very well 
characterised with regards to both its roles in regulating DNA-based processes and 
the enzymes responsible for addition and removal of this moiety.  Lysine HMTs can 
be divided into two main groups; those containing a SET domain; and those with a 
DOT1 domain, which frequently show exclusivity; preferentially methylating a limited 
number, or often only one specific lysine residue, to only one particular degree 
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Table 1.3 – Summary of Known Protein Arginine Methyltransferase 
Enzymes 
PRMT LOCALISATION HISTONE SPECIFICITY 
TYPE I 
PRMT1 Nucleus / Cytoplasm H4 (R3) 
PRMT4 Nucleus H3 (R2, R17, R26) / H4 (R3) 
PRMT6 Nucleus H3 
PRMT8 Plasma Membrane H4 
TYPE II 
PRMT5 Cytoplasm H2A / H3 (R8) / H4 (R3) 
PRMT7 Nucleus / Cytoplasm H2A / H4 
PRMT9 Nucleus / Cytoplasm H2A / H4 
 
 
A representation of all protein arginine methyltransferase (PRMT) enzymes 
known to date, divided into their appropriate types, their typical localisation 
within cells and the specific histone residues upon which they act.  Devised 
from (Pahlich et al. 2006; Wolf 2009). 
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(mono-, di- or tri-), and also within a restricted genomic location (Table 1.4) (Thomas 
et al. 2008; Smith and Denu 2009). 
 
Originally it was believed that methylation represented a more stable, permanent 
histone modification, as the global turnover rate of this mark was low in comparison 
to acetylation (Ng et al. 2009).  However, the relatively recent discovery of families of 
enzymes capable of removing methyl groups from histones has since shown that this 
mark is equally as dynamic.  These fall into a number of different groups, of which 
there are two major classes; those typified by lysine specific demethylase (LSD1, 
recently re-named KDM1), which can only remove mono- and di-methyl marks; and a 
family of Jumonji-C (JmjC) domain-containing histone demethylases (JHDMs), which 
can de-methylate all three levels of histone lysine methylation (Table 1.5) (Cloos et 
al. 2008; Ng et al. 2009). 
 
1.13. THE ROLE OF POST-TRANSLATIONAL HISTONE MODIFICATIONS IN TRANSCRIPTIONAL 
REGULATION 
 
Even in its most uncondensed form, nucleosomal DNA is essentially repressive for 
transcription, hence nucleosomes must be moved and it has been shown that 
histones are able to cis-translocate or slide along the DNA fragment considerable 
distances and also trans-displace, being entirely removed from the DNA (Pennings et 
al. 1991; Whitehouse et al. 1999).  This process requires considerable energy input 
as the DNA molecule is tightly bound to the core histone proteins, with more than 120 
direct atomic interactions (Pennings et al. 1991; Whitehouse et al. 1999).  It is 
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Table 1.4 – Summary of Common Histone Lysine Methyltransferase 
Enzymes 
KMT ORGANISM HISTONE SPECIFICITY 
SET DOMAIN KMTS 
KMT1/Su(Var)3–9 Flies / Yeast H3K9 
KMT1A/SUV39H1 Humans / Mice H3 (K9me3) 
KMT1B/SUV39H1 Humans / Mice H3 (K9me3) 
KMT1C/G9a Humans H3 (K9me1, me2) 
KMT1E/ESET/SETDB1 Humans H3 (K9me3) 
KMT2/Set1/COMPASS Yeast H3 (K4me1, me2, me3) 
KMT2A/MLL1/Trx Humans / Flies H3 (K4me1, me2, me3) 
KMT2B/MLL2/Trx Humans / Flies H3 (K4me1, me2, me3) 
KMT2C/MLL3/Trr Humans / Flies H3 (K4me1, me2, me3) 
KMT2D/MLL4/Trr Humans / Flies H3 (K4me1, me2, me3) 
KMT2E/MLL5 Humans H3 (K4me1, me2, me3) 
KMT2F/hSET1A Humans H3 (K4me1, me2, me3) 
KMT2G/hSET1B Humans H3 (K4me1, me2, me3) 
KMT3A/SET2 Humans H3 (K36) 
KMT5/Set9 Yeast H4 (K20) 
KMT6/Ezh2/E(Z) Humans / Flies H3 (K27) 
DOT DOMAIN KMTS 
KMT4/DOT1L/Dot1 Humans / Yeast H3 (K79) 
 
 
A selection of common histone lysine methyltransferases (KMTs), divided into 
their appropriate groups, the typical organisms in which they are found, and the 
specific histone residues upon which they act.  Novel nomenclature is displayed 
prior to original names.  Devised from (Zhang and Reinberg 2001; Allis et al. 
2007; Shilatifard 2008; Thomas et al. 2008; Smith and Denu 2009). 
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Table 1.5 – Summary of Common Histone Demethylase Enzymes 
HDM ORGANISM HISTONE SPECIFICITY 
LSD1 KDMS 
KDM1/LSD1/BHC110 Various (yeast to humans) H3 (K4me1, me2, K9me1, me2) 
JHDM1 KDMS 
KDM2/Jhd1 Yeast H3 (K36me1, me2) 
KDM2A/JHDM1a/FBXL11 Humans H3 (K36me1, me2) 
JHDM2 KDMS 
KDM3A/JHDM2a Humans H3 (K9me1, me2) 
KDM3B/JHDM2b Humans H3 (K9) 
JMJD2 KDMS 
KDM4/Rph1 Yeast H3 (K9, K36me2, me3) 
KDM4C/JMJD2C/GASC1 Humans H3 (K9, K36me2, me3) 
KDM4D/JMJD2D Humans H3 (K9me2, me3) 
JARID1 KDMS 
KDM5/Lid/Jhd2/Jmj2 Flies / Yeast H3 (K4me2, me3) 
KDM5A/JARID1A/RBP2 Humans H3 (K4me2, me3) 
KDM5B/JARID1B/PLU-1 Humans H3 (K4me1, me2, me3) 
KDM5C/JARID1C/SMCX Humans H3 (K4me2, me3) 
KDM5D/JARID1D/SMCY Humans H3 (K4me2, me3) 
UTX/JMJD3 KDMs 
KDM6A/UTX Humans H3 (K27me2, me3) 
KDM6B/JMJD3 Humans H3 (K27me2, me3) 
ARGININE-SPECIFIC HDM 
JMJD6 Multicellular H3 (R2me2) / H4 (R3me2) 
 
 
A selection of common histone lysine demethylases (KDMs) and the recently 
discovered arginine-specific methyltransferase.  Demethylases are divided into 
their appropriate groups, and displayed are the typical organisms in which they 
are found, and the specific histone residues upon which they act.  Novel 
nomenclature is displayed prior to original names.  Devised from (Allis et al. 
2007; Chang et al. 2007; Cloos et al. 2008; Smith and Denu 2009; Wolf 2009). 
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therefore catalysed by a group of molecules containing intrinsic ATP-ase activity; 
ATP-dependent nucleosome remodelling complexes, which work in combination with 
the modification of histone proteins to allow displacement of the nucleosome and 
exposure of the raw DNA (Pennings et al. 1991; Whitehouse et al. 1999; Soutoglou 
and Talianidis 2002).  Through the development of genome-wide nucleosomal maps, 
coupled with DNA sequencing and microarray hybridisation, the position of every 
nucleosome across a genome could be determined (Barski et al. 2007; Mavrich et al. 
2008; Schones et al. 2008; Jiang and Pugh 2009).  These works showed that the 
majority of genes conformed to a common, stable theme of organisation, with long 
stretches of raw DNA at the 3` and 5` ends of genes, referred to as the nucleosome 
free region (NFR) (Barski et al. 2007; Mavrich et al. 2008; Schones et al. 2008; Jiang 
and Pugh 2009).  The discovery of these NFR challenged the view that the promoter 
regions of silenced genes would be occluded by nucleosomes, thus preventing 
random transcription as RNA pol II is unable to bind nucleosomal DNA (Bondarenko 
et al. 2006; Jiang and Pugh 2009).  However, the finding that these open promoter 
states occur even in genes with very low transcription rates, which could essentially 
be classed as turned off, suggests that these NFR are not sufficient to induce 
transcription (Jiang and Pugh 2009). 
 
The regulation of euchromatin gene expression therefore requires the recruitment of 
DNA-bound transcription factors to gene promoters.  The array of specific post-
translational histone modifications of core histones, present on the nucleosome 
surface, can serve as recruitment signals for protein effectors able to exert functional 
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effects.  This in turn brings about alterations to the patterns of modifications across 
the locus and ultimately leads to either transcriptional activation or repression. 
 
1.14. MARKS OF GENE ACTIVATION 
 
Many histone modifications have been implicated in the activation of gene expression 
programmes, due to their presence within transcribed loci (Figure 1.8).  In general, 
acetylation of lysine residues is considered a mark of active expression, and many 
transcriptional regulators and transcription factors such as KAT3A/CBP and the basal 
transcription factor TFIID, possess intrinsic HAT activity (Sterner and Berger 2000).  
However, many HATs have been shown to associate preferentially to defined gene 
regions, leading to the deposition of specific acetylation marks in different locations 
(Wang et al. 2008).  For example, the area surrounding transcriptional start sites 
(TSS) has been shown to be enriched for H2AK9ac, H2BK5ac, H3K9ac, H3K36ac 
and H4K91ac, whereas the promoter and coding regions demonstrated H2BK20ac, 
H3K4ac, H4K8ac and H4K16ac, among others (Wang et al. 2008). 
 
In contrast, histone methylation is not as straightforward, with certain methyl marks 
having the potential to influence gene expression in opposing ways, dependent on 
different conditions.  One of the most extensively defined activating modification is 
H3K4me3, which has been shown to be present at the 5` end of open reading frames 
(ORFs) along with the serine 5 phosphorylated, initiating form of RNA pol II, as genes 
are induced, it is known to promote transcription elongation, and also plays a role in 
the regulation of RNA processing, which may be due in part to the recruitment of 





protein effectors known to positively influence transcription (Santos-Rosa et al. 2002; 
Bernstein et al. 2005; Bernstein et al. 2006; Berger 2007; Sims et al. 2007; Shilatifard 
2008).  Proteins can interact with the H3K4me3 mark through the presence of one of 
a number of binding modules which include; PHD domains, like those found in AIRE; 
WD40 domains; and proteins with Royal family domains (chromo-, Tudor- and MBT-
domains) (Berger 2007).  For example, a PHD finger of BPTF (bromodomain and 
PHD finger transcription factor); a subunit within the ATP-dependent chromatin 
remodelling complex NURF, has been shown to bind H3K4me3, leading to targeting 
of the locus for activation (Wysocka et al. 2006).  A direct interaction has also been 
demonstrated between H3K4me3 and the PHD-domain of TAFIII, a subunit of TFIID, 
which enhances gene expression (Vermeulen et al. 2007; van Ingen et al. 2008).  
Within the gene body, active loci are typically marked with H2BK5me1, H3K4me1 
and me2, H3K9me1, H3K27me1 and H4K20me1, levels of which decrease the 
further you move from the TSS (Barski et al. 2007; Li et al. 2007; Schones and Zhao 
2008; Wang et al. 2008).  In addition, the coding regions of active genes also show 
H3K36me3, however, its distribution contrasts with the previous modifications; 
peaking instead at the 3` end (Figure 1.8) (Carrozza et al. 2005; Joshi and Struhl 
2005; Keogh et al. 2005).  This is thought to be due to an interaction with the 
elongating form of RNA pol II, phosphorylated at serine 2, within the 3` end of active 
genes, which, through H3K36me3-induced recruitment of Eaf3, a component of the 
yeast HDAC Rpd3(S), can lead to preferential removal of any acetylation deposited 
within the coding region during transcription, thus re-stabilising nucleosomes, 
restoring the chromatin to its repressive state to prevent aberrant intragenic 
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transcription (Carrozza et al. 2005; Joshi and Struhl 2005; Keogh et al. 2005; Berger 
2007; Kouzarides 2007). 
 
However, as investigation continues, these general classifications of histone 
modifications as strictly activating are constantly being challenged by the finding that 
often, marks which were originally believed to be ‘active’, can be detected within 
silent genes (Berger 2007).  For instance, certain protein complexes associated with 
transcriptional repression have been shown to bind to the classically activating 
modification H3K4me3 including a factor found in the Sin3-HDAC1 deacetylation 
complex, thus removing acetyl marks and shutting down transcription (Shi et al. 
2006).  In addition, H3K4me3 has been shown to act as a recognition site for the 
H3K9me3 and H3K36me3-sepcific demethylase KDM4A/JMJD2A, which is found in 
repressor complexes such as N-CoR (nuclear hormone co-repressor complex) and 
thus implicates H3K4me3 in gene silencing (Huang et al. 2006; Shi et al. 2006; 
Berger 2007).  Together, these two interactions present evidence for a link between 
H3K4me3 and active gene repression, a function which could be dictated by both the 
timing and location of this mark; with the recruitment of positive-acting effector 
complexes during transcriptional initiation or elongation, immediately proceeded by 
binding of negative-acting factors to terminate expression (Berger 2007).  
Interestingly, the impact H3K36me3 has on gene activity also adheres to no strict 
rules and has been shown to be highly dependent on its precise distribution pattern.  
When found at the 3` end of genes, active expression is observed, however, if 
deposited at promoter regions, H3K36me3 exerts a negative effect upon transcription 
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(Strahl et al. 2002; Bannister et al. 2005; Barski et al. 2007; Berger 2007; Kouzarides 
2007). 
 
1.15. MARKS OF GENE REPRESSION 
 
Transcriptional repression has always believed to be brought about by H3K9me2 and 
me3, H3K27me3 and H4K20me3, for example (Barski et al. 2007).  H3K9me2 and 
me3 have been detected in the promoter regions of inactive genes and is found 
associated with heterochromatin protein 1 (HP1), linking this modification with the 
formation of heterochromatic domains (Noma et al. 2001; Barski et al. 2007; 
Motamedi et al. 2008).  H3K27me3 is also implicated in gene silencing, via unique 
interactions with Polycomb group proteins (PcG); originally shown to be essential for 
switching off the developmental homeobox (Hox) genes in Drosophila melanogaster 
(Breiling et al. 2004; Schwartz and Pirrotta 2007; Henikoff 2008).  The PcG system is 
an extensively studied example of maintenance of gene silencing throughout 
development, which work alongside trithorax-group proteins (trxG), to counteract the 
repression, should gene expression be required (Breiling et al. 2004; 
Schuettengruber et al. 2009).  The mammalian Polycomb repressive complex 2 
(PRC2) contains a H3K27-specific methyltransferase KMT6/Ezh2, which, in 
combination with its co-factors Eed (embryonic ectoderm development), Suz12 
(Suppressor of zeste 12), and MTF2 (metal response element-binding transcription 
factor), acts together with PRC1 and Pleiohomeotic (PHO) complexes at Polycomb 
response elements (PREs), to deposit the silencing modification H3K27me3, thus 
keeping genes off during development, even after the PRC and PHO complexes are 
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removed (Breiling et al. 2004; Cao and Zhang 2004; Dellino et al. 2004; Schwartz 
and Pirrotta 2007; Henikoff 2008; Kondo et al. 2008). 
 
The classification of these modifications has also been questioned.  For example, the 
typically silent methylation of H3K9 can also be detected in the coding regions of 
active genes (Vakoc et al. 2005; Squazzo et al. 2006; Vakoc et al. 2006; Kouzarides 
2007).  Although this seemingly contradictory distribution may relate to the level of 
methylation; H3K9me2 and me3 limited to heterochromatic regions and H3K9me1 
restricted to active domains, a trend that was confirmed following the profiling of 
histone methylation across the human genome, instead Vakoc et al (2005) 
demonstrated H3K9me2 and me3 mapping specifically to the transcribed regions of 
active mammalian genes, including the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (Gapdh), suggesting that the presence of these marks 
reflected steady-state transcription rates (Vakoc et al. 2005).  These modifications 
were detected in combination with RNA pol II and the γ form of HP1, which had 
previously been found localised to both heterochromatin and euchromatic areas 
(Vakoc et al. 2005; Vakoc et al. 2006).  This scenario may, in a similar way to 
H3K36me3, be due to the recruitment of negative-acting factors to transcribed genes 
leading to the re-formation of chromatin, preventing irregular transcription, thus 
H3K9me2 / me3 could be acting as a safety feature to ensure genes are switched off 
following expression. 
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1.16. CHROMATIN COMPLEXITIES AND THE HISTONE CODE 
 
In addition to these histone modifications, a number of alternative mechanisms are in 
place to contribute to the management of the genome, and it is these combined 
forces that generate the great diversity of cell types that make up a multicellular 
organism; of which the vast majority share identical genotypes yet have well-defined, 
individual and stable profiles of gene expression (Goldberg et al. 2007).  One of the 
best characterised mechanisms is DNA methylation and its role in the regulation of 
genes and of chromatin organisation is well defined, particularly during 
embryogenesis and gametogenesis (Goll and Bestor 2005; Goldberg et al. 2007).  
Methylation of cytosine residues is a common feature of large-genome eukaryotes, 
occurring mainly in regions of DNA rich in CpG islands; where cytosine nucleotides 
neighbour guanines along the DNA, linked by a phosphate group (Goll and Bestor 
2005).  Methyl groups are put in place on the DNA by a group of highly conserved 
proteins called DNA (cytosine-5) methyltransferases (DNMTs), of which two general 
classes exist (Freitag and Selker 2005; Goll and Bestor 2005).  De novo DNMTs act 
after DNA replication to set up methylation patterns early in development, and 
maintenance DNMTs preserve these patterns throughout cell division and semi-
conservative DNA replication by the addition of methyl groups to hemi-methylated 
CpG dinucleotides (Goll and Bestor 2005; Goldberg et al. 2007).  DNA methylation 
influences a number of different cellular processes including silencing of regions of 
repetitive DNA and centromeric sequences, the inactivation of the second X 
chromosome in females, mammalian imprinting, where genes are expressed either 
from the allele inherited from the mother or from the father, and transcriptional 
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regulation (Reik and Walter 2001; Goldberg et al. 2007; Li and Shogren-Knaak 
2008).  Approximately 76% of human promoters contain high concentrations of CpG 
islands, and the methylation of these regions correlates significantly with 
transcriptional repression (Goll and Bestor 2005; Goldberg et al. 2007).  Non-coding 
RNAs such as repeat-associated small-interfering (si)RNAs, small RNAs in yeast, 
micro RNAs and Xist RNA also contribute to variation in the chromatin template 
through the introduction of stable silencing of genes and repetitive DNA sequences, 
that can be inherited during cell division (Goldberg et al. 2007; Marks et al. 2009). 
 
DNA methylation, in combination with non-coding RNAs and post-translational 
histone modifications, which have evolved to alter the phenotype of a cell without any 
alteration to the underlying DNA sequence, are collectively known as epigenetics.  
Often, these mechanisms do not act alone to alter the chromatin landscape, and 
significant ‘crosstalk’ between epigenetic pathways has been observed (Goldberg et 
al. 2007).  One prominent example is X chromosome inactivation, where non-coding 
Xist RNA coating the inactive X, DNA methylation imprinting, and histone 
modification alterations, act in concert to shut down the inactive X (Okamoto et al. 
2004; Goldberg et al. 2007; Marks et al. 2009).  High-density genomic tiling arrays 
have also recently been employed to show that imprinted gene clusters in mice are 
marked with high levels of DNA methylation, in combination with overlapping 
H3K4me3 and H3K9me3 domains (Dindot et al. 2009).  Epigenetic crosstalk 
frequently occurs between DNMTs and chromatin-modifying enzymes which deposit 
or remove histone tail modifications (Goldberg et al. 2007).  The DNMT-like protein 
DNMT3L is one such example of a protein able to amalgamate epigenetic signals 
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(Deplus et al. 2002; Freitag and Selker 2005; Goldberg et al. 2007).  DNMT3L is an 
accessory protein essential to the germline de novo DNMTs, which through 
interaction with HDAC1, brings about gene repression (Deplus et al. 2002; Freitag 
and Selker 2005; Goldberg et al. 2007). 
 
The traditional view of epigenetic histone modifications as static on/off switches in the 
control of gene expression is also now being replaced with the idea that these marks 
are more dynamic, acting in concert to direct gene expression through organisation 
of the chromatin structure and recruitment of key effector complexes, a fundamental 
concept of the histone code hypothesis.  In support of this, certain modifications are 
also able to crosstalk; with one mark influencing the deposition or removal of another, 
or modulating the binding of effector proteins (Nightingale et al. 2006; Kouzarides 
2007; Suganuma and Workman 2008).  This could be achieved through a number of 
different ways (Figure 1.9).  The simplest form of crosstalk is the antagonism 
between differing modification states on lysine and arginine residues, where addition 
of one moiety can block further modification, which is the case for methylation and 
acetylation, and also for the mutually exclusive mono-, di- and tri-methylation states, 
thus if a lysine residue is methylated, it cannot also be acetylated, and similarly, only 
one level of methylation can be present; either me1, me2 or me3 (Latham and Dent 
2007).  The next level of crosstalk involves recruitment or removal of a protein 
complex by an adjacent modification, as is the case for phosphorylation of serine 10 
on H3 which is necessary for the displacement of H3K9me3-bound HP1 during M-
phase of the cell cycle (Figure 1.9) (Fischle et al. 2005).  Alternatively, one enzyme 
complex can be affected by multiple histone modifications, which has been shown to 
Broad arrays of epigenetic marks are able to act in concert to influence the 
deposition or removal of separate modifications or of effector proteins in a 
process termed ‘crosstalk’.  A, Different modification states on the same lysine 
(K) residue can antagonise each other thereby addition of an acetyl mark (Ac) 
can block methylation (Me), furthermore only one level of methylation can be 
present; either mono- (me1), di- (me2) or tri- (me3) (Latham and Dent 2007).  B, 
Adjacent histone modifications can affect the recruitment or removal of a protein 
complex in cis, for example phosphorylation (P) of serine S10 on histone H3 
disrupts the binding of heterochromatin protein 1 (HP1) to H3K9me3 (Fischle 
et al. 2005).  C, Alternatively, one enzyme complex can be affected by multiple 
histone modifications, for example H3K9ac and H3K14ac enhance the binding of 
the general transcription factor TFIID to H3K4me3, but asymmetric di-methylation 
of H3 arginine R2 prevents it (Vermeulen et al. 2007).  D, Crosstalk can also 
occur in trans, for example mono-ubiquitylation (Ub) of H2BK120 is required for 
H3K4me2 and H3K4me3 deposition (Li et al. 2007; Shilatifard 2008).
Figure 1.9 – Epigenetic Crosstalk
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be the case for the binding of TFIID to H3K4me3; with asymmetric di-methylation of 
arginine 2 on histone H3 (H3R2me2a) impacting negatively on this interaction, but 
H3K9ac and H3K14ac enhancing it (Figure 1.9) (Johnson et al. 1998).  Interestingly, 
H3R2me2a has been shown to prevent tri-methylation of H3K4 through inhibition of 
the HMT KMT2/Set1p required to add methyl groups to H3K4, which may explain the 
negative effect on H3K4me3 binding to the general transcription factor (Allis et al. 
2007; Guccione et al. 2007; Kirmizis et al. 2007; Vermeulen et al. 2007).  Crosstalk 
can even involve trans-histone effects, where modifications on different histone 
proteins can regulate each other, such as mono-ubiquitylation of K120 of histone 
H2B (H2BK120ub1) which is required for di- and tri-methylation of H3K4 (Li et al. 
2007; Shilatifard 2008).  These new insights into the cross-regulation of histone 
modifications, coupled with the identification of novel marks, challenge the paradigms 
of known modifications and highlight their enormous regulatory potential, both 
individually and in combination with each other.  Genome-wide analysis of histone 
modifications has allowed the study of a large number of marks and has revealed 
some emerging themes with respect to particular genes or gene regions.  For 
example, in a study by Wang et al (2008), a panel of 16 modifications were found to 
preferentially co-localise across the human genome at the level of individual 
nucleosomes, and that the promoters harbouring this ‘backbone’ of marks, which 
represent 25% of human promoters, usually displayed higher levels of gene 
expression (Wang et al. 2008).  Of these 16 modifications, acetylation was the most 
prominent (H2BK5ac, H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac, H3K9ac, 
H3K18ac, H3K27ac, H3K36ac, H4K5ac, H4K8ac and H4K91ac), with methylation 
also playing a role (H3K4me1, H3K4me2, H3K4me3 and H3K9me1) (Wang et al. 
 57
2008).  However, as this pattern was only reflected in a quarter of genes, it is likely 
that alternative combinations exist, and that the modifications will fluctuate 
throughout the course of development to direct transcriptional events. 
 
1.17. HISTONE MODIFICATIONS IN THE CONTROL OF DEVELOPMENT 
 
A prominent demonstration of how histone modifications are able to impact on 
developmental gene expression was revealed following investigations into the 
epigenome of mouse embryonic stem (ES) cells and pluripotent cell populations 
(Bernstein et al. 2005; Azuara et al. 2006; Bernstein et al. 2006; Bernstein et al. 
2007; Kouzarides 2007).  It was found that the chromatin of these undifferentiated 
cells harbours domains of the classical silencing modification H3K27me3, coinciding 
with more punctate regions of H3K4me3, a mark which at the time, was considered 
to be present only within active genes (Azuara et al. 2006; Bernstein et al. 2006).  
These regions, aptly named ‘bivalent domains’ due to the occurrence of opposing 
histone modifications at the some locus on the same chromosome, were mainly 
found at genes encoding transcription factors essential for development.  Within the 
pluripotent ES cells, these genes were essentially silent, showing only very low levels 
of ‘leaky’ gene expression, yet they assumed an early-replicating open chromatin 
structure, usually indicative of highly expressed euchromatic loci, thus it was 
anticipated that these genes, although silenced in the undifferentiated state, were 
poised for future gene expression upon development (Azuara et al. 2006; Bernstein 
et al. 2006).  This was confirmed through induced differentiation of the cells, showing 
that genes which switched on retained the active H3K4me3 mark and lost the 
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silencing H3K27me3, and for genes which remained off, the reverse was seen, 
leaving relatively few loci with the bivalent characteristic (Bernstein et al. 2006).  One 
issue that these studies did not address referred to how the fate of each bivalent 
gene was decided upon commitment of the cells to a particular lineage, however, a 
recent study has shed further light on this.  By monitoring genome-wide alterations to 
histone modifications throughout development of hematopoietic stem cells (HSC) into 
erythrocyte precursors, Cui et al (2009) found that those genes which subsequently 
lose the H3K27me3 mark to become active were associated with high levels of 
H3K4me1, H3K9me1, H4K20me1 and RNA pol II within the undifferentiated state, 
and that those which remained silent and lost H3K4me3, displayed none of these 
additional chromatin marks within the HSCs (Cui et al. 2009).  Thus it would appear 
that once again, it is the signature of combinatorial histone marks across genomic 
loci that determine the outcomes of individual genes during development.  Yet even 
this bivalent domain concept has been questioned, with a recent report by 
Golebiewska et al (2009) suggesting a more dominant role for H3K9me2 in the 
silencing of certain bivalent genes in human ES cells, rather than H3K27me3 
(Golebiewska et al. 2009).  It was not until the first stages of lineage commitment that 
the H3K27me3 mark was seen to increase, suggesting that H3K9me2 may be 
required for initiation of silencing for some lineage-specific genes (Golebiewska et al. 
2009). 
 
Clearly, the true nature of every modification is not yet known, although many 
common patterns are emerging; from the relative simplicity of bivalent domains, to 
the vast array of modifications marking promoters (Figure 1.8) (Bernstein et al. 2006; 
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Wang et al. 2008).  What is becoming most apparent however, is the importance of 
context; different combinations of modifications working together with other 
epigenetic phenomena and protein complexes such as chromatin-modifying enzymes 
and transcriptional regulators, to orchestrate transcription and the management of 
the genome.  Undeniably, histone modifications have a major role to play in these 
processes, which is why investigation into their distribution, not only on a genome-
wide scale, but also at a localised gene-specific level is crucial to develop our 
understanding of these fundamentally significant chemical marks. 
 
1.18. HISTONE MODIFICATIONS IN THE CONTROL OF CENTRAL TOLERANCE 
 
In line with this, investigation into the patterns of histone modifications across 
promiscuously expressed genes under the transcriptional control of AIRE may 
provide insight not only into the way AIRE controls their expression, but also into the 
modifications themselves and how they distribute across these highly specific loci 
when expressed outside of their target organ within medullary thymic epithelial cells.  
Transcriptional regulators such as AIRE, often have the capacity to distinguish 
between, and bind to individual histone modification states, providing a direct readout 
of the activity of the gene, and it has been suggested that the first PHD finger of 
AIRE may mediate an association with un-modified H3K4 (me0) (Koh et al. 2008; 
Org et al. 2008; Chignola et al. 2009).  The presence of this un-methylated residue is 
typically a sign of silent or low levels of expression, thus AIRE may be able to 
recognise its target genes through their modification patterning, bind to them through 
H3K4me0-PHD1 interactions and either induce or suppress transcription (Matsumoto 
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2009).  Thus, this novel role for AIRE as a histone-binding effector protein may 
suggest the involvement of epigenetic mechanisms for the regulation of so many 
thousands of AIRE-regulated target genes (Koh et al. 2008; Org et al. 2008; 
Matsumoto 2009). 
 
1.19. THE PATHWAY OF THYMIC EPITHELIAL DEVELOPMENT 
 
The recent categorization of the sequential phases in the embryonic TEC 
developmental pathway has uncovered some interesting and distinct sub-populations 
of cells, and provides an opportunity to investigate how AIRE may function as a 
transcriptional regulator of promiscuous gene expression as mTECs mature in vivo.  
In the early embryo, at embryonic day (E) 12, the murine thymic rudiment consists 
simply of undifferentiated epithelial cells and a mesenchyme capsule (Manley 2000).  
Isolation and culture of these undeveloped structures revealed a capacity for the 
generation of normal thymic structures including cortical and medullary regions, 
suggesting the pre-programmed nature of the undifferentiated cells even at such 
early stages (Rossi et al. 2006).  This scenario was clarified by Rossi et al (2006), 
who, through attempts to isolate sub-populations of epithelial progenitor cells at E12, 
discovered that the thymic rudiment at this stage is phenotypically homogeneous; 
expressing the cell surface markers EpCAM1, cytokeratins 5 and 8, and MTS24 
(Rossi et al. 2006).  Using individually isolated enhanced yellow fluorescent protein 
(eYFP)-positive E12 thymic precursor cells, transferred to wild-type thymic lobes and 
grafted to the kidney capsule, this group were able to demonstrate the development 
of normal thymic architecture (Rossi et al. 2006).  Furthermore, after sufficient 
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growth, it was revealed that both cortical and medullary regions of the newly formed 
thymic lobes exhibited eYFP signals, which led to the conclusion that a single 
bipotent TEC progenitor cell can generate both cortical and medullary lineages 
(Figure 1.10) (Rossi et al. 2006).  This group then went on to further characterise the 
developmental pathway of mTECs, showing that the two known sub-populations of 
Ly51-EpCAM1+ mTECs which are either CD80-AIRE- or CD80+AIRE+, represent 
different maturational states rather than distinct lineages, with mature CD80+AIRE+ 
mTECs developing from an immature CD80-AIRE- mTEC progenitor population 
(Figure 1.10) (Rossi et al. 2007).  In this same report, the signal responsible for this 
maturation was also examined, which was found to emanate from CD4+CD3− 
lymphoid tissue inducer cells (LTi) (Rossi et al. 2007).  Receptor activator of NF-κB 
(RANK), a cell surface marker expressed at high levels by CD80-AIRE- mTECs, 
responds to LTi-derived RANK ligand (RANKL), or alternatively to CD4+-derived 
signals, and these RANK-RANKL signals, in addition to other molecular interactions 
such as CD40-CD40L, are the trigger for the up-regulation of AIRE and subsequent 
promiscuous gene expression (Rossi et al. 2007; Akiyama et al. 2008; White et al. 
2008; Zhu and Fu 2008). 
 
Two alternative models have arisen following investigation into the role of AIRE in 
thymic embryogenesis, proposed to explain the high levels of PGE within the thymus.  
The developmental / progressive restriction model suggests that immature mTEC 
progenitors exhibit a wide catalogue of TRA, but that as differentiation occurs, 
Within the developing embryo, thymic organogenesis involves a well defined 
pathway of thymic epithelial cell (TEC) differentiation.  The two distinct lineages 
of TECs; medullary (mTECs) and cortical (cTECs), are derived from a common 
bipotent TEC progenitor present in the murine thymus at embryonic day E12 
(Rossi et al. 2006; Rossi et al. 2007).  These progenitor cells do not express 
AIRE or tissue-restricted antigens (TRA), however, these genes will be poised for 
activation should the cells develop into mTECs.  An immature CD80-AIRE- mTEC 
progenitor population exists, which do not express AIRE or TRA but produce a 
cell surface receptor; RANK (Rossi et al. 2007; Akiyama et al. 2008; White et 
al. 2008; Zhu and Fu 2008).  Stimulation from RANK ligand induces AIRE up-
regulation and promiscuous gene expression, generating mature CD80+AIRE+ 
mTECs (Rossi et al. 2007; Akiyama et al. 2008; White et al. 2008; Zhu and Fu 
2008).  Bipotent TEC progenitors can also differentiate into mature cTECs, which 
will never express AIRE or TRA (Rossi et al. 2006; Rossi et al. 2007).  The four 
main subpopulations of cells are displayed.
Figure 1.10 – The Pathway of Embryonic Thymic Development
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transcriptional promiscuity is progressively restricted (Farr and Rudensky 1998; Farr 
et al. 2002).  This would ultimately generate a mosaic of fully mature mTECs 
throughout the medulla which display only a limited number of related TRAs, thus 
masquerading as terminally differentiated peripheral tissue cells such as hepatocytes 
or oligodendrocytes, hence the medulla would resemble a patchwork of different 
tissues (Farr et al. 2002; Kyewski and Derbinski 2004; Kyewski and Klein 2006).  
Alternatively, the terminal differentiation model assumes PGE to be an autonomous 
trait of TECs, and that a random de-repression or dysregulation of transcriptional 
control occurs as mTECs continuously differentiate and turnover, allowing the 
expression of genes only typically expressed in terminally differentiated cells (Farr et 
al. 2002; Kyewski et al. 2002; Gotter and Kyewski 2004; Devoss and Anderson 
2007).  Therefore, the discovery of an immature CD80-AIRE- mTEC population, from 
which CD80+AIRE+ mature mTECs develop provides evidence in favour of the 
terminal differentiation model, and the recent finding that AIRE+ mTECs only acquire 
the machinery for PGE upon maturation, with AIRE controlling the differentiation 
programme of these cells, also supports this theory (Rossi et al. 2007; Yano et al. 
2008). 
 
The breakdown of the mTEC developmental pathway provides an obvious foundation 
for the analysis of the epigenetic control of AIRE-regulated PGE.  Bipotent TEC 
progenitors, although AIRE- and TRA-negative themselves, have the potential to 
develop into either fully mature cTECs, which will never express AIRE or its target 
genes, or alternatively into mTECs that will ultimately become AIRE-positive and 
therefore switch on TRA (Figure 1.10).  Hence, could TRAs within the bipotent TEC 
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progenitors be marked in some way for future gene expression, possibly by poised 
bivalent domains?  The more recent discovery of the intermediate population of 
immature mTECs adds to this story, allowing observation of any changes to the 
distributions of histone modifications as the cells progress through the developmental 
programme.  As AIRE is switched on, which in turn leads to the expression of TRAs, 
the distribution of histone modifications may alter to reflect the imminent up-
regulation of the AIRE-regulated genes.  Due to the large number of AIRE target 
genes, and their significant clustering across chromosomes, it could be possible that 
alteration to chromatin on a domain-wide or global scale could allow for the up-
regulation of so many TRA.  As already discussed, acetylation is typically a mark of 
active gene expression, however it is also often a pre-requisite, allowing protein 
effectors access to their target promoters or binding sites prior to transcriptional 
activation (Ferguson et al. 2008).  Histone acetylation across AIRE target genes, 
particularly those located in clusters could therefore be required to relax and open up 
the chromatin structure in either immature or newly formed mature mTECs.  The 
interaction between AIRE and the histone acetyltransferase KAT3A/CBP is 
consistent with this hypothesis (Ferguson et al. 2008).  Although these large-scale 
changes to chromatin have been shown to result in cellular stress, which can lead to 
DNA damage and ultimately apoptosis, this could potentially explain the finding that 
AIRE+ mTECs have very rapid turnover rates, representing a short-lived fraction of 
stromal cells which are destined to die (Konishi et al. 2003; Gray et al. 2007; 
Ferguson et al. 2008).  Furthermore, given that PGE is a feature of a terminally 
differentiated cell population, the formation of a permissive chromatin background 
would potentially facilitate transcriptional regulation by AIRE, and being inherently 
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cytotoxic would simply allow for the development of the next generation of mTECs 
and hence a new array of TRA, or promote cross-presentation of TRA by thymic 
antigen-presenting cells (Figure 1.3) (Gray et al. 2007; Ferguson et al. 2008). 
 
Modelling of mature AIRE+ mTECs and AIRE- TECs can be accomplished through 
application of a thymic epithelial (TEP) cell line stably transfected with a MIg virus 
construct containing AIRE and GFP, in parallel with a negative control cell line 
transformed with MIg-GFP alone, verified for both wild-type AIRE expression and 
PGE.  Investigation into the epigenetic status of TRA requires the use of native 
chromatin immunoprecipitation (NChIP), a procedure which utilises unfixed 
chromatin, prepared by nuclease digestion.  This process maintains the strong 
associations between histone proteins and DNA, yet allows greater resolution across 
defined DNA domains and higher levels of immunoprecipitation when antibodies to 
individual histone modifications are applied (O'Neill and Turner 2003).  Large cell 
numbers can be generated through culture systems and greater amounts of 
chromatin can be isolated and analysed with unlimited numbers of antibodies, and 
hence NChIP offers an important insight into the regulation of PGE, restricted to the 
comparison of fully differentiated cell lines; those expressing AIRE and those not.  To 
truly understand the role of AIRE in PGE and its impact throughout development, it 
would be invaluable to be able to examine the distribution of histone modifications 
across TRA within each step of the TEC developmental pathway. 
 
A technique that has been used successfully to study the individual cell populations 
within the developing thymus and tease apart the T-cell developmental programme 
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in full; foetal thymic organ cultures (FTOC) allows maintenance of the in vivo 
characteristics of the embryonic thymus (Jenkinson and Anderson 1994).  The 
complex three-dimensional architecture of the developing thymus, and phenotype of 
thymic stromal cells are preserved through this technique and therefore the defined 
programmes of cell development, in particular that of TECs, can occur as normal 
(Jenkinson and Anderson 1994; Anderson and Jenkinson 1995; Anderson and 
Jenkinson 2008).  Through FTOC and FACS sorting based upon specific cell 
surface markers, the four cell subsets in the TEC developmental pathway can be 
isolated and pure populations of the EpCAM1+ bipotent TEC progenitor, immature 
CD45-EpCAM1+Ly51-CD80-, and mature CD45-EpCAM1+Ly51-CD80+ mTECs, and 
mature CD45-EpCAM1+Ly51+ cTECs can be obtained and individually investigated 
(Rossi et al. 2007). 
 
Chromatin immunoprecipitation on cultured thymic epithelial cells in vitro and on cells 
isolated from the TEC developmental pathway in vivo should give insight into how 
AIRE may impact on post-translational modifications of core histones across its target 
genes.  Thus, the influence of epigenetics upon promiscuous expression of tissue-





• To reproduce AIRE in vitro in a thymic cellular environment, ensuring wild-type 
AIRE localisation and function.  A Mus musculus thymic epithelial (TEP) cell 
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line transfected with MIg virus bicistronic constructs containing either AIRE-
GFP (TEP-AIRE), or MIg-GFP alone (TEP-GFP) will be employed for 
modelling mature AIRE+ mTECs and AIRE- TECs. 
• An investigation into whether promiscuous gene expression is associated with 
any epigenetic changes, through examining a panel of activating and 
repressive post-translational histone modifications and the binding status of 
certain histone-modifying enzymes, across a catalogue of AIRE-regulated 
target loci and AIRE-independent control genes. 
• To further these studies and establish the role histone modifications play 
throughout the TEC developmental pathway in vivo, the distribution of these 
marks across TRA within each step of TEC development will be examined 
through carrier chromatin immunoprecipitation (CChIP) with small numbers of 
FACS sorted primary Mus musculus thymic stromal cells, generated through 
foetal thymic organ cultures (FTOC). 
• To assay and compare the epigenetic status of TRA in TEC from athymic 
FoxN1-deficient nude mice, within which normal TEC development is 
disrupted, with wild-type primary Mus musculus TEC, to highlight the 
importance these modifications have in the establishment of promiscuous 
gene expression in vivo. 
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2. MATERIALS AND METHODS 
 
2.1. CELL CULTURE AND PREPARATION OF PRIMARY CELL POPULATIONS 
 
2.1.1. Mus musculus Thymic Epithelial Cell Culture 
Mus musculus thymic epithelial (TEP) cells were a gift from Dr D. Kioussis of the 
National Institute of Medical Research.  TEP cells, retrovirally transfected with the 
MIg virus, containing either GFP and AIRE, (TEP-AIRE cells), or GFP alone as a 
control line (TEP-GFP cells), were maintained in monolayers at 37°C in a 5% CO2 
humidified atmosphere.  Cells were grown in 1xDulbecco’s Modified Eagle’s Medium 
(DMEM, Gibco) supplemented with 10% heat inactivated foetal bovine serum (FBS, 
Gibco), 1xMEM non-essential amino acids (without glutamine) (Gibco), 10mM Hepes 
(Sigma), 5x10-5M mercaptoethanol (Gibco), 4mM L-glutamine, 5000 IV/ml Penicillin 
(Gibco) and 5000μg/ml Streptomycin (Gibco).  Cells were cultured in T75 (Sarstedt) 
tissue culture flasks.  Passage by trypsinisation (0.05% trypsin-EDTA, Gibco) was 
performed once cells reached 70% confluence.  Cells were harvested by 
trypsinisation at 37oC and washed three times in ice-cold Ca2 / Mg2-free 1xphosphate 
buffered saline (1xPBS) containing 5mM sodium butyrate and centrifuged at 
1200rpm (MSE 3000) for 5 minutes. 
 
2.1.2. Mus musculus 3T3 Fibroblast Cell Culture 
Mus musculus fibroblast cells (3T3s) were also transfected with MIg-GFP-AIRE (3T3-
AIRE) or MIg-GFP (3T3-GFP) and grown following the same protocol as for TEP cell 
lines. 
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2.1.3. Drosophila melanogaster SL2 Cell Culture 
Drosophila melanogaster SL2 cells were grown anaerobically in suspension at 26oC 
in Schneider’s medium (Gibco) supplemented with 8% FBS and antibiotics (50 
units/ml Penicillin and 50μg/ml Streptomycin). 
 
2.1.4. Mouse Husbandry and Breeding 
Wild-type BALB/c (haplotype H-2d) and FoxN1-deficient BALB/c nude (nu/nu) mice 
used in this study were housed and maintained in the Biomedical Sciences Unit 
(BMSU), University of Birmingham, in accordance to home office regulations. 
 
2.1.5. Foetal Thymic Organ Culture (FTOC) 
FTOC preparation and the sorting of thymic epithelial subsets were performed by Dr 
A. White (Anderson lab, University of Birmingham) (Jenkinson et al. 1992; Anderson 
et al. 1993).  For reference, protocols for these methods are given below. 
 
Thymic lobes were removed from mice embryos at the required stage of gestation 
(typically embryonic day E15) and placed on 0.8µm sterile nucleopore filters 
(Millipore) on sterile artiwrap sponges (Medipost Ltd) in DMEM in 90mm, single vent 
sterile Petri dishes (Sterilin).  Organ cultures were grown in DMEM containing 10% 
FBS for seven days at 37°C, 10% CO2. 
 
2.1.5.1. Isolation of Primary Cell Populations 
Cultured embryonic thymic lobes were washed three times in Ca2 / Mg2-free 
1xphosphate buffered saline (1xPBS) (Sigma) and incubated in 600µl 0.25% trypsin, 
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0.02% EDTA (Sigma) for 15-20 minutes, 37°C (precise timing depends on the stage 
of thymus development and days in organ culture).  Trypsinisation was stopped by 
the addition of RPMI-1640 Hepes (RF10-H), and stromal cell suspensions were 
generated from disaggregated lobes through gentle pipetting.  An equal volume of 
RF10-H medium was added and cells were centrifuged for 10 minutes at 1000rpm 
and the supernatant removed.  The cell pellet was resuspended in 1ml RF10-H and 
the cells counted in a haemocytometer.   
 
An immunomagnetic separation technique was employed using Dynabeads (Dynal) 
for the depletion of any residual haematopoietic cells.  Anti-rat IgG magnetic beads 
(Dynal), coated with anti-mouse CD45 (clone M1-9; ATCC) were added to cell 
suspensions in 200μl RF10-H at an approximate ratio of 10:1.  Cells and beads were 
centrifuged for 10 minutes at 1000rpm, 4°C and allowed to bind.  Once positive 
binding was detected, unbound cells were isolated from cell-bound beads using an 
Eppendorf (1.5ml) Dynal Magnetic Particle Concentrator (Dynal).  Supernatants 
contained thymic stromal cell populations that were used for sorting of thymic 
epithelial subsets. 
 
2.1.5.2. Flow Cytometric High Speed Sorting 
EpCAM1+ E12 bipotent TEC progenitors and EpCAM1+ E12 FoxN1-deficient nude 
TEC were isolated from suspensions of E12 thymus lobes on the basis of expression 
of EpCAM1, as described (Rossi et al. 2006).  To isolate TEC subsets, we used the 
following phenotypes: immature CD45-EpCAM1+Ly51-CD80- mTECs, mature CD45-
EpCAM1+Ly51-CD80+ mTECs, and mature CD45-EpCAM1+Ly51+ cTECs (Derbinski 
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et al. 2001; Rossi et al. 2007).  In brief, cell lymphocyte-depleted suspensions were 
immunolabelled with the appropriate antibodies.  Cells were resuspended in 50µl of 
the relevant primary antibody (Table 2.1) and incubated for 30 minutes on ice.  
Appropriate single colour controls and negative controls (secondary antibody only) 
were also set up.  Cells were washed in 1ml 1xPBS and centrifuged.  Where primary 
antibodies were not directly conjugated to a fluorochrome, relevant secondary 
antibodies (Table 2.1) were added to cells and incubated for 30 minutes on ice.  
Following immunolabelling, cells were washed and resuspended in RF10-H.  Single 
colour controls, of approximately 100,000 cells, were resuspended in 200μl RF10-H.  
Experimental samples of no less than 1x106 cells were resuspended in 1ml RF10-H.  
Sorting was performed on a MoFlo high speed sorter (Dako Cytomations) with 
forward and side scatter gates set to exclude nonviable cells.  Sorted cells were 
counted and snap frozen for storage at -80°C until use.  Sorting performed by Dr R. 
Bird (University of Birmingham). 
 
2.1.6. Snap Freezing of Cell Populations 
Cell populations were transferred into 1.5ml RNase-free microcentrifuge tubes and 
centrifuged at 1000rpm (MSE 3000) for 10 minutes.  Supernatants were removed to 
leave a dry pellet before immersion in liquid nitrogen and storage at -80°C. 
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Table 2.1 – Antibodies for Isolation of Primary Cell Populations 
ANTIBODY SPECIFICITY ORIGIN 
PRIMARY ANTIBODIES 
Anti-CD45 biotin (clone 30F11) eBioscience 
Anti-EpCAM1 (G8.8) conjugated to Alexa 647 Gift from Andy Farr 
Anti-Ly51 (clone BP-1) PE eBioscience 
Anti-CD80 (clone 16-10A1) FITC eBioscience 
SECONDARY ANTIBODIES 
Streptavidin PeCy7 eBioscience 
Streptavidin APC BD 
Streptavidin PE eBioscience 
 
 
Foetal thymic organ culture was employed for the investigation of the epigenetic 
status of tissue-restricted antigens across the embryonic thymic epithelial 
developmental pathway.  Fluorescent Activated Cell Sorting (FACS) was used 
to isolate four cell populations; EpCAM1+ bipotent TEC progenitors, immature 
CD45-EpCAM1+Ly51-CD80-, and mature CD45-EpCAM1+Ly51-CD80+ mTECs, 
and mature CD45-EpCAM1+Ly51+ cTECs.  Primary and secondary antibodies 
used in FACS along with their origin are displayed. 
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2.2. ANALYSIS OF THE INTEGRITY OF THE TEP AND 3T3 MODEL SYSTEMS 
 
2.2.1. Immunofluorescence Labelling 
TEP-GFP, TEP-AIRE, 3T3-GFP and 3T3-AIRE cells were grown to 70% confluence 
on sterile 22mm x 22mm glass coverslips in 6-well plates, each well containing 2ml 
DMEM.  Coverslips were transferred to fresh acetone for a 6 minute fixation then 
dried and washed for 5 minutes in 1xPBS with 0.1% Tween20 (Sigma) (PBST).  To 
each coverslip, 50µl fluorescein isothiocyanate (FITC)-conjugated primary anti-AIRE 
antibody (rat anti-Aire (B1/02-5H12-2), a gift from H. Scott), diluted 1:100 in PBST, 
was added, and incubated for 1hr at room temperature in the dark.  Following 
incubation, coverslips were washed for 5 minutes in PBST.  Slides were prepared 
with 10µl mounting medium with 4',6-diamidino-2-phenylindole (DAPI) (Vectashield).  
Coverslips were dried, placed cell-side down onto the mounting medium and sealed.  
Images were captured using a Zeiss Axioplan microscope and SmartCaptureX 
Software (Digital Scientific). 
 
2.2.2. Fluorescence-Activated Cell Sorting (FACS) Analysis for GFP Levels 
For analysis of the efficiency of retroviral transfection, harvested TEP and 3T3 lines 
were washed in 1xPBS and transferred to 12.5ml polystyrene FACS tubes (Becton 
Dickinson) for FACS analysis.  Acquisition was performed using a Becton Dickinson 
LSR flow cytometer and subsequent analysis was carried out using FloJo software.  
Freshly isolated thymocytes were used as negative control sample in order to set 
negative peaks for GFP.  Where possible at least 100,000 events were recorded per 
experimental sample, with forward and side scatter gates to exclude non-viable cells. 
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2.2.3. Analysis of the Expression Levels of Promiscuous Genes 
 
2.2.3.1. High Purity cDNA Extraction 
For the analysis of promiscuous gene expression within cultured TEP and 3T3 lines 
or MoFlo-sorted primary cell populations, high purity cDNA was obtained from 
purified mRNA using the μMACs™ mRNA Isolation Kit (Miltenyi Biotec) and 
μMACs™ cDNA Synthesis Module (Miltenyi Biotec) according to the manufacturers 
instructions.  The whole procedure was carried out in a laminar flow cabinet.  
Lysis/binding and wash buffers were allowed to equilibrate to room temperature prior 
to use.  Frozen primary cell populations obtained from MoFlo cell sorting were 
suspended in 900μl lysis/binding buffer and vigorously vortexed for 3 minutes to 
ensure total cell lysis.  Cultured TEP and 3T3 cells were snap frozen (section 2.1.6.), 
suspended in 900μl lysis/binding buffer and lysed using 21-gauge needles. 
 
Cell lysates were then centrifuged at 13000rpm (MSE microcentaur) for 3 minutes in 
LysateClear columns.  To each lysate, 50μl oligo microbeads were added and gently 
mixed.  Lysates were transferred to μMACS™ columns; previously primed with 100μl 
lysis/binding buffer.  Magnetically labelled mRNA remains bound to the column.  
Columns were rinsed twice with 200μl lysis/binding buffer to remove proteins and 
DNA, followed by four 100μl rinses with wash buffer to remove ribosomal RNA and 
DNA.  For direct cDNA synthesis, bound mRNA was not eluted from the column.  
Instead, columns were washed twice with 100μl equilibration/wash buffer.  
Lyophilised enzyme mix was dissolved in 20μl resuspension buffer and applied on 
top of the column followed by 1μl of sealing solution, applied directly to the top of the 
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column to prevent evaporation.  The thermoMACSTM Separator was then turned on 
to 42°C and left for 1 hour 15 minutes for reverse transcription to take place.  
Columns were rinsed twice with 100μl equilibration/wash buffer.  To release cDNA, 
20μl release solution was added and incubated for 30 minutes at 42°C.  Synthesised 
cDNA was eluted with 50μl elution buffer, collected into 1.5ml RNase-free 
microcentrifuge tubes and stored at -20°C.  High purity cDNA extraction and 
expression analysis of primary cell populations performed by S. Parnell (Anderson 
Lab, University of Birmingham). 
 
2.2.3.2. Quantitative Real-Time Polymerase Chain Reaction (qPCR) Analysis of 
Expression 
Quantitative real-time PCR (qPCR) was performed on the Rotor-Gene™ RG-3000 
(Corbett Research) using SYBR Green with expression primers specific for various 
genes of interest (Table 2.2 and 2.3).  For sample normalisation prior to amplifying 
target genes, β-actin was used as the housekeeping gene.  Primers were made by 
Invitrogen and primer pairs were designed using the aid of Primer3 software 
(http://frodo.wi.mit.edu/primer3/). 
 
PCR reactions were performed as described previously (Shakib et al. 2009).  
Reactions were carried out in triplicates or duplicates in 15μl volumes in 2xSensiMix 
(Quantace) reaction buffer containing 50xSYBR© Green1 Solution (Quantace) and 
200nM forward and reverse primers.  After an initial denaturation step (95°C, 10 
minutes), cycling was performed at 95°C for 15 seconds, 59-62°C (depending on 
primer pair) for 20 seconds and 72°C for 5 seconds (39 cycles).  The fluorescent 
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Table 2.2 – Sequences of the Mus musculus Expression Primer Sets for 
Tissue-Restricted Antigens Used in Quantitative Real-Time Polymerase 
Chain Reaction (PCR) with cDNA 
PRIMER NAME NCBI REFERENCE 
AMPLICON 
LENGTH Tm 
Beta-Actin [Actb] NM_007393 100bp 60°C 
Forward: 5` -CGTGAAAAGATGACCCAGATCA- 3` 
Reverse: 5` -TGGTACGACCAGAGGCATACAG- 3` 
Autoimmune Regulator [AIRE] NM_009646 186bp 62°C 
Forward: 5` -TGCATAGCATCCTGGACGGCTTCC- 3` 
Reverse: 5` -CCTGGGCTGGAGACGCTCTTTGAG- 3` 
Casein-Alpha [Csn1s1] NM_007784 190bp 60°C 
Forward: 5` -CATCATCCAAGACTGAGCCAG- 3` 
Reverse: 5` -CCTGTGGAAAGTAAGCCCAAAG- 3` 
Salivary Protein-1 [Spt1] NM_009267 116bp 59°C 
Forward: 5` -AGCAGTGTTGGTATCATCAGTG- 3` 
Reverse: 5` -CTGGTGAAAATACTGGCTCTGAA- 3` 
Salivary Protein-2 [Spt2] (Renamed Mucin-like 1 
[Mucl1] 14.04.09) NM_009268 122bp 60°C 
Forward: 5` -TCAGACCAAAGTGGGTGACA- 3` 
Reverse: 5` -CCTCTTGTTTCTCATTGGAGGT- 3` 
Selection and Upkeep of Intraepithelial T-cells 1 
[Skint1] NM_001102662 143bp 60°C 
Forward: 5` -TTCAGATGGTCACAGCAAGC- 3` 
Reverse: 5` -GAACCAGCGAATCTCCATGT- 3` 
Proteasome Subunit Beta-Type 11 [Psmβ11] NM_175204 231bp 60°C 
Forward: 5` -ATCGCTGCGGCTGATACTC- 3` 
Reverse: 5` -GCAGGACATCATAGCTGCCAA- 3` 
 
 
For the analysis of promiscuous gene expression within cultured TEP and 3T3 
lines or FACS-sorted primary cell populations, high purity cDNA was obtained 
from purified mRNA and quantitative real-time PCR (qPCR) performed with 
expression primers specific for AIRE and the AIRE-regulated tissue-restricted 
antigens (Csn1s1, Spt1, Spt2) and control genes (Skint1, Psmβ11) listed.  For 
sample normalisation prior to amplifying target genes, β-actin was used as the 
housekeeping gene.  Illustrated are the NCBI reference code, the length of 
amplicon generated and the annealing temperature (Tm) of each primer set. 
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Table 2.3 – Sequences of the Mus musculus Expression Primer Sets for 
the Keratin Cluster Used in Quantitative Real-Time Polymerase Chain 
Reaction (PCR) with cDNA 
PRIMER NAME NCBI REFERENCE 
AMPLICON 
LENGTH Tm 
Keratin 4 [Krt4] NM_008475 188bp 60°C
Forward: 5` -GAGCATCTCGGTAGTTGGCG- 3` 
Reverse: 5` -GAGCACCAGGAAGACTGGAG- 3` 
Keratin 79 [Krt79] NM_146063 166bp 60°C
Forward: 5` -GGAGCTGAGGAACGTACAGG- 3` 
Reverse: 5` -TGTCAAGCTGTCCACTTTGC- 3` 
Keratin 78 [Krt78] NM_212487 228bp 60°C
Forward: 5` -GCCTCAGGAAGCAGAATGAC- 3` 
Reverse: 5` -CCTCACTCTCCAGCAACCTC- 3` 
Keratin 8 [Krt8] NM_031170 151bp 62°C
Forward: 5` -ATCGAGATCACCACCTACCG- 3` 
Reverse: 5` -TGAAGCCAGGGCTAGTGAGT- 3` 
Keratin 18 [Krt18] NM_010664 161bp 60°C
Forward: 5` -TCCTTCTGCATCTGGAG- 3` 
Reverse: 5` -ATCGTTGAGACTGAAATC- 3` 
Eukaryotic Translation Initiation Factor 4b [Eif4b] NM_145625 222bp 60°C
Forward: 5` -GTTGCTGATCAAGCACAGGA- 3` 
Reverse: 5` -GTCCCGATATCCGTCCCTAT- 3` 
Tensin like C1 Domain-containing Phosphatase 
[Tenc1] NM_153533 199bp 60°C
Forward: 5` -CAGGACCCTTGGCTTCTACA- 3` 
Reverse: 5` -GGAGACCTGGTGGTGTCTTG- 3` 
SPRY Domain-containing 3 [Spryd3] NM_001033277 240bp 60°C
Forward: 5` -GCCCAGATCTTCTTCACCAA- 3` 
Reverse: 5` -CTTCCCCAAATACTCCAGCA- 3` 
 
 
For the analysis of gene expression across the keratin cluster within cultured 
TEP lines, cDNA was obtained from purified mRNA and quantitative real-time 
PCR (qPCR) performed with expression primers specific for the genes listed.  
For sample normalisation prior to amplifying target genes, β-actin was used as 
the housekeeping gene.  Illustrated are the NCBI reference code, the length of 
amplicon generated and the annealing temperature (Tm) of each primer set. 
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signal produced from the amplicon was acquired at the end of each polymerisation 
step.  Specific amplification of target genes was verified by melt curve analysis (72-
99°C, hold 30 seconds on 1st step then 5 seconds on next steps) and by fractionation 
of PCR products on a 2% agarose gels, which were identified by their fragment size.  
Reaction amplification efficiency and Ct values were obtained using Rotor-GeneTM 
6.0 software (Corbett Research).  Standard curves with reaction efficiencies no 
greater than 1 and R2 values no less than 0.98 were generated for each primer set 
using serial dilutions of cDNA from E15 BALB/c foetal thymic organ cultures 
(FTOCs), mammary gland cells and salivary gland cells.  For calculation of the 
relative expression values for samples normalised to β-actin, the Pfaffl model that 
takes gene-dependent differences in the amplification efficiency into account was 
employed (Pfaffl 2001). 
 
2.3. ANALYSIS OF HISTONE PROTEINS 
 
2.3.1. Affinity-Purified Antibodies 
Rabbit polyclonal antisera to H3K4me1, H3K4me2, H3K4me3, H3K9ac, H4K8ac and 
H4K16ac were raised by immunization with synthetic peptides conjugated to 
ovalbumin as previously described (Turner et al. 1989; O'Neill and Turner 1995; 
White et al. 1999).  Rabbit anti-H3K27me3 (07-449) and anti-H3K9me2 (07-212) 
were purchased from Millipore.  Specificity was assayed by inhibition ELISA for all in-
house and commercial antisera used and checked by Western blotting.  For all 
antisera, cross-reaction with epitopes other than that against which the antiserum 
was raised was insignificant (O'Neill et al. 2006). 
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2.3.2. Histone Acid Extraction from Cultured Thymic Epithelial Cells 
For the analysis of histone proteins in the two cell lines, TEP-GFP and TEP-AIRE 
cells were harvested, washed in ice-cold 1xPBS and cell numbers determined using 
an Improved Neybauer Haemocytometer Counting Chamber.  Cells were 
resuspended at 1x107 cells/ml in Triton extraction buffer (TEB; 10% Triton X-100, 
0.1M PMSF, 2% Na azide in 1xPBS/5mM Na butyrate), incubated on ice for 10 
minutes and pelleted at 1200rpm (MSE 3000) for 10 minutes at 4°C.  Histones were 
extracted in 0.4N HCl (2x106 cells / 50μl) at 4°C overnight.  Histones were isolated by 
centrifugation at 13000rpm (MSE microcentaur) for 1 minute, and histone-containing 
supernatants removed and stored at 4°C.  Protein concentration of histone samples 
was determined using the Pierce assay.  Samples were diluted 50x in Pierce-3 Agent 
(ThermoScientific) and left on ice for the colour change to develop.  The absorbance 
(595nm) of histones was then compared against a standard curve generated using a 
dilution series of bovine serum antigen (1-0.2mg/ml) to determine their 
concentrations. 
 
2.3.3. Sodium Dodecyl Sulphate (SDS) Polyacrylamide Gel Electrophoresis 
(PAGE) 
SDS-PAGE was performed as described in Laemmli (1970) with the isolated histone 
fractions (Laemmli 1970).  For histone separation, resolving gels were prepared 
(15% acrylamide, 0.4% NN’bisacrylamide, 375mM Tris-HCl pH 8.8, 0.1% SDS 
polymerised with 300μl 10% w/v ammonium persulphate and 30μl TEMED per 30ml 
gel solution).  These were overlaid with iso-butanol during polymerisation to prevent 
evaporation which was then washed off before addition of the stacking gel (3% 
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acrylamide, 0.16% N,N’bisacrylamide, 125mM Tris-HCl pH 6.9, 0.1% SDS, 
polymerised with 100μl 10% w/v ammonium persulphate and 10μl TEMED per 10ml 
of gel solution). 
 
Samples were prepared in 100µl volumes with 10µg histone proteins, 50% glycerol, 
0.02% bromophenol blue and 10x standard dissociating buffer (SDB; 1M Tris-HCl pH 
7.2, 10mM Na2EDTA, 10% SDS, 1.432M 2-mercaptoethanol).  Proteins were 
denatured for 10 minutes at 95°C and incubated on ice for 5 minutes prior to being 
loaded onto the gel.  Electrophoresis was performed at 400 volts, 30 mA for at least 2 
hours in Mini Protean II™ (BIO-RAD) apparatus and 1xSDS running buffer (50mM 
Tris base, 380mM Glycine, 0.1% SDS). 
 
2.3.4. Analysis of Global Levels of Histone Modifications by Western Blot 
Histone proteins were transferred onto Hybond C-Extra nitrocellulose paper 
(Amersham) as described (Towbin et al. 1979).  Briefly, Hybond C, pre-soaked in 
transfer buffer (25M Tris-HCl, 192mM Glycine, 20% Methanol) was overlaid on top of 
the SDS-PAGE gel.  Gels were sandwiched between Whatman No1 filter paper and 
Scotch brite sponge pads.  All air bubbles were removed and the gel, plus pads, 
placed in a cassette and slotted into Trans Blot Cell apparatus (BIO-RAD).  Protein 
transfer was carried out for 3 hours (180V, 300mA, 20w).  Staining with Ponceau Red 
prior to antibody binding ensured an equal transfer of histones.  Membranes were 
incubated for 1 hour at room temperature in blocking solution (5% milk in 1xPBS with 
0.1% Tween20 (PBST)) in order to prevent non-specific antibody binding.  Primary 
antibody (diluted in blocker; Table 2.4) was added and incubated at room 
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Table 2.4 – Primary and Secondary Antibodies Used for Western Blot and 
Immunofluorescence Analysis of the Global Levels of Histone 
Modifications 
ANTIBODY SPECIFICITY ORIGIN DILUTION (IN PBST) 
PRIMARY ANTIBODIES 
Rabbit anti-H3K4me1 In-house R204 1:200 
Rabbit anti-H3K4me2 In-house R148 1:400 
Rabbit anti-H3K4me3 In-house R614 1:400 
Rabbit anti-H3K9ac In-house R609 1:100 
Rabbit anti-H4K8ac In-house R404 1:1000 
Rabbit anti-H4K16ac In-house R252 1:400 
Rabbit anti-H3K9me2 In-house R616 1:400 
Rabbit anti-H3K27me3 Millipore (07-449) 1:800 
SECONDARY ANTIBODIES 
Peroxidase Goat anti-Rabbit IgG Sigma 1:1500 
 
 
For the analysis of global levels of histone modifications in cultured TEP lines, 
Western blot analysis of bulk histones and immunofluorescence staining of 
metaphase chromosomes was performed.  The names and specificities of 
primary and secondary antibodies used in these procedures are displayed 




temperature for 1 hour, followed by washing of the membranes three times in PBST.  
Secondary antibody peroxidase goat anti-rabbit IgG was applied and the filters left for 
a further hour at room temperature.  After washing the filters three times with PBST, 
antibody binding was detected using enhanced chemiluminescence (ECL) Detection 
Reagents (Amersham) as per the manufacturers instruction. 
 
2.3.5. Immunofluorescence Labelling of Metaphase Chromosomes from Thymic 
Epithelial Cells 
For visualisation of the effects of AIRE upon the global distribution of histone 
modifications across metaphase chromosomes, TEP-GFP and TEP-AIRE cells were 
cultured with 10μl/ml Colcemid for 3 hours, and then harvested and washed twice in 
1xPBS.  A cell count was performed and samples diluted to 2x105 cells/ml in 0.1M 
KCl and incubated for 10 minutes at room temperature.  Cytospins were performed 
with 200µl/chamber (4x104 cells/slide) in a Shandon cytospin® cytocentrifuge 
(ThermoFisher Scientific) at 1800rpm for 10 minutes.  Cell areas were marked with a 
diamond pen and immediately immersed in KCM buffer (120mM KCl, 20mM NaCl, 
10mM Tris-HCl pH 8.0, 0.5mM EDTA, 0.1% v/v Triton X-100) for 8 minutes at room 
temperature.  Primary antibodies (Table 2.4) were diluted in KCM buffer with 0.1% 
BSA, then 40μl were applied to each slide, covered with parafilm and left at 4oC for 1 
hour in humid chamber.  Slides were washed twice in KCM, 10 minutes each wash, 
then incubated with 40μl FITC-conjugated secondary antibody (Table 2.4) for 1 hour, 
4oC.  Slides were again washed twice in KCM, 10 minutes each wash, then fixed in 
4% formaldehyde in KCM for 10 minutes, and finally washed in distilled water then 
mounted in 7.5μl DAPI.  Performed by R. Muraleedharan. 
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2.4. CHROMATIN IMMUNOPRECIPITATION 
 
2.4.1. Chromatin Isolation 
 
2.4.1.1. Preparation of Unfixed Chromatin from Cultured Thymic Epithelial Cells 
for Native Chromatin Immunoprecipitation 
Extraction and subsequent digestion of chromatin was performed as previously 
described (O'Neill and Turner 1995).  TEP-GFP and TEP-AIRE cultures were 
trypsinised and washed in ice-cold 1xPBS/5mM Na butyrate (PBS-NaB) three times.  
Cell counts were performed then cells were resuspended in 1xTBS (15mM NaCl, 
10mM Tris-HCl pH 7.5, 3mM CaCl2, 2mM MgCl2, 5mM Na butyrate) to a density of 
2x107 cells/ml.  An equal volume of 1% Tween40/TBS and 1/200th volume 0.1M 
PMSF was added to the suspension and the cells were stirred on ice for 1 hour in 
order to puncture the cell membranes for release of the nuclei.  Nuclei were released 
by homogenisation, on ice, using 10 strokes with a Dounce all-glass homogeniser 
with a “tight” pestle, which resulted in a 75-80% yield of intact nuclei, verified by 
microscopy.  The nuclei suspension was then centrifuged (2000rpm, MSE 3000, 4°C, 
10 minutes) and pellets were resuspended in 5ml 5% sucrose/TBS.  After 
centrifugation (3000rpm, MSE 3000, 4°C, 10 minutes), nuclei pellets were 
resuspended in 5ml digestion buffer (0.32M Sucrose, 50mM Tris-HCl pH 7.5, 4mM 
MgCl2, 1mM CaCl2, 0.1mM PMSF, 5mM Na butyrate) and a rough estimate of 
concentration determined using A260/280 absorbance.  Samples were then centrifuged 
(2000rpm, MSE 3000, 4°C, 10 minutes) and pellets were resuspended in digestion 
buffer to a concentration of 0.5mg/ml. 
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For analysis of chromatin, a chromatin ladder rich in mono-, di-, tri-, tetra-, and penta-
nucleosomes is required.  Chromatin was released from the nuclear preparations by 
digestion at 37°C for 5 minutes with 50U micrococcal nuclease (Amersham) per 
0.5mg chromatin.  Digestion was terminated by addition of 0.5M EDTA to a final 
concentration of 5mM and placed on ice for 5 minutes.  The samples were 
centrifuged at 13000rpm (MSE microcentaur) and the first supernatant (S1) was 
removed and stored at 4oC.  Pellets were resuspended in 500μl lysis buffer (1mM 
Tris-HCl pH 7.4, 0.2mM Na2EDTA, 0.2mM PMSF, 5mM Na butyrate) and dialysed 
overnight against 2l lysis buffer at 4oC.  Samples were centrifuged (2000rpm, MSE 
3000, 4oC, 10 minutes) and the second supernatant (S2) collected and the insoluble 
pelleted material (P) resuspended in 200μl lysis buffer before the concentration 
(A260/280) of DNA within S1, S2 and P samples determined.  For each sample, 2µg 
(with 0.3% SDS), were loaded onto 1.2% agarose gels for agarose gel 
electrophoresis (AGE), followed by ethidium bromide staining to determine the extent 
of micrococcal nuclease digestion.  S1 and S2 fractions were routinely combined, 
representing approximately 90% total chromatin, and the DNA concentration (A260/280) 
determined. 
 
2.4.1.2. Preparation of Unfixed Chromatin from Primary Thymic Epithelial Cells 
for Carrier Chromatin Immunoprecipitation 
For the CChIP procedure, extraction and subsequent digestion of chromatin was 
performed as previously described (O'Neill et al. 2006).  Drosophila melanogaster 
SL2 cells were pelleted and washed three times in ice-cold PBS-NaB.  Cells were 
resuspended to 5x107 cells in 1ml ice-cold NB buffer (15mM Tris-HCL pH 7.4, 60mM 
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KCl, 15mM NaCl, 5mM MgCl2, 0.1mM EGTA, 0.5mM 2-mercaptoethanol, 0.1mM 
PMSF, 5mM Na butyrate) then snap frozen and stored at -80oC.  For the CChIP 
procedure, SL2 cells were resuspended in 400μl ice-cold NB buffer.  Small numbers 
of Mus musculus thymic epithelial cell populations obtained from MoFlo cell sorting 
(section 2.1.5.2.), which had previously been frozen, were resuspended in 100μl ice-
cold NB buffer, transferred to each aliquot of 5x107 SL2 cells and an equal volume 
1% Tween40/NB buffer/0.1mM PMSF added, bringing the final volume to 1ml.  For a 
75-80% yield of intact nuclei, homogenisation was performed on ice with seven 
strokes using a Dounce all-glass homogeniser with a “tight” pestle.  Nuclei were 
pelleted (2000rpm, MSE 3000, 4oC, 10 minutes), resuspended in 5ml NB buffer, 5% 
(v/v) sucrose and pelleted (2000rpm, MSE 3000, 4oC, 10 minutes).  Nuclei were 
resuspended in 2ml digestion buffer and the DNA concentration determined, samples 
were centrifuged (2000rpm, MSE 3000, 4oC, 10 minutes) then routinely resuspended 
in 500μl digestion buffer.  Micrococcal nuclease (25U) was added to each aliquot and 
incubated for 7 minutes 30 seconds at 28oC.  The S1, S2 and P fractions were 
isolated and the DNA concentration (A260/280) determined followed by analysis on 
1.2% AGE.  S1 and S2 fractions were routinely combined. 
 
2.4.1.3. Preparation of Fixed Chromatin from Cultured Thymic Epithelial Cells 
for Cross-linked Chromatin Immunoprecipitation 
Formaldehyde cross-linked chromatin was prepared essentially by the method 
outlined previously (Orlando and Paro 1993).  Essentially, TEP cells were harvested, 
washed three times in PBS-NaB and resuspended at a concentration of 1x106 
cells/ml.  Cells were cross-linked in 1% paraformaldehyde for 8 minutes at room 
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temperature.  The reaction was stopped by addition of glycine to a final concentration 
of 150mM.  Cross-linked cells were washed twice with PBS-NaB and resuspended in 
130μl XChIP lysis buffer (50mM Tris-HCl, 10mM EDTA, 1% SDS, 5mM Na butyrate).  
Cells were sonicated using the Diagnode Biorupter for 10 minutes on medium at 4oC.  
An aliquot of cross-linked chromatin was taken for reversal of the cross-links by 
proteinase K digestion at a concentration of 50μg/ml at 68oC, 300rpm for 2 hours in 
an Eppendorf Thermomixer.  DNA was extracted by two phenol/chloroform 
extractions and one chloroform extraction.  DNA was precipitated by centrifuging at 
13000rpm (MSE microcentaur) and resuspended in water.  DNA was ran out on a 
1% agarose gel to check the size of the fragments.  Fragments were typically 




2.4.2.1. Immunoprecipitation from Unfixed Chromatin (NChIP and CChIP) 
From this point onwards, the use of siliconised microcentrifuge tubes, Pasteur 
pipettes and 15ml centrifuge tubes maximised DNA recovery throughout the 
immunoprecipitation.  To 100-200μg freshly prepared, unfixed chromatin, 100-200μl 
(50-100μg Ig) affinity purified antibody (Table 2.5) was added in fresh pre-lubricated 
siliconised 1.5ml centrifuge tubes, and the volume adjusted to 1ml with incubation 
buffer (50mM NaCl, 20mM Tris–HCl pH 7.5, 20mM Na butyrate, 5mM, Na2EDTA, 
0.1mM PMSF).  After overnight incubation on a slowly rotating platform at 4°C, 200μl 
protein A-sepharose (50% w/v, Pharmacia) was added and the incubation continued 
at room temperature for a further 3 hours on a fast rotating turntable.  After 
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Table 2.5 – Affinity Purified Antibodies Used for Chromatin 
Immunoprecipitation 
ANTIBODY SPECIFICITY ORIGIN 
NCHIP / CCHIP ANTIBODIES 
Rabbit anti-H3K4me1 In-house R204 
Rabbit anti-H3K4me2 In-house R149 
Rabbit anti-H3K4me3 In-house R612 
Rabbit anti-H3K9ac In-house R607 
Rabbit anti-H4K8ac In-house R403 
Rabbit anti-H4K16ac In-house R252/R232 
Rabbit anti-H3K9me2 Millipore (07-212) 
Rabbit anti-H3K27me3 Millipore (07-449) 
Rabbit Pre-immune In-house 
XCHIP ANTIBODIES 
Rat anti-AIRE (B1/02-5H12-2) A gift from H. Scott 
Rabbit anti-RNA Polymerase II Abcam (ab26721) 
Rabbit anti-KMT2A/MLL1 Abcam (ab25735) 
Rabbit anti-KMT6/Ezh2 Abcam (ab3748) 
Rabbit anti-Eed Abcam (ab4469) 
 
 
For the quantitation of levels of histone modifications across AIRE-regulated 
genes, native chromatin immunoprecipitation (NChIP), carrier CChIP and 
formaldehyde-fixed XChIP were employed.  Immunoprecipitation was 




centrifugation (13000rpm, MSE microcentaur, 10 minutes) the supernatant was 
removed and stored on ice (unbound fraction, UB) and the protein A-sepharose pellet 
was washed three times in 10ml wash buffer (50mM Tris-HCl pH 7.5, 10mM EDTA, 
5mM sodium butyrate, 150mM NaCl), with centrifugation at 2000rpm (MSE 3000, 
4°C, 7 minutes).  For the elution of the immunoprecipitated (bound, B) material from 
the protein A-sepharose, pellets were resuspended in 250μl 1% SDS/incubation 
buffer and incubated for 15 minutes on a fast rotating turntable at room temperature.  
After centrifugation (13000rpm, MSE microcentaur, 10 minutes) the supernatant (B) 
was removed and stored on ice.  This was then repeated with a further 250μl 1% 
SDS/incubation buffer.  The two extracts were combined and an equal volume of 
incubation buffer added to reduce the concentration of SDS to 0.5% (B). 
 
For the isolation of DNA, both the B and UB fractions were treated to two 
phenol/chloroform washes and one chloroform extraction.  DNA was ethanol 
precipitated with 1/10th volume (100μl) 4M LiCl, 50μg glycogen as a carrier, and 4x 
volume of ice-cold ethanol.  The samples were vortexed thoroughly and allowed to 
precipitate overnight at -80°C.  Precipitated DNA was centrifuged (3000rpm, MSE 
3000, 4°C, 25 minutes) then pellets were re-dissolved in 300μl UltraPure d.H2O 
(NChIP samples) or 40-80μl UltraPure d.H2O (CChIP samples). 
 
2.4.2.2. Immunoprecipitation from Fixed Chromatin (XChIP) 
Antibody-bead complexes were formed by first washing Dynabeads protein A 
(Invitrogen) four times in RIPA buffer (10mM Tris-HCl pH 7.5, 1mM EDTA, 0.5mM 
EGTA, 1% Triton, 0.1% SDS, 0.1% Na deoxycholate, 150mM NaCl) and then 
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incubating with 2.5μg antibody (Table 2.5) overnight at 4oC.  To each antibody/bead 
complex, 25μg cross-linked chromatin was added and rotated at room temperature 
for 2 hours on a fast turntable.  Beads were washed with 200μl RIPA buffer five times 
before washing once with TE (1mM EDTA, 10mM Tris).  Antibody-bound DNA was 
eluted by addition of Elution buffer (20mM Tris-Hcl pH 7.5, 5mM EDTA, 5mM Na 
butyrate, 50mM NaCl, 1% SDS).  Cross-links were reversed by proteinase K 
digestion at a concentration of 50μg/ml at 68oC, 300rpm for 2 hours in an Eppendorf 
Thermomixer.  DNA was ethanol precipitated following two phenol/chloroform 
extractions and one chloroform extraction.  DNA was recovered by centrifuging at 
13000rpm (MSE microcentaur) and resuspended in 20μl UltraPure d.H2O. 
 
2.4.3. PicoGreen Assay of ChIP DNA 
For the determination of the yield of DNA in both the B and UB samples following 
immunoprecipitation, 2μl DNA was diluted 1:100 in Quant-iT PicoGreen reagent 
(Invitrogen).  The percentage pull down (B/UBx100) for each antibody was then 
calculated and NChIP UB samples were diluted in d.H2O to the concentration of the 
appropriate B sample concentration, to ensure that equal amounts of DNA were 
analysed.  CChIP UB samples were diluted 1:2 in UltraPure d.H2O. 
 
2.4.4. Quantitative Real-Time Polymerase Chain Reaction (qPCR) Analysis of 
NChIP and XChIP DNA 
For the analysis of the relative levels of histone modifications across specific 
promiscuously-expressed genes following NChIP or XChIP, quantitative real-time 
PCR (qPCR) was performed on the Rotor-Gene™ RG-3000 (Corbett Research) or 
 90
ABI 7900HT (Applied Biosystems) using SYBR Green with primers specific for 
various genes of interest (Table 2.6, 2.7 and 2.8).  Primers were made by Invitrogen 
and primer pairs were designed using the aid of Primer3 software 
(http://frodo.wi.mit.edu/primer3/). 
 
PCR reactions were carried out in triplicates in 10-15μl volumes in 1xQuantiTect 
SYBR Green PCR Master Mix (Qiagen) and 500nM forward and reverse primers, 
with equal concentrations of either B or UB or input ChIP DNA.  After an initial 
denaturation step (95°C, 15 minutes), cycling was performed at 94°C for 15 seconds, 
57-60°C (depending on primer pair) for 30 seconds and 68-72°C for 15 seconds (44 
cycles).  The fluorescent signal produced from the amplicon was acquired at the end 
of each polymerisation step.  Specific amplification of target genes was verified by 
melt curve analysis (72-99°C, hold 30 seconds on 1st step then 5 seconds on next 
steps) and by fractionation of PCR products on 2% agarose gels, which were 
identified by their fragment size.  Reaction amplification efficiency and Ct values were 
obtained using Rotor-Gene™ 6.0 software (Corbett Research).  Standard curves with 
reaction efficiencies no greater than 1 and R2 values no less than 0.98 were 
generated for each primer set using serial dilutions of Mus musculus genomic DNA 
(gDNA), and used to generate concentrations for each PCR product.  B:UB ratios 
were then calculated.  XChIP data was a ratio of B:input and was normalised to 
results for glyceraldehyde-3-phosphate dehydrogenase (Gapdh). 
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Table 2.6 – Sequences of Mus musculus Genomic DNA Tissue-Restricted 
Antigen Primer Sets Used in Quantitative Real-Time Polymerase Chain 
Reaction (PCR) with ChIP DNA 




Pseudogene (Gm12033) [Gapdh] 100042746 149bp 60°C 
Promoter Region Forward: 5` -TGTGGCCAAGCACTTGTATAAC- 3` 
Promoter Region Reverse: 5` -TATGTCTGACCAGAGGAGAGCA- 3` 
Casein-Alpha [Csn1s1] (Extension at 68°C) NM_007784 150bp 57°C 
Promoter Region Forward: 5` -CCCTACTCTTGGGTTCAAGG- 3` 
Promoter Region Reverse: 5` -GCTCTTAGCGTACTGGAACAAA- 3` 
Salivary Protein-1 [Spt1] NM_009267 120bp 60°C 
Promoter Region Forward: 5` -TGGCTGTGTGGTTGATTCTC- 3` 
Promoter Region Reverse: 5` -CAGGGTTCCACATCAAGGAC- 3` 
Salivary Protein-1 [Spt1] NM_009267 108bp 60°C 
Coding Region Forward: 5` -GGTGGGACCAATAACATTCC- 3` 
Coding Region Reverse: 5` -GCCTGAGTTTCAGAGCCAGT- 3` 
Salivary Protein-2 [Spt2] (Renamed Mucin-like 1 
[Mucl1] 14.04.09) NM_009268 140bp 60°C 
Promoter Region Forward: 5` -TAATTGGCCTCTGGCTGTGT- 3` 
Promoter Region Reverse: 5` -TCTTGACACCAGGGTTCCAC- 3` 
Salivary Protein-2 [Spt2] (Renamed Mucin-like 1 
[Mucl1] 14.04.09) NM_009268 200bp 60°C 
Coding Region Forward: 5` -GGTGGGACCAATAACATTCC- 3` 
Coding Region Reverse: 5` -GCCTGAGTTTCAGAGCCAGT- 3` 
Recombination Activating Gene 1 [Rag1]  NM_009019 154bp 60°C 
Coding Region Forward: 5` -AACTCAGGCTAGGGTCAGCA- 3` 
Coding Region Reverse: 5` -GGGATCAGCCAGAATGTGTT- 3` 
Selection and Upkeep of Intraepithelial T-cells 1 
[Skint1] NM_001102662 143bp 60°C 
Promoter Region Forward: 5` -CAATGGGATCCACAGGACTA- 3` 
Promoter Region Reverse: 5` -TGCTCCTAACTATTCCCAACAAA- 3` 
Proteasome Subunit Beta-Type 11 [Psmβ11] NM_175204 197bp 60°C 
Promoter Region Forward: 5` -GTTCTCTGAGGTGGGTGGAG- 3` 
Promoter Region Reverse: 5` -GCTGAGTGAGAATCGGAAGG- 3` 
 
 
For the quantitation of levels of histone modifications across AIRE-regulated 
and control genes following chromatin immunoprecipitation, quantitative real-
time PCR (qPCR) was performed with primers specific for the genes listed.  
Illustrated are the NCBI reference code, the length of amplicon generated and 
the annealing temperature (Tm) of each primer set. 
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Table 2.7 – Sequences of Mus musculus Genomic DNA Keratin Cluster 
Primer Sets Used in Quantitative Real-Time Polymerase Chain Reaction 
(PCR) with ChIP DNA 
PRIMER NAME NCBI REFERENCE 
AMPLICON 
LENGTH Tm 
Keratin 4 [Krt4] NM_008475 181bp 60°C 
Promoter Region Forward: 5` -AGCTCCCATCCAAGATCACA- 3` 
Promoter Region Reverse: 5` -CAGACCCTGGAACCTGAGAG- 3` 
Keratin 79 [Krt79] NM_146063 173bp 60°C 
Coding Region Forward: 5` -GTGGTGGCAGCTGCTCTTAT- 3` 
Coding Region Reverse: 5` -GGTACCAGGACTCAGCCTCA- 3` 
Keratin 78 [Krt78] NM_212487 225bp 60°C 
Promoter Region Forward: 5` -CAGCAAGTGGCAGACACAGT- 3` 
Promoter Region Reverse: 5` -AAAGGCAGAACACGCTGAGT- 3` 
Keratin 8 [Krt8] NM_031170 187bp 60°C 
Promoter Region Forward: 5` -GTTAGGCCCTGCCCTCTAGT- 3` 
Promoter Region Reverse: 5` -TGGACATGGTGAAGTCTGGA- 3` 
Keratin 18 [Krt18] NM_010664 169bp 60°C 
Promoter Region Forward: 5` -CTCCCAAGTGCTGGGATAAA- 3` 
Promoter Region Reverse: 5` -AGCATACCTGCCATCCTCAC- 3` 
Eukaryotic Translation Initiation Factor 4b [Eif4b] NM_145625 134bp 60°C 
Promoter Region Forward: 5` -AAAAGCCCATGGTTCAAATG- 3` 
Promoter Region Reverse: 5` -GGGTGTGCCACAATTGATTT- 3` 
Tensin like C1 Domain-containing Phosphatase 
[Tenc1] NM_153533 206bp 60°C 
Promoter Region Forward: 5` -CCTGCACTTCCCTCCACTT- 3` 
Promoter Region Reverse: 5` -GCTCTGAGCAACCTTTCCAC- 3` 
SPRY Domain-containing 3 [Spryd3] NM_001033277 226bp 60°C 
Promoter Region Forward: 5` -GCTGAGAGGCCTATGGATGA- 3` 
Promoter Region Reverse: 5` -ACCTGTCAATGAGGCTACGC- 3` 
 
 
For the quantitation of levels of histone modifications across AIRE-regulated 
genes of the keratin cluster following chromatin immunoprecipitation, 
quantitative real-time PCR (qPCR) was performed with primers specific for the 
genes listed.  Illustrated are the NCBI reference code, the length of amplicon 
generated and the annealing temperature (Tm) of each primer set. 
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Table 2.8 – Sequences of Mus musculus Genomic DNA Keratin Cluster 
Intergenic Region Primer Sets Used in Quantitative Real-Time Polymerase 
Chain Reaction (PCR) with ChIP DNA 
PRIMER NAME AMPLICON LENGTH Tm 
Krt4?Krt79 Intergenic Region [INT1] 166bp 60°C 
Forward: 5` -CCCTAGCTCCCAGGGTAGAG- 3` 
Reverse: 5` -ATGTCAGGCAGTGCTGTGAG- 3` 
Krt79?Krt78 Intergenic Region [INT2] 234bp 60°C 
Forward: 5` -TTGGGCTTAATTCCTGAACG- 3` 
Reverse: 5` -CAAAATATCCCCCACCACAG- 3` 
Krt78?Krt8 Intergenic Region A [INT3A] 187bp 60°C 
Forward: 5` -TCTTTTCAGGACTGGGGATG- 3` 
Reverse: 5` -CCAATTCCAGGGATCGAGTA- 3` 
Krt78?Krt8 Intergenic Region B [INT3B] 179bp 60°C 
Forward: 5` -CATGCTCCGTGCAAACTAGA- 3` 
Reverse: 5` -CCTCCACACAGACCTGGAAT- 3` 
Krt78?Krt8 Intergenic Region C [INT3C] 196bp 60°C 
Forward: 5` -GTGGCTTTGGATTTGAGAGC- 3` 
Reverse: 5` -AATGGTGACCTGAGGCAAAC- 3` 
Krt8?Krt18 Intergenic Region [INT4] 234bp 60°C 
Forward: 5` -CTGATGATGGTGACCTGGTG- 3` 
Reverse: 5` -TGCCTCCTAGCCGCTATTTA- 3` 
Krt18?Eif4b Intergenic Region A [INT5A] 206bp 60°C 
Forward: 5` -TGCTGGGGTGGTATTGTGTA- 3` 
Reverse: 5` -GGCCTGCCTCTTAGGATCTC- 3` 
Krt18?Eif4b Intergenic Region B [INT5B] 192bp 60°C 
Forward: 5` -CCAGACCCTGTCTCAGGAAA- 3` 
Reverse: 5` -TCACCACATGGAGGTCAGAA- 3` 
Krt18?Eif4b Intergenic Region C [INT5C] 188bp 60°C 
Forward: 5` -GTGGTCAGGCTGAAAACCAT- 3` 
Reverse: 5` -TCACCGTGCTTGGTAGATTG- 3` 
Eif4b ? Tenc1 Intergenic Region [INT6] 243bp 60°C 
Forward: 5` -CCTAGCCTTTGCCAGAACAG- 3` 
Reverse: 5` -CAGCGTTCCTTAGCAGATCC- 3` 
Tenc1 ? Spryd3 Intergenic Region [INT7] 118bp 60°C 
Forward: 5` -GCCGCCGAGTGTTAGGTA- 3` 
Reverse: 5` -CCGCTAAATCTGACCAATCC- 3` 
 
For the quantitation of levels of histone modifications across AIRE-regulated 
genes of the keratin cluster following chromatin immunoprecipitation, 
quantitative real-time PCR (qPCR) was performed with primers specific for the 
genes listed.  Illustrated are the length of amplicon generated and the annealing 
temperature (Tm) of each primer set. 
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2.4.5. Radioactive Polymerase Chain Reaction (PCR) Analysis of CChIP DNA 
To assay histone modifications in primary cell populations following CChIP, 
radioactive PCR was performed with B and UB CChIP DNA, alongside Mus 
musculus and Drosophila melanogaster gDNA controls to monitor cross-
hybridization, using primers specific for various genes of interest (Table 2.6).  Primers 
were made by Invitrogen and primer pairs were designed using the aid of Primer3 
software (http://frodo.wi.mit.edu/primer3/). 
 
PCR reactions were carried out in 50μl volumes in Reddy Mix PCR Master Mix (AB 
Gene) and 500nM forward and reverse primers, with 2μl neat B and 2μl 1:2 diluted 
UB DNA.  To each reaction, 0.1µCi of dCTP radiolabelled with α-32P (Perkin Elmer) 
was added.  Cycling was performed at 94°C for 60 seconds, 57-60°C (depending on 
primer pair) for 60 seconds and 68-72°C for 90 seconds (41 cycles). 
 
As standard, 7μl aliquots were removed after 38 and 41 cycles, loaded onto 5% 
polyacrylamide gels and electrophoresed at 250 volts, 120 mA for 30 minutes.  Gels 
were dried onto filter paper (SpeedGel System, Thermo Savant) for a minimum of 2 
hours.  Filters were exposed to a phosphor screen overnight and scanned with a 
PhosphorImager (Typhoon 9200, Amersham).  Intensity values for each PCR product 
were analysed with ‘Image Quant TL’ software (Molecular Dynamics), the ratio of B to 





3.1. CHARACTERISATION OF THE THYMIC EPITHELIAL CELL MODEL SYSTEM 
 
To date, promiscuous gene expression (PGE) of tissue-restricted antigens (TRA) 
within the thymus is very well characterised in terms of the panel of TRA regulated 
by AIRE, the timing of AIRE expression in vivo, and the specific cell type in which 
this process occurs.  However, many questions remain unanswered about this 
phenomenon (Derbinski et al. 2001; Anderson et al. 2002; Rossi et al. 2007).  
Although AIRE has demonstrated transcriptional transactivational properties, is 
found within large multi-protein complexes at distinct foci throughout the nucleus, 
along with the histone acetyltransferase CREB-binding protein (KAT3A/CBP) and is 
able to bind unmethylated histone H3 lysine 4, the fundamental aspects of how this 
protein functions as a transcriptional regulator remain unknown (Pitkanen et al. 
2000; Pitkanen et al. 2005; Ruan et al. 2007; Koh et al. 2008; Org et al. 2008).  To 
decipher the molecular complexities of AIRE’s control of PGE, we undertook an 
analysis of the epigenetic status of TRA under the transcriptional control of AIRE.  
Investigating the role AIRE plays in vivo is particularly challenging as the number of 
mature CD80+AIRE+ mTECs is extremely low, thus a Mus musculus thymic epithelial 
(TEP) cell model system was employed, in order to replicate AIRE function in vivo.  
The TEP cell line, which normally lacks AIRE, was transfected with MIg virus 
bicistronic constructs containing both AIRE and GFP (TEP-AIRE), or GFP alone as a 
control (TEP-GFP).  Both parent lines were FACS sorted based on GFP expression, 
and purified populations clonally expanded prior to experimental analysis to ensure 
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GFP+AIRE+ cells were expressing AIRE at 100% efficiency which was verified by 
flow cytometric analysis (Figure 3.1). 
 
3.1.1. Localisation and Expression of AIRE and Tissue-Restricted Antigens in 
the Thymic Epithelial Cell Line 
The up-regulation of AIRE upon RANK-RANKL stimulation is known to result in the 
induced expression of a wide range of TRA within mature CD80+AIRE+ mTECs, and 
this event has been successfully modelled in mammalian cell culture previously, by 
numerous groups (Pitkanen et al. 2001; Halonen et al. 2004; Pitkanen et al. 2005; 
Org et al. 2008).  Correct localisation and activity of AIRE within the TEP cell line 
was verified through immunofluorescence microscopy and expression analysis 
(Figure 3.2). 
 
AIRE displays a predominantly nuclear localisation pattern, forming distinct, punctate 
nuclear speckles in vivo, although associations with microtubular structures within 
the cytoplasm have also been observed in transfected cell lines (Pitkanen et al. 
2001; Hubert et al. 2008).  Cultured TEP-AIRE and TEP-GFP cells were 
immunostained for AIRE and counterstained with DAPI for DNA, which revealed a 
speckled pattern of AIRE, limited to the nucleus, in the majority of AIRE-positive 
cells, not seen in control TEP-GFP cells (Figure 3.2 A).  Comparison to AIRE in wild-
type BALB/c (haplotype H-2d) mTEC in vivo, revealed an analogous distribution 
(Figure 3.2 B).  Quantitative real-time PCR (qPCR) with cDNA, prepared from TEP-
AIRE and TEP-GFP mRNA, was performed for AIRE and three known TRA, 
positively influenced by AIRE; casein-α (Csn1s1), salivary protein-1 (Spt1) and 
Mus musculus thymic epithelial (TEP) cell lines were transfected with MIg virus 
bicistronic constructs containing either AIRE-GFP (TEP-AIRE), or GFP alone 
(TEP-GFP) as a control.  Transfected populations were clonally expanded and 
purified.  For verification of the efficiency of transfection, flow cytometric analysis 
was carried out, gated on GFP, with freshly isolated thymocytes as a negative 
control.  TEP-AIRE and TEP-GFP lines were seen to express GFP at greater 
than 96% efficiency.
Figure 3.1 – Characterisation of Thymic Epithelial Cell Lines: Transfection 
Efficiency
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A, Immunofluorescence of Mus musculus thymic epithelial (TEP) cell lines, revealed 
a subcellular nuclear localisation of AIRE equivalent to AIRE in mTECs in vivo. 
TEP cells transfected with either MIg-AIRE-GFP (TEP-AIRE), or MIg-GFP (TEP-
GFP), were cultured and stained with FITC anti-AIRE antibody (green) and DNA 
counterstained with DAPI (blue).  Punctate AIRE nuclear bodies were observed in 
TEP-AIRE cells (i, ii), but not in TEP-GFP (iii).  B, Subcellular localisation of AIRE 
(green) within thymic medulla (i, ii), for comparison.  Medullary TECs denoted 
by cytokeratins 5 staining (red).  Punctate AIRE nuclear staining of individual 
mTECs shown in (ii).  C, Real-time quantitative PCR was used to compare the 
relative mRNA expression levels of AIRE and three tissue-restricted antigens; 
casein-α (Csn1s1); salivary protein-1 (Spt1); and salivary protein-2 (Spt2), as 
indicated, showing active expression of AIRE and its target genes.  Turquoise 
columns represent data from TEP-GFP cells and pink columns represent results 
from TEP-AIRE cells.  Data was normalised to β-actin expression levels as 
standard.  Data are the mean ±SEM from technical triplicate reactions, and are 
representative of at least two distinct cDNA preparations.
Figure 3.2 – Characterisation of Thymic Epithelial Cell Lines: Subcellular 




salivary protein-2 (Spt2), and as standard expression levels were normalised to β-
actin, which remained constant for the two cell populations.  High levels of AIRE, 
Csn1s1, Spt1 and Spt2 transcript were detected in TEP-AIRE cells, which were not 
observed for TEP-GFP cells (Figure 3.2 C).  In conclusion, these findings indicate 
that the TEP cell line expresses AIRE in the appropriate sub-cellular compartment, 
leading to AIRE-dependent TRA expression.  On this basis, this system was used in 
initial experiments to study the epigenetic status of AIRE-dependent genes in the 
presence and absence of AIRE. 
 
3.1.2. Global Analysis of the Relative Levels of Post-translational Histone 
Modifications in AIRE-Positive and AIRE-Negative Thymic Epithelial Cells 
Since AIRE has been reported to complex with the transcriptional co-activator 
KAT3A/CBP, a known histone acetyltransferase, and given that AIRE has been 
shown to directly regulate expression of a large number of genes found within 
clusters along chromosomes of mature mTECs, we wanted to investigate whether 
alterations to the global levels of histone modifications could account for PGE.  
Histones were extracted from TEP-AIRE and TEP-GFP cells and equal 
concentrations of protein were separated by SDS-PAGE, Western blotted and 
labelled with antibodies specific to acetylation (H3K9ac, H4K8ac and H4K16ac) and 
methylation (H3K4me1, me2 and me3, H3K9me2 and H3K27me3) post-translational 
histone modifications (Figure 3.3).  The functional relevance of these histone 
modifications is displayed in Table 3.1.  This revealed an equal distribution of all 
eight marks across the two TEP populations, suggesting that, at the protein level, 
AIRE does not impact on histone modifications on a global scale.  However, this 
SDS-PAGE and Western blot analysis of global post-translational histone 
modifications in Mus musculus thymic epithelial (TEP) cell lines revealed no 
change in the presence and absence of AIRE.  Core histones were acid extracted 
from cultured TEP-AIRE and TEP-GFP populations, resolved by SDS-PAGE and 
transferred to membranes for Western blot analysis.  Equivalent loading was 
determined by Ponceau red staining of bulk histones (control).  Blots were probed 
with antibodies directed against acetylation and methylation of specific lysine 
residues on histones H3 and H4 (H3K4me1, H3K4me2, H3K4me3, H3K9ac, 
H4K8ac, H4K16ac, H3K9me2 and H3K27me3).  Immunocomplexes were 
detected following secondary antibody peroxidase goat anti-rabbit IgG binding, 
by enhanced chemiluminescence.
Figure 3.3 – Characterisation of Thymic Epithelial Cell Lines: Global Levels 
of Post-Translational Histone Modifications
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Table 3.1 – Typical Functions of the Histone Modifications Investigated 
Through Native and Carrier Chromatin Immunoprecipitation 
ChIP ANTIBODIES AND THEIR FUNCTIONS 
ANTIBODY SPECIFICITY FUNCTION 
R204 H3K4me1 ACTIVE 
R149 H3K4me2 ACTIVE 
R612 H3K4me3 ACTIVE 
R607 H3K9ac ACTIVE 
R403 H4K8ac ACTIVE 
R252 H4K16ac ACTIVE 
07-212 H3K9me2 INACTIVE 
07-449 H3K27me3 INACTIVE 
PI Pre-immune CONTROL 
 
 
The name of each antibody used in native chromatin immunoprecipitation with 
cultured AIRE-negative and AIRE-positive thymic epithelial cell lines is 
displayed along with the histone modification against which they act.  For 
reference, the general role these marks play in the control of transcription is 
represented.  Pre-immune is a no antibody control. 
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procedure does not fully address the issue of whether AIRE imparts its function 
through a genome-wide effect on epigenetic marks.  We therefore employed a 
technique which has been used frequently to assess the global distribution of 
histone modifications across metaphase chromosome spreads, revealing highly 
defined banding patterns along the individual chromosome arms, and thus making 
any large-scale changes easily identifiable (O'Neill et al. 1999; O'Neill et al. 2003).  
Unfixed metaphase chromosomes from TEP-AIRE and TEP-GFP cells were 
immunolabelled with antibodies to an acetylation mark H3K9ac, an active methyl 
mark H3K4me3 and a silent methyl mark H3K27me3, and counterstained with DAPI 
for DNA (Figure 3.4). 
 
The spread and intensity of acetylation and methylation was consistently 
comparable to the control cells across the genome in the presence of AIRE, with no 
loss of the characteristic banding patterns.  It should be noted that the TEP cell line 
is tetraploid, with double the expected number of chromosomes, however, this trait is 
common to both the TEP-AIRE and TEP-GFP cells.  These data suggest that AIRE 
does not impart its function through any detectable genome-wide alterations to 
acetylation or methylation levels on the histone protein tails, despite the global 
distribution of its thousands of target genes, and given its known association with a 
histone acetyltransferase and localisation within PML-like bodies within the nucleus. 
Metaphase chromosome spreads were prepared from Mus musculus thymic 
epithelial (TEP) cells transfected with either MIg-AIRE-GFP (TEP-AIRE), or MIg-
GFP (TEP-GFP).  Chromosomes were immunostained with primary antibodies 
(green) to H3K9ac, H3K4me3 and H3K27me3, with FITC goat anti-rabbit 
secondary antibody, as indicated.  DNA was counterstained with DAPI (false 
coloured red).  Spreads were captured at a high magnification (x100 objective) 
and show equivalent banding patterns characteristic of each modification, in both 
the presence and absence of AIRE.  Both cell populations also present with a 
tetraploid genome.
Figure 3.4 – Characterisation of Thymic Epithelial Cell Lines: Acetylation 
and Methylation Levels across Metaphase Chromosomes
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3.2. ANALYSIS OF THE EFFECTS OF AIRE IN A NON-THYMIC CELL LINE 
 
3.2.1. Localisation and Expression of AIRE and Tissue-Restricted Antigens in a 
Non-Thymic 3T3 Fibroblast Cell Line 
In a thymic epithelial cell background, we have demonstrated that AIRE is able to 
assemble and localise to nuclear sub-structures and exert its transcriptional activity, 
mirroring its behaviour in vivo.  However, in order to determine whether AIRE alone is 
sufficient for promiscuous gene expression, or whether factors unique to thymic-
derived cells are required for correct functioning, a Mus musculus fibroblast 3T3 line 
was stably transfected with either MIg-GFP-AIRE (3T3-AIRE), or MIg-GFP alone 
(3T3-GFP) as a control.  As for the TEP model system, both 3T3 populations were 
FACS sorted to ensure 100% transfection efficiency, verified through flow cytometric 
analysis (Figure 3.5 A).  Immunofluorescence staining with anti-AIRE antibody 
revealed a sub-cellular localisation similar to that shown for AIRE in the thymic 
epithelial cell background, with AIRE-positive 3T3 cells displaying a punctate nuclear 
localisation of AIRE not observed in the 3T3-GFP control cells (Figure 3.5 B). 
 
We next sought to determine whether the presence of AIRE within these cells was 
sufficient to trigger promiscuous gene expression.  The degree of expression of 
AIRE and the three TRA Csn1s1, Spt1 and Spt2 was analysed with 3T3-AIRE and 
3T3-GFP cDNA, and compared to β-actin, levels of which were equal for both 3T3 
populations.  Transcript levels of AIRE, Csn1s1, Spt1 and Spt2 were detected at 
elevated levels in 3T3-AIRE cells, while the 3T3-GFP control cells showed little or no 
A, Mus musculus 3T3 fibroblast (3T3) cell lines were transfected with MIg virus 
bicistronic constructs containing either AIRE-GFP (3T3-AIRE), or GFP alone (3T3-
GFP) as a control.  Transfected populations were clonally expanded and purified. 
For verification of the efficiency of transfection, flow cytometric analysis was 
carried out, gated on GFP, with freshly isolated thymocytes as a negative control. 
3T3-AIRE and 3T3-GFP lines were seen to express GFP at 100% efficiency.  B, 
Immunofluorescence of 3T3 cells, staining with FITC anti-AIRE antibody (green) 
and DNA counterstained with DAPI (blue).  Punctate AIRE nuclear bodies were 
observed in 3T3-AIRE cells (i, ii), but not in 3T3-GFP (iii).  C, Real-time quantitative 
PCR was used to compare the relative mRNA expression levels of AIRE and 
three tissue-restricted antigens; casein-α (Csn1s1); salivary protein-1 (Spt1); and 
salivary protein-2 (Spt2), as indicated, showing active expression of AIRE and 
its target genes.  Yellow columns represent data from 3T3-GFP cells and blue 
columns represent results from 3T3-AIRE cells.  Data was normalised to β-actin 
expression levels as standard.  Data are the mean ±SEM from technical triplicate 
reactions, and are representative of at least two distinct cDNA preparations.
Figure 3.5 – Analysis of the Effects of AIRE in a Non-Thymic Cell Line: 
Transfection Efficiency, Subcellular Distribution and Expression of the 
Autoimmune Regulator and Tissue-Restricted Antigens
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amount of these genes (Figure 3.5 C).  These results clearly illustrate that AIRE is 
able to exert its function independently of a thymic cell environment; localising to 
nuclear speckles and inducing the expression of TRA, in a manner directly 
comparable to that within wild-type mTECs and the TEP model cell line.  These 
findings also confirm that AIRE is capable of up-regulating TRA without additional 
molecular requirements and that the presence of AIRE is itself sufficient for the 
initiation of promiscuous gene expression.  However, the absolute transcript levels 
detected for AIRE, Spt1 and Spt2 in the 3T3-AIRE cells were considerably lower 
compared to the levels within TEP-AIRE cells (Figure 3.6).  This was not a result of 
transfection efficiency since both parent lines were FACS sorted and purified prior to 
experimental analysis and frequent analysis of AIRE expression confirmed the 
maintenance of this transfection.  Therefore this decreased expression level of AIRE 
and the two salivary proteins in the 3T3-AIRE cells may imply that AIRE requires 
certain unidentified thymic factors to function optimally. 
 
3.3. PATTERNS OF HISTONE MODIFICATIONS ACROSS TISSUE-RESTRICTED ANTIGENS IN 
THE THYMIC EPITHELIAL CELL MODEL SYSTEM AS REVEALED BY NATIVE CHROMATIN 
IMMUNOPRECIPITATION 
 
AIRE, with its SAND domain, two PHD-zinc fingers and LXXLL motifs, shows 
transcriptional transactivating properties and is predicted to be a transcriptional 
regulator, contributing to central tolerance through the control of promiscuous gene 
expression within the thymus (Pitkanen et al. 2000; Kumar et al. 2001; Su and 
Anderson 2004; Devoss and Anderson 2007).  Current technologies enable the 
Real-time quantitative PCR was used to compare the relative mRNA expression 
levels of AIRE and three tissue-restricted antigens in Mus musculus thymic 
epithelial (TEP) and 3T3 fibroblast (3T3) cell lines, transfected with MIg virus 
bicistronic constructs containing either AIRE-GFP (TEP-AIRE / 3T3-AIRE), or 
GFP alone (TEP-GFP / 3T3-GFP) as a control.  Data displayed is a comparison 
of the levels of AIRE expression, and its three target genes; casein-α (Csn1s1); 
salivary protein-1 (Spt1); and salivary protein-2 (Spt2), as indicated.  Although 
AIRE-positive populations were sorted to ensure 100% transfection efficiency, 
expression of AIRE, Spt1 and Spt2 was more efficient in the thymic background. 
Csn1s1 levels appear unaffected.  Turquoise columns represent data from TEP-
GFP cells, pink columns; results from TEP-AIRE cells, yellow columns; from 3T3-
GFP cells and blue columns; from 3T3-AIRE cells.  Data was normalised to β-actin 
expression levels as standard and all expression levels were set relative to those 
of TEP-AIRE for comparison.  Data are the mean ±SEM from technical triplicate 
reactions, and are representative of at least two distinct cDNA preparations.
Figure 3.6 - Analysis of the Transcriptional Effects of AIRE: Comparative 
Expression Levels of the Autoimmune Regulator and Tissue-Restricted 
Antigens within Thymic and Non-Thymic Backgrounds
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comprehensive study of gene expression, and with the advance of knowledge 
regarding the role nucleosomal histone proteins play in these processes, the 
function of effector molecules involved in transcriptional activation, such as AIRE, 
can be examined more thoroughly. 
 
Post-translational modifications to the tails of histone proteins, such as acetylation 
and methylation, are important epigenetic marks, playing a role in the control of 
eukaryotic gene expression programmes by influencing chromatin structure 
(Kouzarides 2007).  Whilst immunofluorescence microscopy and Western blotting 
have proved invaluable for investigating the distribution of histone modifications on a 
genome-wide scale, they are unable to directly address the epigenetic status of 
chromatin at the single gene level.  Through the development of native chromatin 
immunoprecipitation (NChIP), investigation into the relative levels of a variety of 
histone tail modifications at specific gene regions has been made possible (O'Neill 
and Turner 2003). 
 
Given AIRE’s ability to switch on so many TRA, we sought to analyse the histone 
modifications associated with these AIRE-regulated genes through NChIP.  Cultured 
TEP-AIRE and TEP-GFP cells were harvested in the absence of a cross-linker and 
chromatin was isolated and prepared through mild micrococcal nuclease digestion.  
Subsequent analysis on 1.2% agarose gels consistently revealed classical 
oligonucleosomal ladders, with the first supernatant (S1) fractions showing a high 
proportion of mononucleosomes, the S2 fractions displaying the di-, tri-, tetra- and 
pentanucleosomes, and the pellet (P) samples showing the higher molecular 
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insoluble material.  For immunoprecipitation, an input sample representative of the 
starting material was required and therefore supernatants S1 and S2 were routinely 
combined, which together approximate to 90% of the DNA.  Input chromatin was 
then incubated with antibodies directed against a panel of activating and silencing 
histone modifications (Table 3.1), global levels of which were previously shown to be 
unaffected by AIRE (Figures 3.3 and 3.4).  Immunocomplexes were then isolated 
through addition of protein A-sepharose, generating bound (B) and unbound (UB) 
fractions following elution.  The success of each IP was routinely monitored by 
calculation of the percentage pull-down of DNA in the bound fraction and visually by 
1.2% AGE (Figure 3.7), and typically antibody pull-downs were in the range of 1 to 
28% (Table 3.2). 
 
For the determination of the relative amounts of histone modification across specific 
promiscuous gene regions, qPCR was employed.  To ensure accurate measurement 
and interpretation of the data generated for each gene region, a standard curve was 
generated for each primer set with a range of Mus musculus genomic DNA 
standards, to which comparisons were made following each qPCR run.  Equal 
concentrations of bound and unbound NChIP DNA were used for qPCR analysis, 
and the ratio of bound to unbound signal was calculated.  For each histone 
modification, a bound:unbound ratio less than 1 suggests a depletion of that specific 
mark, whereas a ratio greater than 1 equates to enrichment over that specific gene 
region. 
Outline of the native chromatin immunoprecipitation (NChIP) protocol.  A, 
Diagrammatic representation of the NChIP procedure.  Chromatin from cultured 
cell nuclei is isolated and digested with micrococcal nuclease (Mic Nuc) then 
immunoprecipitated with antibodies directed against post-translational histone 
modifications.  DNA from antibody-bound and –unbound fractions is then purified 
for analysis of the relative levels of each modification.  B, Routine analysis of 
chromatin fractions by 1.2% agarose gel electrophoresis.  Chromatin from a 
minimum of 1x107 unfixed AIRE-positive and AIRE-negative Mus musculus 
thymic epithelial (TEP) cells was isolated and digested with micrococcal nuclease, 
generating a ladder rich in mono-, di-, tri-, tetra-, and pentanucleosomes.  Equal 
amounts of the first supernatant (S1), soluble (S2) and insoluble (P) fractions 
were analysed by electrophoresis and visualised with ethidium bromide.  Size 
was determined by reference to a 100 base pair molecular marker (Invitrogen). 
Mono-, di- and tri-nucleosomes are indicated.
Figure 3.7 – Native Chromatin Immunoprecipitation: Isolation and Micrococcal 
Nuclease Digestion of Chromatin from Unfixed Thymic Epithelial Cells
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Table 3.2 – Efficiency of Pull-Down for Each Histone Modification 
Following Native Chromatin Immunoprecipitation 
NChIP PERCENTAGE PULL-DOWNS 
ANTIBODY SPECIFICITY TEP-GFP TEP-AIRE REPLICATES 
R204 H3K4me1 0.70-6.06% 1.17-10.68% 3 
R149 H3K4me2 0.76-5.15% 0.90-10.34% 3 
R612 H3K4me3 1.28-5.05% 5.19-12.38% 3 
R607 H3K9ac 6.86-9.53% 0.49-6.92% 3 
R403 H4K8ac 0.70-12.55% 1.49-28.15% 4 
R252 H4K16ac 0.65-4.25% 1.56-28.67% 4 
07-212 H3K9me2 1.64-1.77% 1.08-1.18% 3 
07-449 H3K27me3 3.18-7.53% 2.19-15.24% 3 
PI Pre-immune 0.46-0.61% 0.23-0.61% 4 
 
 
Native chromatin immunoprecipitation was performed with cultured AIRE-
negative (TEP-GFP) and AIRE-positive (TEP-AIRE) thymic epithelial cell lines, 
using antibodies directed against the post-translational histone modifications 
displayed above.  DNA from antibody-bound (B) and –unbound (UB) fractions 
was purified and the percentage pull down (B/UBx100) for each antibody was 
then calculated.  Pre-immune no antibody controls were included which show 
comparatively low pull-down efficiencies.  The number of biological replicates 
for each modification is displayed. 
 
 112
3.3.1. Pattern of Histone Modifications at the Casein-α Promoter Region and the 
Glyceraldehyde-3-phosphate Dehydrogenase Locus in the Thymic Epithelial 
Cell Model System 
The expression of the TRA Csn1s1 has been reliably demonstrated to be heavily 
dependent on AIRE, both within the thymic medulla, and in the presence of AIRE 
within our TEP model system and thus represents an ideal candidate gene 
(Anderson et al. 2002; Derbinski et al. 2005; Derbinski et al. 2008).  The panel of 
histone modifications examined reflects a diversity of potential functional outcomes, 
with three acetylation marks; H3K9ac, H4K8ac and H4K16ac, which are generally 
associated with active euchromatic genes, and three active methylation marks; 
H3K4me1, me2, me3, and two silent methylation marks H3K9me2 and H3K27me3 
(Table 3.1) (Kouzarides 2007).  Verification that the global levels of these 
modifications were unaffected by AIRE means that any changes observed on a 
gene-by-gene basis can be attributed to AIRE’s control of PGE. 
 
For TEP-AIRE cells, in which Csn1s1 is actively expressed, the promoter region of 
this gene is marked by significantly elevated levels of H3 and H4 acetylation, 
modifications usually indicative of active gene expression (Figure 3.8 A) (Fuchs et al. 
2009).  All three forms of H3K4 methylation are also enriched, in particular, high 
levels of H3K4me3 (bound:unbound ratio 4.68) were detected.  H3K4 methylation is 
generally considered to be associated with active euchromatic genes, as revealed by 
whole-genome ChIP-Seq approaches (Barski et al. 2007; Kouzarides 2007).  
H3K4me3 is often found localised to the promoter region of transcriptionally active 
genes, whereas me1 and me2 can occur in a more widespread pattern downstream 
Quantitation by native chromatin immunoprecipitation (NChIP) of levels of histone 
modifications at the promoter regions of casein-α (Csn1s1, A) and glyceraldehyde-
3-phosphate dehydrogenase (Gapdh, B) in cultured Mus musculus thymic 
epithelial (TEP) cell lines.  Turquoise columns represent results from AIRE-
negative TEP-GFP cells.  Purple columns are from TEP cells transfected with AIRE. 
Immunoprecipitation performed with affinity-purified antibodies to H3K4me1, 
H3K4me2, H3K4me3, H3K9ac, H4K8ac, H4K16ac, H3K9me2 and H3K27me3, 
as indicated.  Relative levels (bound:unbound) of histone modifications were 
calculated from immunoprecipitated (bound) and unprecipitated (unbound) 
DNA by quantitative real-time PCR.  Data are the mean ±SEM from at least two 
separate NChIP experiments.
Figure 3.8 - Quantitation of the Relative Levels of Histone Modifications 
across the Promoter Region of Casein-α and Glyceraldehyde-3-phosphate 
Dehydrogenase by Native Chromatin Immunoprecipitation
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of transcriptional start sites (TSS), with the marks becoming progressively more 
restricted to the TSS as the degree of methylation increases from me1 to me2 to me3 
(Barski et al. 2007).  In contrast, lower levels of H3K9me2 and H3K27me3 were seen 
in the presence of AIRE, with H3K9me2 showing a very low bound:unbound ratio of 
0.40, yet H3K27me3 was not depleted, with a bound:unbound ratio of 2.69.  For 
control TEP-GFP cells, the promoter region of Csn1s1 is marked by a contrasting 
pattern of modifications with a general depletion of active marks including H3K4me1, 
H3K4me3, H3K9ac and H4K8ac.  However, the promoter of this silent gene was not 
devoid of active modifications as H3K4me2 and H4K16ac were detected, although 
these levels were matched by enrichment of silencing modifications H3K9me2 and 
H3K27me3 (bound:unbound ratio 1.31 and 1.96 respectively).  The presence of 
these marks at the promoter of a non-expressed gene is typical as these histone 
modifications are frequently associated with transcriptional repression; H3K9me2 
through recruitment of heterochromatin protein 1 (HP1); and H3K27me3 via 
interactions with PcG proteins such as PRC1 (Cao and Zhang 2004; Dellino et al. 
2004; Kondo et al. 2008).  Overall, we see how the presence of AIRE leads to 
heightened levels of active marks, a loss of H3K9me2 but a maintenance of 
H3K27me3. 
 
Changes to the levels of histone modifications at the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were notably more moderate 
across the two cell populations in comparison to those seen for Csn1s1 (Figure 3.8 
B).  It should be noted that normalisation to Gapdh, or any other gene, was not 
carried out as this would assume maintenance of a constant epigenetic state, which 
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is not always the case (Valls et al. 2005; O'Neill et al. 2006).  Most importantly, this 
analysis showed a depletion of the marks characteristic of silent promoters, 
H3K9me2 and H3K27me3 in TEP-AIRE and TEP-GFP cells for this actively-
expressed gene, with both cell populations displaying similar levels of the two 
modifications.  Noticeably, there appears to be an overall depletion in all histone 
modifications for TEP-GFP, with only H4K8ac and H3K4me2 detected at levels 
greater than H3K9me2 and H3K27me3.  In addition, H3K9 acetylation, which is 
frequently enriched in active genes, is approximately 3-fold greater at Gapdh when 
compared to the Csn1s1 promoter (Roh et al. 2005).  However, AIRE does appear 
to influence the distribution of marks across this housekeeping gene, as TEP-AIRE 
cells show an enrichment of the active methylation and acetylation marks on 
histones H3 and H4, while TEP-GFP cells show a general depletion of these marks. 
 
3.3.2. Analysis of the Effects of AIRE upon the Salivary Protein Genes on Mus 
musculus Chromosome 15 in the Thymic Epithelial Cell Model System 
The TRA Spt1 and Spt2 have been well documented in terms of their AIRE-
dependence by numerous groups, and showed induced expression in the presence 
of AIRE within our TEP model system (Anderson et al. 2002; Rossi et al. 2007; Kont 
et al. 2008).  These genes are located adjacent to each other on Mus musculus 
chromosome 15 and we therefore wanted to investigate the pattern of histone 
modifications across the promoter (p) and coding (c) regions of both salivary 
proteins to determine AIRE’s affect on neighbouring genes. 
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The distribution of modifications for both salivary proteins essentially reflected those 
seen for Csn1s1, however, in general, all eight modifications were less enriched in 
both cell populations across the two salivary proteins, when compared to the levels 
seen for Csn1s1.  When we compare the pattern of modifications across Csn1s1 
and the two salivary proteins it would appear that a common theme is arising for 
TEP-GFP cells, with an overall depletion of H3 and H4 acetylation and mono-, di- 
and tri-methylation at histone H3K4; levels consistently showing me3 < me1 < me2 
preference (Figures 3.8 and 3.9).  For the salivary proteins, TEP-GFP cells show a 
depletion of all but H3K27me3, levels of which are maintained across the promoter 
and coding regions of both Spt1 and Spt2 at around a bound:unbound ratio of 2.00 
(Figure 3.9).  In contrast, H3K9me2 appears to show a preferential localisation at the 
3` end of both salivary proteins (Spt1(c) 1.04, Spt2(c) 0.74), with comparatively 
lower levels at the promoters (Spt1(p) 0.38, Spt2(p) 0.54).  Although the levels of 
H3K9me2 are surprisingly low, given this marks recognised localisation in silenced 
genes, they are consistently higher than the archetypal active modifications including 
H3K4me3 and H3K9ac in the TEP-GFP cells (Barski et al. 2007).  Therefore the 
dominance of H3K27me3 and H3K9me2 at these silent gene regions in the control 
cells may dictate the silencing of these genes.  TEP-AIRE cells also show some 
commonalities across all three TRA Csn1s1, Spt1 and Spt2 including 
hyperacetylation of histone H4, elevated levels of methylation of histone H3K4, and 
a depletion of H3K9me2, yet detectable levels of H3K27me3, often equalling the 
background TEP-GFP levels (Figures 3.8 and 3.9).  As for Csn1s1, the trend 
observed for the salivary proteins in the presence of AIRE is that of enriched levels 
Quantitation by native chromatin immunoprecipitation (NChIP) of levels of histone 
modifications at the promoter and coding regions of salivary protein-1 (Spt1, 
A) and salivary protein-2 (Spt2, B) in cultured Mus musculus thymic epithelial 
(TEP) cell lines.  Turquoise columns represent results from AIRE-negative 
TEP-GFP cells.  Purple columns are from TEP cells transfected with AIRE. 
Immunoprecipitation performed with affinity-purified antibodies to H3K4me1, 
H3K4me2, H3K4me3, H3K9ac, H4K8ac, H4K16ac, H3K9me2 and H3K27me3, 
as indicated.  Relative levels (bound:unbound) of histone modifications were 
calculated from immunoprecipitated (bound) and unprecipitated (unbound) 
DNA by quantitative real-time PCR.  Data are the mean ±SEM from at least two 
separate NChIP experiments.
Figure 3.9 - Quantitation of the Relative Levels of Histone Modifications 




of active marks, most noticeably for H3K9ac and H3K4me3, with little change to the 
silencing modifications. 
 
Distinct differences not only present themselves between the two salivary proteins 
themselves, but also between the promoter and coding regions.  TEP-AIRE cells 
display subtly diverse patterns of histone modifications which fluctuate as you move 
from the 5` to the 3` of both Spt1 and Spt2.  Acetylation, for example, appears to be 
generally constant across both loci, with H4K8ac levels remaining relatively constant 
at a bound:unbound ratio of around 1.50, as does H3K9ac (≈1.00).  H4K16ac also 
shows a domain-wide enrichment, starting at a ratio of 1.40 in Spt1(p) then 
increasing to around 3.00 in the coding regions, a level which is then maintained 
across Spt2.  Methylation however, shows a less consistent distribution.  For 
Spt1(p), the highest level of enrichment is for H3K4me3, however, as you move to 
the coding region of this gene, H3K4me2 levels peak, whereas the reverse is seen 
for Spt2. 
 
Analysis and comparison of histone modifications across three TRA under the 
transcriptional control of AIRE; Csn1s1, Spt1 and Spt2, has revealed some 
interesting and distinct differences.  The arrangement of epigenetic marks in TEP-
AIRE cells varies greatly from what appears to be a set pattern for these three genes 
within the TEP-GFP control population, particularly with regards to H3K4 
methylation, which shows significant enrichment in the presence of AIRE.  This 
investigation has also highlighted the specificity of histone modifications, with unique 
arrangements occurring even when two genes are adjacent to each other on a 
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chromosome, possibly suggesting individual regulation of each gene.  These 
distinctions become even more apparent when comparisons are made between 
genes located on different chromosomes (Spt1 / Spt2; Mus musculus chromosome 
15, Csn1s1; Mus musculus chromosome 5).  However, some of our findings do 
suggest that the regulation of these genes may occur through a domain-wide 
deposition of histone modifications, as evidenced by the high levels of H4K8 and 
H4K16 acetylation across both salivary proteins. 
 
3.3.3. Analysis of the Effects of AIRE upon a Cluster of AIRE-Regulated Genes; 
the Keratin Cluster on Mus musculus Chromosome 15 in the Thymic Epithelial 
Cell Model System 
Genome-wide analysis of genes under the control of AIRE highlighted the significant 
impact this molecule has on transcriptional programmes within mTECs (Anderson et 
al. 2002; Gotter et al. 2004).  The many thousands of TRAs influenced by AIRE were 
found to cluster along individual chromosomes and currently the issue of how AIRE 
controls the expression of each individual gene remains elusive (Gotter et al. 2004; 
Derbinski et al. 2005; Johnnidis et al. 2005).  AIRE is not believed to induce gene 
expression on a gene-by-gene basis, but instead is thought to regulate transcription 
through a domain-wide process (Gotter et al. 2004; Derbinski et al. 2005; Johnnidis 
et al. 2005).  Interestingly however, the impact of AIRE on each gene within a cluster 
is not a simple on or off switch of all loci, but rather disperse; some genes increasing 
in expression, while neighbouring genes were either unaffected or their expression 
decreased (Gotter et al. 2004; Derbinski et al. 2005; Johnnidis et al. 2005).  This 
punctate expression pattern of certain AIRE-regulated clusters tends to argue 
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against a domain-wide control such as deposition of activating histone modifications 
across the whole locus, but instead may suggest that individual genes within the 
cluster are affected in distinct ways. 
 
The keratin cluster is one such example of an AIRE-regulated gene cluster 
(Johnnidis et al. 2005).  This cluster, located on Mus musculus chromosome 15, 
contains five keratin genes (Krt4, Krt79, Krt78, Krt8 and Krt18) at its 5` end, and 
eukaryotic translation initiation factor 4b (Eif4b), tensin-like C1 domain-containing 
phosphatase (Tenc1) and SPRY domain-containing 3 (Spryd3) further downstream.  
Expression profiling had been performed with a number of the genes in this cluster, 
revealing differential expression levels in the presence of AIRE, however, Krt79, 
Krt78, Krt8, Tenc1 and Spryd3 had not been investigated (Johnnidis et al. 2005).  
We therefore completed this analysis within our TEP model system for all genes 
across the cluster.  Interestingly, transcript levels of all genes showed up-regulation 
in the presence of AIRE (Figure 3.10).  We observed particularly strong signals for 
keratin 4, in agreement with published expression data, but also for keratin 79 and 
78, with little or no detection in TEP-GFP cells when normalised to β-actin.  We 
found that the next gene in the cluster, keratin 8 was expressed in the control cells, 
however, TEP-AIRE cells displayed an approximate 4-fold up-regulation.  In 
addition, keratin 18, which had shown to be negatively-regulated by AIRE, displayed 
a consistent level of expression in both cell populations, suggesting that this gene is 
not under the transcriptional control of AIRE (Johnnidis et al. 2005).  We found that 
for Eif4b, which had previously shown decreased transcription in the presence of 


























































































































































































































































































































































































































increasing approximately 4-fold in TEP-AIRE cells (Johnnidis et al. 2005).  Transcript 
levels of Tenc1 and Spryd3 were consistently 2-fold higher in the presence of AIRE, 
however, robust expression was occurring in the TEP-GFP cells for all three 3` 
genes.  Collectively, this confirms that the keratin cluster represents a true AIRE-
regulated cluster, with AIRE acting on a gene-by-gene basis to either induce 
transcription or, as is the case for keratin 18, exert no influence. 
 
3.3.3.1. Levels of Methylation at Histone H3 Lysine 4 across the Keratin Cluster 
in the Thymic Epithelial Cell Model System 
NChIP was used to assay levels of mono-, di- and tri-methylation of histone H3K4 
across the promoter or coding regions of the genes in the keratin cluster, in addition 
to intergenic (INT) regions, in the TEP model system (Figure 3.11).  The most 
striking observation was that all three forms of methylation at this residue were 
enriched in the presence of AIRE, while TEP-GFP cells showed markedly lower 
levels.  Across the entire cluster, the degree of methylation progressively increased 
in TEP-AIRE cells, the lowest amounts being for H3K4me1 and the highest for 
H3K4me3, which may be expected as expression of all genes is high in the 
presence of AIRE, and the three forms of methylation are known to compete with 
each other for the same lysine (Zhang and Reinberg 2001; Fuchs et al. 2009).  
Despite these initial similarities, some well defined differences do emerge between 
H3K4 methylation levels.  For example, TEP-AIRE H3K4me1 (Figure 3.11 A) rises 
and falls in waves along the cluster, with peaks at the intergenic regions INT2, 3C, 4 
and 5B and finally at Spryd3.  In contrast, TEP-GFP cells show depletion of 
H3K4me1 at the promoter regions of keratins 4, 79 and 78 which are silent, with 

Figure 3.11 - Impact of AIRE on a Cluster of Genes: Quantitation of the 
Relative Levels of Histone H3 Lysine 4 Methylation across the Keratin 
Cluster by Native Chromatin Immunoprecipitation
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correspondingly higher levels at the intergenic regions.  However, this trend is lost at 
keratin 8, a gene actively expressed by these cells (albeit at a level 4–fold lower than 
in the presence of AIRE), when there is an obvious peak of H3K4me1, enrichment 
rising to a bound:unbound ratio of 1.95, equalling that of TEP-AIRE for this locus.  
TEP-GFP H3K4me1 levels then fall and remain low, with minor peaks occurring at 
Tenc1 and Spryd3 promoter regions, which correspond with the active expression of 
these genes in the control population. 
 
The levels of H3K4me2 (Figure 3.11 B) displayed an overall increase across the 
cluster when compared to H3K4me1.  TEP-AIRE H3K4me2 showed a similar 
distribution to me1 in the first half of the cluster, with waves of enrichment peaking at 
the intergenic regions INT2, 3C and 4.  However, at the 3` end of the cluster, unlike 
the mono-methyl mark, H3K4me2 appears to show a domain of higher levels of 
enrichment, from Tenc1 (ratio 6.78) and remaining high until the end of the cluster.  
TEP-GFP cells show an overall depletion of H3K4me2, similar to the mono-methyl 
mark, however, on a gene-by-gene basis some subtle contrasts were observed.  For 
example, in general there was little distinction between TEP-GFP H3K4me2 levels at 
genes and intergenic regions in the 5` end of the cluster, whereas H3K4me1 showed 
more distinct peaks in the 5` intergenic regions.  However, at the 3` end of the 
cluster, H3K4me2 peaks do appear in the intergenic regions, with correspondingly 
lower levels in the gene regions of Eif4b, Tenc1 and Spryd3 which show active 
transcription in the TEP-GFP cells, again a reversal of the pattern of H3K4me1 for 
TEP-GFP cells, which marked the 3` gene promoter regions preferentially. 
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The distribution of H3K4me3 (Figure 3.11 C) in TEP-AIRE cells, showed a more 
uniform pattern, especially in the first half of the cluster, in comparison to the waves 
of H3K4me1 and me2.  H3K4me3 remained consistently high across all gene and 
intergenic regions, with particularly increased levels at the extreme 3` end of the 
cluster at Tenc1 (bound:unbound ratio 6.42) and Spryd3 (bound:unbound ratio 8.84).  
However, it is in the control population where the most distinctive pattern is 
observed, which appears to contrast with those of H3K4me1 and me2 for these 
cells.  An almost total depletion of H3K4me3 occurred across the first half of the 
cluster until keratin 18 when levels start to rise.  This corresponds directly with the 
TEP-GFP expression profile; transcription not taking place at significantly high levels 
until keratin 18.  Interestingly, for keratin 8 where we do detect low levels of 
transcript in the control cells, H3K4me3 remains depleted.  A definite domain of 
H3K4me3 is then identified in the downstream region, with peaks occurring 
specifically at the promoter regions of Eif4b, Tenc1 and Spryd3 at levels equal to 
those detected in the presence of AIRE, which again correlates well with the active 
transcription of these genes in the control cells.  Taken together, the variations 
between the arrangements of H3K4 methylation across the cluster are particularly 
interesting and suggest a complex regulation of these genes, although each level of 
H3K4 methylation does appear to be affected by AIRE in a distinct way.  Further 
analysis of alternative histone modifications is needed however, to clarify the role 
AIRE is playing in the regulation of the genes. 
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3.3.3.2. Levels of Acetylation at Histones H3 and H4 across the Keratin Cluster 
in the Thymic Epithelial Cell Model System 
Three acetylation marks were analysed across the keratin cluster; H3K9, H4K8 and 
H4K16 (Figure 3.12).  On first inspection, the patterns of acetylation vary widely for 
both TEP-AIRE and TEP-GFP cells, and between the three acetylation marks 
themselves, with a prominently defined domain of H3K9 acetylation detected 
downstream of the cluster for both cell lines, yet a more widespread distribution of 
H4 acetylation across all loci. 
 
The pronounced domain of H3K9 acetylation (Figure 3.12 A) in the latter half of the 
cluster mirrors that observed for the other classically activating histone mark 
H3K4me3.  This resemblance is particularly significant as these two modifications 
have been shown to be associated with active transcription (Barski et al. 2007).  
Both TEP-AIRE and TEP-GFP cells show a similar trend for H3K9ac, with a 
pronounced hyperacetylated domain in the 3` region of the cluster.  Peaks of this 
modification occur mainly in the gene regions for both cell populations and correlate 
with the expression profile.  TEP-AIRE cells show enrichment of H3K9ac at all genes 
across the cluster which is indicative of their active status.  For TEP-GFP cells 
however, active expression is not detected in the first half of the cluster, where levels 
of H3K9ac remain very low, however from INT3C, levels of acetylation increase; 
correlating with the up-regulation of the 3` genes.  By keratin 18; a gene whose 
expression is equally high in both the presence and absence of AIRE, we observed 
a high level of H3K9ac in the TEP-GFP cells (bound:unbound ratio 4.45); equalling 
the levels seen for this gene in the TEP-AIRE cells.  As you continue along the 

Figure 3.12 - Impact of AIRE on a Cluster of Genes: Quantitation of the 




cluster, H3K9ac levels briefly fall in the intergenic INT5 region of TEP-GFP cells, but 
then increase dramatically for the final three genes, with enrichment matching or 
surpassing the values observed for TEP-AIRE cells; in particular for Eif4b (1.34-fold 
higher) and Tenc1 (2.44-fold higher), despite the increased levels of expression in 
the presence of AIRE. 
 
For acetylation of H4K8, an analogous distribution to H3K9ac is seen for the TEP-
AIRE cells, with peaks at Tenc1 and Spryd3, although H4K8ac is less dynamic, 
showing a more even distribution across the cluster (Figure 3.12 B).  However, for 
the control TEP-GFP population, a striking contrast between H3K9 and H4K8 
acetylation is observed with no indication of a 3` domain of H4K8 hyperacetylation.  
Instead, TEP-GFP H4K8ac shows a small domain of enrichment spreading from 
INT3A onwards, remaining relatively unchanged despite the altering levels of gene 
expression.  INT3A is the intergenic region proceeding keratin 8, which is the first 
gene in the cluster to show expression in TEP-GFP cells, though at a very low level.  
Unlike for H3K9ac, this spread of H4K8ac does not show dramatic gene-specific 
peaks at Eif4b, Tenc1 and Spryd3 in the control cells, instead marking both 
promoters and intergenic regions equally, whereas H3K9ac shows a more specific 
preference for actively expressed genes. 
 
The pattern of H4K16 acetylation, in stark contrast to the previous marks, differs 
greatly for the TEP-AIRE and TEP-GFP populations (Figure 3.12 C).  AIRE seems to 
induce a blanket of H4K16 hyperacetylation across the entire cluster, while the 
control cells present with very low levels of this modification, regardless of 
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transcriptional activity.  This is particularly significant for keratin 18, whose 
expression is equal in both cell populations.  Hence, this modification shows no 
specification for actively-transcribed genes, unlike the other acetylation marks.  
Lysine 16 of histone H4 is the first residue to be post-translationally modified and the 
addition of an acetyl moiety is known to disrupt the bridges between neighbouring 
nucleosomes (Luger et al. 1997; Shogren-Knaak et al. 2006).  This mark may 
therefore represent a domain-wide opening of the chromatin, orchestrated by AIRE, 
thus facilitating the higher levels of gene expression across the cluster in the 
presence of AIRE. 
 
3.3.3.3. Levels of Methylation at Histone H3 Lysine 9 and Lysine 27 across the 
Keratin Cluster in the Thymic Epithelial Cell Model System 
Given the fluctuating levels of expression across the keratin cluster, analysis of two 
marks; H3K9me2 and H3K27me3, whose presence within a gene is usually 
indicative of repression was carried out (Figure 3.13) (Barski et al. 2007).  The most 
striking observation is the strong enrichment of these two histone modifications at 
the 5` end of the cluster; an almost perfect reversal of the trend observed for the 
archetypal active histone modifications H3K4me3 and H3K9ac.  Levels of the two 
silent marks correlated significantly with transcription levels in the control TEP-GFP 
population, with the highest levels present in the genes for which no transcription 
was detected.  It should be noted that levels of H3K9me2 were much lower than 
those of H3K27me3, however it is clear that this modification still plays a role in the 
silencing of the genes in TEP-GFP cells (Figure 3.13 A).  In the TEP-GFP control 
population, the four initial genes in the cluster (keratin 4, 79, 78 and 8) are either not 
Quantitation by native chromatin immunoprecipitation (NChIP) of levels of histone 
modifications across the keratin cluster on Mus musculus chromosome 15 in 
cultured thymic epithelial (TEP) cell lines.  Turquoise columns represent results 
from AIRE-negative TEP-GFP cells.  Purple columns are from TEP cells transfected 
with AIRE.  Immunoprecipitation performed with affinity-purified antibodies to; A, 
H3K9me2; and B, H3K27me3, as indicated.  Relative levels (bound:unbound) 
of histone modifications were calculated from immunoprecipitated (bound) and 
unprecipitated (unbound) DNA by quantitative real-time PCR.  Data are the mean 
±SEM from at least two separate NChIP experiments.
Figure 3.13 - Impact of AIRE on a Cluster of Genes: Quantitation of the 
Relative Levels of Histone H3 Lysine 9 and Histone H3 Lysine 27 Methylation 
across the Keratin Cluster by Native Chromatin Immunoprecipitation
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expressed, or expressed at a very low level and therefore increased levels of both 
inactive histone modifications within these gene regions echoes their silent nature.  
Further along the cluster, both modifications become dramatically depleted, 
H3K9me2 from keratin 18 onwards and H3K27me3 from INT3A as gene expression 
begins in the TEP-GFP cells.  Although TEP-AIRE H3K9me2 levels were similarly 
very low, the specific 5` domain-wide enrichment was not detected to as great a 
level than in the control population.  Peaks were seen at keratin 8 in the middle of 
the cluster and at Eif4b and Spryd3 in the 3` end, which are all expressed 
approximately 4-fold higher in the presence of AIRE.  For H3K27me3 however, 
these downstream peaks were not seen and a more well-defined distribution of this 
silent mark was observed for both TEP-AIRE and TEP-GFP populations, with a 
region of H3K27 hypermethylation at the first three genes (keratin 4, 79 and 78), 
followed by a depletion of this mark for the remainder of the cluster. 
 
As a further control we wanted to analyse a gene silent in both TEP populations, for 
which recombination activating gene-1 (Rag1) was chosen.  Rag1, in combination 
with Rag2, controls the assembly and rearrangement of antigen receptor genes 
during the early stages of B- and T-cell development in a process known as V(D)J 
recombination.  They are highly lymphoid-specific and hence permanently silenced 
within thymic epithelial cells.  We were unable to detect signal in either the bound or 
unbound material for Rag1, thus highlighting this gene’s inactive status within these 
cells.  The aberrant expression of this gene within thymic stromal cells may result in 
serious consequences, thus the absence of active histone modifications may reflect 
a more permanent silencing of Rag1, possibly suggesting a heterochromatic 
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compaction of this gene leading to its retention in the insoluble pellet following 
chromatin isolation. 
 
3.3.4. Analysis of the Binding Status of AIRE, RNA Polymerase II and Histone 
Methyltransferases within AIRE-Regulated Gene Regions in the Thymic 
Epithelial Cell Model System 
Given that AIRE has demonstrated putative associations with DNA, mediated 
through its SAND domain, and can bind un-modified H3K4 via its first PHD-zinc 
finger, we wanted to determine whether AIRE was able to interact directly with its 
target genes (Gibson et al. 1998; Kumar et al. 2001; Koh et al. 2008; Org et al. 2008; 
Chignola et al. 2009).  AIRE has also been shown to associate with positive 
transcription elongation factor-b (P-TEFb) at the promoters of TRA, where Oven et al 
(2007) found RNA pol II already engaged, thus we also sought to establish the 
binding status of RNA pol II (Oven et al. 2007).  Consequently, we performed 
conventional cross-linked chromatin immunoprecipitation (XChIP) with cultured TEP-
AIRE and TEP-GFP lines.  Cells were fixed with 1% paraformaldehyde, and 
chromatin was isolated and prepared through sonication, generating 300-600bp 
fragments.  Input chromatin was then immunoprecipitated with antibodies directed 
against AIRE and RNA pol II.  Relative amounts of these complexes across the 
promoter regions of the TRA Spt1 and Spt2 were determined by qPCR, through 
normalisation to the levels across Gapdh.  This analysis revealed the presence of 
AIRE at the Spt1 and Spt2 promoter regions, which was absent or negligible in the 
TEP-GFP cells, suggesting that AIRE exerts its action through a direct association at 
each of its target genes (Figure 3.14 A and B).  We also found increased levels of 
Quantitation by cross-linked chromatin immunoprecipitation (XChIP) of levels 
of AIRE, RNA polymerase II, KMT2A/MLL1, H3K4me3, KMT6/Ezh2, Eed and 
H3K27me3 across the promoter regions (p) of the tissue-restricted antigens 
salivary protein-1 (Spt1, A) and salivary protein-2 (Spt2, B) in cultured Mus 
musculus thymic epithelial (TEP) cell lines.  Turquoise columns represent 
results from AIRE-negative TEP-GFP cells.  Purple columns are from TEP cells 
transfected with AIRE.  Immunoprecipitation performed with affinity-purified 
antibodies to AIRE, RNA polymerase II, KMT2A/MLL1, H3K4me3, KMT6/Ezh2, 
Eed and H3K27me3, as indicated.  Relative levels (enrichment) of each protein/
modification were calculated from immunoprecipitated (bound) and input DNA by 
quantitative real-time PCR.  Data was normalised to relative levels of enrichment 
at glyceraldehydes-3-phosphade dehydrogenase (Gapdh) as standard.  Data are 
the mean ±SEM from at least two separate XChIP experiments.
Figure 3.14 – The Epigenetic Binding Status of Genes under the Transcriptional 
Control of the Autoimmune Regulator: Quantitation of the Relative Levels 




RNA pol II in the presence of AIRE, with only low levels in the control cells.  This 
seems to contrast with the findings of Oven et al (2007), who reported the presence 
of stalled RNA pol II at TRA in the absence of AIRE, however in a report by Org et al 
(2009), RNA pol II was only detectable on approximately 4% of AIRE target 
promoters in the absence of AIRE, thus our data clearly supports their findings (Org 
et al. 2009).  In its role as a transcriptional regulator, AIRE may also recruit additional 
protein complexes to the local chromatin environment to facilitate the reading and 
transcribing of each locus.  Our results thus far have indicated that AIRE is able to 
modulate certain histone modifications both on a gene-by-gene basis and on a 
greater scale.  For example, we have shown increases in H3K4me3 and 
maintenance of H3K27me3 levels across many AIRE-regulated genes, modifications 
which are put in place by very well-defined histone methyltransferases and we 
therefore wanted to determine the binding status of these enzymes in the presence 
and absence of AIRE.  We again employed XChIP to ascertain whether the H3K4 
methylation-specific methyltransferase KMT2A/MLL1, and the two PcG proteins; 
KMT6/Ezh2, an H3K27 methylation-specific methyltransferase; and its co-factor Eed, 
were present at the promoters of TRA (Figure 3.14 A and B).  We also verified our 
findings from unfixed NChIP analysis, using antibodies directed against H3K4me3 
and H3K27me3 (Figure 3.14 A and B).  This showed that in the control cells, levels of 
KMT2A/MLL1 are very low at AIRE-regulated TRA, along with its product H3K4me3, 
which confirmed our previous observations.  In the presence of AIRE, higher levels of 
KMT2A/MLL1 were seen, however levels of H3K4me3 increased dramatically.  This 
could suggest that AIRE engagement at the locus results in the recruitment of 
KMT2A/MLL1 for the deposition of H3K4me3.  At the Spt1 promoter (Figure 3.14 A), 
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moderate levels of KMT6/Ezh2 were detected in the TEP-GFP population, along with 
H3K27me3, with low amounts of Eed, however levels of these were higher in the 
control cells for Spt2 (Figure 3.14 B).  Interestingly, levels of all three increased in the 
presence of AIRE, which may account for the maintained or heightened levels of 
H3K27me3 revealed within the TEP-AIRE population through NChIP.  Taken 
together, this implies that AIRE is able to bind chromatin at its individual target 
genes, leading to the recruitment of RNA pol II and KMT2A/MLL1 for deposition of 
positive-acting H3K4 methylation, but also of negative-acting PcG proteins 
KMT6/Ezh2 and Eed, which results in a maintenance or increase in H3K27me3. 
 
In conclusion, it would appear that AIRE is able to interact directly with TRA and 
influence histone modifications not only on a gene-by-gene basis, as demonstrated 
by the distinct differences between individual TRA; Csn1s1 (Figure 3.8) and the two 
salivary proteins (Figure 3.9), but also on a more large-scale, seen for the domain-
wide hyperacetylation at H4K16 (Figure 3.12). 
 
3.4. ELUCIDATION OF AIRE’S CONTROL OF PROMISCUOUS GENE EXPRESSION WITHIN THE 
THYMUS IN VIVO 
 
Within the thymus, AIRE is expressed exclusively within stromal cells of the medulla; 
the site of PGE, generating TRA which promote the self-tolerance of developing 
thymocytes (Anderson et al. 2002).  However, AIRE expression is only carried out by 
fully differentiated mTECs and recently a complex developmental network of thymic 
epithelial cells has been elucidated, revealing four main subpopulations of cells 
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(Rossi et al. 2006; Rossi et al. 2007).  It was found that the two distinct medullary 
and cortical lineages of thymic stromal cells, are derived from a common bipotent 
TEC progenitor present in the embryonic murine thymus (Rossi et al. 2006; Rossi et 
al. 2007).  Additionally, an immature CD80-AIRE- mTEC progenitor population exists, 
which do not express AIRE but produce a cell surface receptor; RANK (Rossi et al. 
2007; Akiyama et al. 2008; White et al. 2008; Zhu and Fu 2008).  Upon stimulation 
from lymphoid tissue inducer cell-derived RANK ligand, these immature mTECs 
switch on AIRE and promiscuous gene expression begins, giving rise to mature 
CD80+AIRE+ mTECs (Rossi et al. 2007; Akiyama et al. 2008; White et al. 2008; Zhu 
and Fu 2008).  Through foetal thymic organ culture and FACS sorting based upon 
specific cell surface markers (Table 3.3), the four cell subsets in the TEC 
developmental pathway (bipotent TEC progenitors, immature and mature mTECs 
and mature cTECs) can be isolated and pure populations obtained. 
 
Although clearly successful for elucidation of AIRE’s effects upon histone 
modifications associated with key TRA within a thymic epithelial cell background, 
NChIP is limited in its application as it requires a minimum of 1x107 cells.  This is 
easily achievable with cultured cell systems, however these are often not a true 
reflection of the in vivo situation.  Typically the number of cells in each population of 
the TEC developmental pathway following FACS are very low; in the range of 103-
104 cells and for this reason investigation into histone modifications associated with 
the activation or silencing of TRA across the TEP developmental pathway has until 
now not been possible.  It is therefore necessary to employ a technique recently 
developed in our laboratory termed carrier chromatin immunoprecipitation (CChIP)
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Table 3.3 – The Fluorescent Activated Cell Sorting Parameters Used to 
Isolate Primary Cell Populations from Mus musculus Foetal Thymic Organ 
Cultures 
Mus musculus EMBRYONIC THYMIC CELL POPULATIONS 
POPULATION FACS PARAMETERS CELL NUMBERS PER IP 
E12 Bipotent TEC Progenitors EpCAM1+ 3.4X104 














































E12 FoxN1-Deficient Nude TEC EpCAM1+ 5X103 
 
 
Foetal thymic organ culture was employed for the investigation of the epigenetic 
status of tissue-restricted antigens across the embryonic thymic epithelial 
developmental pathway.  Fluorescent Activated Cell Sorting (FACS) was used 
to isolate four cell populations; EpCAM1+ bipotent TEC progenitors, immature 
CD45-EpCAM1+Ly51-CD80-, and mature CD45-EpCAM1+Ly51-CD80+ mTECs, 
and mature CD45-EpCAM1+Ly51+ cTECs, with the parameters displayed.  
Typical cell numbers following FACS, used subsequently for each individual 
immunoprecipitation (IP) by carrier chromatin IP, are also illustrated. 
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(O'Neill et al. 2006).  The CChIP method is an adaptation of the more conventional 
NChIP procedure, drawing on the same basic principles and methodology, and 
published data shows a close correlation between CChIP and NChIP results (O'Neill 
et al. 2006).  The CChIP technique involves mixing of the very low numbers of target 
Mus musculus cells with a ‘carrier’ Drosophila melanogaster cell line (SL2) and in 
doing so protects the target cells from the harsh isolation conditions required to 
obtain clean chromatin (Figure 3.15).  Preparation of nuclei and chromatin is then 
performed as for NChIP, however due to the very low numbers of target cells, the 
volumes are kept low to minimise losses.  Standard immunoprecipitation is then 
carried out but strict species-specific PCR is required for detection of target Mus 
musculus DNA.  All primers were tested to ensure species specificity, as cross-
reactivity with SL2 DNA would result in an over-representation of the signal (Figure 
3.16). 
 
3.4.1. Analysis of the Effects of AIRE upon Tissue-Restricted Antigens in vivo 
In order to elucidate the distribution of histone modifications throughout the TEC 
developmental pathway, purified bipotent TEC progenitors, immature and mature 
mTECs and mature cTECs were mixed separately with SL2 cells for CChIP analysis.  
Due to the limited number of target FACS sorted cells, a restricted number of histone 
modifications could be analysed.  We therefore chose to investigate four 
modifications (H4K8ac, H3K4me3, H3K27me3 and H3K9me2) which, in the TEP 
model system, were shown to be heavily influenced by AIRE.  The presence of the 
functionally opposing modifications H3K4me3 and H3K27me3 have been shown to 
co-localise across key developmental genes, priming them for future transcription
Diagrammatic representation of the carrier chromatin immunoprecipitation (CChIP) 
protocol.  The CChIP technique involves mixing of small numbers of primary cell 
populations; Mus musculus cells from the thymic epithelial cell developmental 
pathway in this case, with Drosophila melanogaster cells (SL2) which act as a 
‘carrier’, protecting the target cells throughout the procedure.  Chromatin is isolated 
from the target cell/SL2 combination and digested with micrococcal nuclease (Mic 
Nuc) then immunoprecipitated with antibodies directed against post-translational 
histone modifications.  DNA from antibody-bound and –unbound fractions is 
then purified for analysis of the relative levels of each modification, through strict 
species-specific PCR.
Figure 3.15 - Carrier Chromatin Immunoprecipitation
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For the verification of strict Mus musculus species specificity of primers, ensuring 
no cross-reactivity with Drosophila melanogaster (SL2) DNA, fixed point 
polymerase chain reaction (PCR) was carried out with Mus musculus (Mus) and 
Drosophila melanogaster (SL2) genomic DNA, along with d.H2O no template 
controls (NTC), with each primer set.  Primer sets were targeted to the promoter 
(p) and coding (c) region of salivary protein-1 (Spt1), and the promoter regions 
of salivary protein-2 (Spt2), casein-α (Csn1s1), glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), selection and upkeep of intraepithelial T-cells 1 (Skint1) 
and proteasome subunit β-type 11 (Psmβ11), as indicated.  Size was determined 
by reference to a 100 base pair molecular marker (Invitrogen).
Figure 3.16 – Verification of the Species Specificity of Primer Sets Utilised 
for the Analysis of DNA from Carrier Chromatin Immunoprecipitation
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(Azuara et al. 2006; Bernstein et al. 2006).  We wanted to monitor whether genes 
regulated by AIRE carried these bivalent modifications in the bipotent progenitor 
which changed upon activation of gene transcription as the cells differentiated.  In 
addition, we investigated H3K9me2, whose presence within euchromatic genes has 
been linked to their silencing, although the reported association with active genes is 
intriguing, and from our analysis in the TEP model system, this mark clearly has a 
role to play (Vakoc et al. 2005; Squazzo et al. 2006; Vakoc et al. 2006; Gierman et 
al. 2007).  Following CChIP, the concentration of DNA within antibody-bound and 
unbound fractions was analysed and the percentage pull-down of each 
immunoprecipitation calculated (Table 3.4).  For the determination of levels of 
enrichment of histone modifications across TRA within the precipitated Mus 
musculus DNA, we initially attempted quantitative real-time PCR (qPCR), using the 
same analysis technique as for NChIP with the TEP cell line.  Unfortunately, we 
were met with numerous technical difficulties.  The samples presented with a 
background noise of SYBR Green signal (Figure 3.17) which may have been due to 
the large concentration of SL2 DNA within each sample, quenching the signal.  
Attempts to reduce the concentration of SL2 DNA through dilution of the samples did 
not alleviate the problem, making accurate analysis through qPCR impossible, 
especially considering the limited sample sizes (typically bound samples were 
resuspended in 40µl, unbound in 80µl to avoid over-dilution of the Mus musculus 
signal).  Amplification curves were unreliable and we therefore turned to the analysis 
technique adopted in the original CChIP method (O'Neill et al. 2006).  Radioactive 
PCR incorporating α-32P dCTP into the reaction which, although more time 
consuming, reliably produced specific mouse products without quenching from the 
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Table 3.4 – Efficiency of Pull-Down for Each Histone Modification 
Following Carrier Chromatin Immunoprecipitation 
CChIP PERCENTAGE PULL-DOWNS 
POPULATION ANTIBODY SPECIFICITY PULL-DOWN REPLICATES 







R232 H4K8ac 1.85-4.83% 2 
R612 H3K4me3 2.23-5.88% 2 
07-449 H3K27me3 7.36-7.74% 2 
07-212 H3K9me2 3.67-4.93% 2 
PI Pre-immune 0.62-2.61% 2 







R232 H4K8ac 7.96-12.50% 2 
R612 H3K4me3 5.16-5.94% 2 
07-449 H3K27me3 6.49-28.17% 2 
07-212 H3K9me2 8.39-24.78% 2 
PI Pre-immune 1.44-2.55% 2 







R232 H4K8ac 7.21-16.63% 2 
R612 H3K4me3 6.90-8.45% 2 
07-449 H3K27me3 10.80-14.88% 2 
07-212 H3K9me2 5.10-14.89% 2 
PI Pre-immune 0.24-4.90% 2 







R232 H4K8ac 2.06-2.67% 2 
R612 H3K4me3 3.61-7.75% 2 
07-449 H3K27me3 4.50-5.66% 2 
07-212 H3K9me2 1.12-1.86% 2 
PI Pre-immune 0.34-1.47% 2 







R232 H4K8ac 4.10-5.75% 2 
R612 H3K4me3 5.91-20.70% 2 
07-449 H3K27me3 16.21-24.27% 2 
07-212 H3K9me2 7.67-11.99% 2 
PI Pre-immune 2.03-2.04% 2 
 
 
Carrier chromatin immunoprecipitation was performed with Mus musculus 
embryonic thymic cell populations, using antibodies directed against the post-
translational histone modifications displayed above.  DNA from antibody-bound 
(B) and –unbound (UB) fractions was purified and the percentage pull down 
(B/UBx100) for each antibody was then calculated.  Pre-immune no antibody 
controls were included which show comparatively low pull-down efficiencies.  
The number of biological replicates for each modification is displayed. 
Quantitative real-time polymerase chain reaction (qPCR) on DNA isolated from 
antibody-bound (B) and –unbound (UB) fractions following native chromatin 
immunoprecipitation (NChIP) with cultured Mus musculus thymic epithelial (TEP) 
cell lines or carrier chromatin immunoprecipitation (CChIP) with Drosophila 
melanogaster and primary Mus musculus target cells.  Immunoprecipitation with 
anti-H3K27me3 antibody and qPCR with primer set salivary protein-2 promoter 
are displayed as an example.  Mus musculus (Mus) and Drosophila melanogaster 
(SL2) genomic DNA were included as controls.  Raw data (fluorescence per 
cycle), quantitation data (log fluorescence per cycle) and melt data (dF/dT per 
degree) are illustrated to show efficiency and specificity of primers.
Figure 3.17 – Comparison of Quantitative Real-Time Polymerase 




carrier SL2 DNA, and was therefore used in all subsequent analysis.  Through 
polyacrylamide gel electrophoresis (PAGE) and phosphorimaging, the specificity of 
each amplification can be monitored routinely, and levels of bound and unbound 
signal be determined.  Figure 3.18 shows a typical radioactive PAGE gel (using 
Spt2(p) primer set), highlighting the specificity of primers through the absence of 
signal in SL2 negative controls. 
 
Examination of the three TRA; Csn1s1, Spt1, Spt2 and genes of the keratin cluster 
in the TEP cell line, indicated that AIRE is able to induce alterations to the 
distribution of histone modifications, forming clear and distinct patterns, unique to 
each mark.  Positively-regulated TRAs have a very well-defined expression profile 
throughout the TEC developmental pathway.  In the bipotent TEC progenitor cells 
TRAs are silent and remain so in the immature mTECs, however, following 
stimulation by RANK ligand and subsequent AIRE up-regulation in mature mTECs, 
these genes are turned on.  Differentiation into mature cTECs however, means the 
genes will never be expressed (Figure 3.19).  To determine whether TRA are 
marked with specific epigenetic patterns throughout development, we chose to 
assay the four histone modifications at each stage of the pathway through CChIP. 
 
3.4.1.1. Pattern of Histone Modifications for Salivary Protein-1 in vivo 
Bipotent TEC progenitors are an undifferentiated population of cells within which all 
TRA such as Spt1 are silenced.  Our observation of silencing modifications in this 
population at the Spt1 promoter supports this with the presence of enriched 
H3K27me3 and H3K9me2 (Figure 3.20 B).  However, we also detect equally high 
Radioactive PCR incorporating α-32P dCTP was employed for quantitation of relative 
levels of histone modifications following carrier chromatin immunoprecipitation 
(CChIP).  Immunoprecipitation was with affinity-purified antibodies to H4K8ac, 
H3K4me3, H3K27me3 and H3K9me2, as indicated.  Radioactive PCR reactions 
were carried out with 2μl neat bound (B) and 2μl 1:2 diluted unbound (UB) 
DNA.  Samples were taken after 38 and 41 cycles and visualised through 5% 
polyacrylamide gel electrophoresis and phosphorimaging.  Relative levels of 
histone modifications (bound:unbound) were generated from intensity values for 
each PCR product and calculated from the percentage pull-down values of each 
immunoprecipitation.  Specificity of each amplification was monitored through 
inclusion of Mus musculus (Mus) and Drosophila melanogaster (SL2) genomic 
DNA, and d.H2O no template controls (NTC).  Data displayed is from radioactive 
PCR with primer set salivary protein-2 promoter as an example.
Figure 3.18 – Analysis of DNA from Carrier Chromatin Immunoprecipitation: 
Radioactive Polymerase Chain Reaction
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AIRE-regulated promiscuous gene expression of tissue-restricted antigens 
throughout the developmental pathway of thymic epithelial cells (TECs).  Foetal 
thymic organ culture was employed, followed by FACS to isolate the four Mus 
musculus cell populations indicated, based on surface EpCAM1, CD45, Ly51 
and CD80 expression.  Real-time quantitative PCR was used to compare the 
relative mRNA expression levels of AIRE and three tissue-restricted antigens; 
casein-α (Csn1s1), salivary protein-1 (Spt1) and salivary protein-2 (Spt2), as 
indicated, for each cell type.  Data was normalised to β-actin expression levels 
as standard.  Data are the mean ±SEM from technical triplicate reactions, and are 
representative of at least two distinct cDNA preparations.
Figure 3.19 - Analysis of AIRE’s Role in vivo: Expression of the Autoimmune 



























































































levels of the active mark H3K4me3, which is interesting as the status of the Spt1 
gene within these progenitors is essentially in a poised state awaiting the correct 
signals to be either silenced or up-regulated depending on whether the bipotent 
population commit to mTECs where Spt1 will be switched on, or cTECs in which 
Spt1 expression will never occur.  Hence, H3K4me3 within the progenitor cells may 
be acting as a predictive mark for future expression of this gene within the mTEC 
lineage, with H3K27me3 and H3K9me2 keeping Spt1 silent in the progenitors.  As 
development continues through to the immature mTEC stage, the cells move one 
step closer towards the imminent expression of Spt1 and this saw a dramatic 
depression of all four histone modifications.  Upon AIRE activation in the mature 
mTEC population, where Spt1 becomes active, we saw an increase in the active 
marks H4K8ac and H3K4me3 at the promoter, compared to the immature mTECs, 
correlating with the active transcriptional status of this gene.  Levels of H3K27me3 
remained stable and an increase in the levels of H3K9me2 was also observed, their 
presence possibly representing a safety feature for this gene, allowing for tight 
regulation of its expression.  This cell population is represented in our TEP model 
system by TEP-AIRE cells, which are permanently expressing AIRE.  Comparisons 
with the results from the AIRE-positive cell line highlighted some differences, for 
example; in the cell line the Spt1 promoter is marked predominantly by active 
histone modifications such as H3K4me3 and H4K8ac (Figure 3.9).  Interestingly, of 
the two silent modifications investigated, higher levels of H3K27me3 were frequently 
present in the TEP line, whereas in the primary mature mTECs this was not the case 
for the Spt1(p).  Analysis of the distribution of histone modifications in the reverse 
scenario whereby bipotent TEC progenitors differentiate to mature cTECs reveals a 
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contrasting re-organisation of chromatin to that seen in the mTEC lineage.  Mature 
cTECs, which will never express AIRE or Spt1, show a decrease in H3K4me3 and 
H3K27me3 along with a small increase in H4K8ac, however, the most striking 
change is the dramatic increase in H3K9me2 from a bound:unbound ratio of 10.69 
within the bipotent TEC progenitors, to a ratio of 26.50 within the mature cTECs.  
This possibly signifies the more permanent silencing of this gene within these 
cortical cells.  The mature cTECs could be compared to TEP-GFP control cells, 
where again we observed contrasting results.  While the cultured cell line displayed 
very high levels of H3K27me3, this is not observed in vivo.  These differences 
between the two model systems may possibly point to a more strict H3K9me2-
mediated regulation of the genes under the transcriptional control of AIRE in vivo as 
their expression within an incorrect cell type or at an inappropriate stage may be 
detrimental to the development of a functional, self-tolerant T-cell repertoire. 
 
Analysis of an area within the coding region of Spt1 shows a similar pattern to the 
promoter region of this gene, in particular for the distribution of H3K4me3 which 
follows the same trend throughout the four cell populations (Figure 3.20 B).  
However, comparisons between the promoter region and the gene body do show 
some differences.  For example, in the bipotent TEC progenitor cells, there appears 
to be a switch in the silencing modifications, with the promoter showing higher 
H3K27me3 but in the coding regions H3K9me2 predominates.  In addition, these 
progenitor cells display particularly high levels of H4K8ac in the gene body, which 
were not seen at the promoter.  Thus, although the classical H3K4me3 / H3K27me3 
bivalency was not observed in the Spt1 coding region, it is clear that this locus does 
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display a poised chromatin signature with the presence of equally high levels of 
active and silent marks.  Within the immature mTECs, again we saw a dramatic 
reduction in the histone modifications, similar to the promoter region, the only 
change being an approximate 3-fold increase in H3K27me3 from the 5` to the 3` 
region of Spt1.  As the mTECs mature, we again found a re-organisation of the 
epigenetic marks with levels of H4K8ac and H3K27me3 increasing from the 
immature mTECs.  In comparison to the Spt1 promoter region in mature mTECs, the 
coding region displays very high H4K8ac, however there is a reversal of the 
silencing modifications, with H3K27me3 predominating in the exonic region.  A 
significant finding for the coding region of Spt1 is the almost identical distribution of 
modifications within the mature cTEC population when compared to the promoter 
region, with the low levels of H3K4me3 and H3K27me3, slightly higher enrichments 
of H4K8ac, but most importantly, a dramatic increase in H3K9me2; to a 
bound:unbound ratio of 26.5 at the promoter region and 46.2 in the coding region, 
thus confirming our observations. 
 
These results give a good indication of how AIRE-regulated genes are controlled 
throughout thymic development.  TRA within the bipotent TEC progenitor cells are 
marked with a combination of active and silent modifications, keeping them in a 
poised but ‘off’ state.  Chromatin is then reorganised as the cells differentiate, with a 
fall in all four marks in immature mTECs.  As Spt1 is up-regulated, elevated levels of 
the activating acetylation and methylation marks are induced, in combination with 
high levels of H3K9me2 and H3K27me3, potentially regulating expression.  However 
as the bipotent progenitor cells differentiate to mature cTECs, a strong pattern of 
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modifications is displayed, with strikingly high levels of H3K9me2 possibly keeping 
Spt1 more permanently silenced. 
 
3.4.1.2. Pattern of Histone Modifications at the Salivary Protein-2 Promoter 
Region in vivo 
Histone modifications across the promoter region of the second salivary protein 
show a distribution distinct from Spt1 (Figure 3.21 B).  Although the classical 
H3K4me3 / H3K27me3 bivalent chromatin structure is not observed at Spt2, the 
bipotent TEC progenitors do present with a bivalency of sorts; with predominance 
instead of acetylation at H4K8, which may be acting as an alternative predictive 
mark, in combination with H3K9me2, which may aid in the silencing of this gene 
within the progenitor population.  Similar to findings for this subset at Spt1, we 
detected a general depression in all modifications as the cells develop into immature 
mTECs, with the exception of H3K27me3, levels of which rise from the bipotent TEC 
progenitors for Spt2 thus shifting the balance of silencing modifications from 
H3K9me2 to H3K27me3.  Maturation of the mTECs and subsequent AIRE-induced 
up-regulation of Spt2, brought about only a minor alteration to histone modifications 
from the immature mTECs; maintenance of H4K8ac, H3K4me3 and H3K27me3 and 
a 1.8-fold increase in H3K9me2, whereas for Spt1 dramatic changes to the 
epigenetic markings were observed as maturity was reached, particularly in the 
coding regions.  Most striking is the distribution of marks within the cTECs, where 
Spt2 is silenced, results for which mirror those seen at both the promoter and coding 
regions of Spt1.  The lowest levels being H3K4me3 and H3K27me3, minimal 


























































































































































































































































































































































































































































































































from the bipotent TEC progenitors at Spt2.  This distribution of marks within cTECs 
across both salivary proteins is particularly intriguing, especially considering the 
variation observed between the bipotent TEC progenitors for these genes, and may 
suggest that this arrangement of chromatin is essential for their silencing within the 
cortical cells. 
 
3.4.1.3. Pattern of Histone Modifications at the Casein-α Promoter Region in 
vivo 
The epigenetic status of the promoter region of Csn1s1 contrasts remarkably with 
the data for the two salivary proteins, which may be suggestive of alternative modes 
of regulation for these genes (Figure 3.22 B).  The histone modifications assayed 
fluctuate dramatically as the cells progress through development, for example the 
levels of H4K8ac show an inverse correlation with gene expression.  A clear pattern 
is seen throughout the developmental pathway, marking the progenitors with high 
levels, which fall as the cells mature to mTECs, but increase in the cTEC population, 
resulting in a cTEC > progenitors > immature mTECs > mature mTECs distribution.  
For Csn1s1, the bipotent TEC progenitors again displayed a mix of active and silent 
modifications, however the precise combination of modifications at this locus was 
unique, with enrichment of H3K27me3 and H4K8ac, and correspondingly low levels 
of H3K4me3 and H3K9me2, reflecting the poised nature of this gene, but a pattern 
not observed in the salivary proteins.  Progression down the mTEC lineage to the 
immature mTECs again shows a unique pattern of histone marks.  In addition to the 
decline in H4K8ac, we observed increased H3K9me2 and H3K4me3 in combination 




















































































































































































































































































































































































































































































































of the mTECs and subsequent up-regulation of Csn1s1 again reveals a unique re-
distribution of modifications, ultimately leading to an almost total loss of H3K9me2 
and H4K8ac (bound:unbound ratio 4.22 and 3.45 respectively).  Yet, high levels of 
H3K4me3 and H3K27me3 (bound:unbound ratio 14.63 and 21.63 respectively) are 
maintained.  However, it is the development through to mature cTECs where the 
most interesting differences were observed, which have until now displayed an 
almost identical pattern across both salivary proteins.  Whereas for the salivary 
proteins, the predominant mark was H3K9me2, for Csn1s1 the cTEC population 
displays very high levels of H4K8ac, with correspondingly lower amounts of the 
three methylation marks.  The dramatic and characteristic peak in H3K9me2 was not 
seen, however there was a 2.0-fold increase of this mark from the progenitor cells.  
Thus it would seem that the distribution of modifications across the TEC 
developmental pathway differs dramatically on a gene-by-gene basis. 
 
3.4.1.4. Pattern of Histone Modifications at the Glyceraldehyde-3-phosphate 
Dehydrogenase Locus in vivo 
As a control, we chose to assay the housekeeping gene Gapdh which is ubiquitously 
expressed throughout the TEC developmental pathway.  The profile of histone 
modifications across each of the four stages of thymic development, does reflect this 
(Figure 3.23 B), a common theme being the dominance of the active histone 
modifications H4K8ac and H3K4me3.  However, some variations between cell 
populations are observed.  While the bipotent progenitors and mature cTECs are 
marked by high H4K8ac and H3K9me2, mTECs display low levels of these 









































































































































































































































































































































































































































































































































across the TEC developmental pathway, they also highlight the complexities of 
epigenetic modifications, with no single defined combination of marks signifying the 
activity of a given gene. 
 
3.4.1.5. Pattern of Histone Modifications at the Selection and Upkeep of 
Intraepithelial T-cells 1 Promoter Region in vivo 
As a further control we wanted to analyse the distribution of histone modifications 
across a gene not under the transcriptional control of AIRE, whose expression 
pattern correlates with TRAs.  Selection and upkeep of intraepithelial T-cells 1 
(Skint1) is a newly identified gene whose expression within the thymus has been 
shown to be involved in the previously undefined selection of γδ T-cells, in particular, 
those which express the Vγ5Vδ1 T-cell receptor (Boyden et al. 2008).  Expression 
analysis of Skint1 (Figure 3.24 A), demonstrated the presence of this gene within the 
mature mTEC population, but not within the bipotent TEC progenitors, the immature 
mTECs or the mature cTEC lineage.  Despite this pattern of regulation akin to an 
AIRE-regulated gene, Skint1 is not under the transcriptional control of AIRE, as its 
expression is undetected in both the presence and absence of AIRE in the TEP cell 
line (Figure 3.24 A). 
 
Bipotent TEC progenitors are marked with an enrichment of H3K4me3, which is 
matched by equal levels of H3K9me2 indicating the poised nature of Skint1 (Figure 
3.24 C).  Increases in both active marks H4K8ac and H3K4me3 are observed in the 
immature mTEC population, along with maintenance of H3K9me2 and a 2.5–fold 




















































































































observed a domain-wide blanket of all marks, with comparatively high levels of 
active and repressive modifications.  The cTEC lineage, where Skint1 is not 
expressed, displays a significant enrichment of H3K9me2; at least 3.9 times greater 
than the other three marks, resulting in a pattern equivalent to those seen for the 
cTECs across the AIRE-regulated genes.  This reflects the more permanent silent 
nature of this gene within the cTEC population.  Comparisons between the findings 
for the Skint1 promoter region and TRA, showed a divergent pattern of histone 
modifications at this non-AIRE-regulated gene and this may reflect the fact that this 
gene is mTEC-specific, unlike the TRA whose native expression is within peripheral 
tissues outside of the thymus. 
 
3.4.1.6. Pattern of Histone Modifications at the Proteasome Subunit β-Type 11 
Promoter Region in vivo 
For a final control, we wanted to analyse the epigenetic status of a gene whose 
expression is limited to the cTEC lineage, and therefore not influenced by AIRE in 
any way.  The discovery of a previously unrecognised catalytic subunit of the 
proteasome, a structure responsible for cleaving polypeptides into smaller fragments 
for presentation by the class I MHC, provided us with a useful gene for this analysis.  
Proteasome subunit β-type 11 (Psmβ11) was found to be essential for the positive 
selection of MHC class I-restricted CD8+ T-cell repertoire, and is therefore 
exclusively expressed by cortical thymic epithelial cells (Murata et al. 2007).  This 
was further confirmed when expression analysis was carried out (Figure 3.25 A) 
showing high levels of expression in cTECs and low or no expression in the 











































































































unaffected by AIRE as its expression within the TEP model system is not detected in 
both cell populations (Figure 3.25 A).  What was instantly evident following CChIP 
analysis for Psmβ11 was the significant enrichment of acetylation in the bipotent 
TEC progenitors, coupled with lower levels of methylation.  This acetylation mark is 
not however balanced by the presence of a silencing mark, yet it could signify a 
mark within the bipotent cells for future expression of Psmβ11 in cTECs (Figure 3.25 
C). 
 
For the immature mTECs, there was little change to the three methyl marks, yet a 
dramatic 16.7-fold fall in H4K8ac at the Psmβ11 promoter resulting in a distribution 
of marks akin to those seen for Spt1, which is surprising as this gene is silent within 
the mTEC lineage.  Continuation to fully mature mTECs again reveals unexpected 
results for Psmβ11, with a prevalence of H3K4me3, a mark usually associated with 
active gene transcription, resulting in a distribution of marks similar to that seen in 
this cell population for the ubiquitously-expressed Gapdh.  Finally, for mature 
cTECs, where Psmβ11 is expressed exclusively, a high level of H4K8ac was 
observed which, although lower than the level of this mark in the progenitor 
population, represents one of the highest of the modifications in the cTECs, matched 
only by H3K9me2.  This predominance of H4K8ac is not observed in the mTECs 
and may therefore be responsible for the active status of this gene in cTECs.  
Interestingly, there was also an enrichment of H3K9me2, as observed for the genes 
which are silent within mature cTECs, however, for the TRA, with the exception of 
Csn1s1, the level of H3K9me2 is significantly higher than all other marks, whereas 
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for Psmβ11, this is not the case due to the elevated amounts of the active 
acetylation mark. 
 
3.5. EXAMINATION OF THE DISTRIBUTION OF HISTONE MODIFICATIONS ACROSS TISSUE-
RESTRICTED ANTIGENS WITHIN FOXN1-DEFICIENT NUDE THYMIC EPITHELIAL CELLS 
 
To more thoroughly assess the role histone modifications play in PGE, we used 
CChIP to analyse the epigenetic status of TRA when thymus embryogenesis is 
disrupted.  For this we turned to the athymic nude mouse model which is deficient in 
the forkhead transcription factor FoxN1.  FoxN1 is required in a cell-autonomous 
fashion for initial TEC differentiation (Jenkinson et al. 2008; Chen et al. 2009).  These 
mice present with a non-functional cystic thymic rudiment due to the block in normal 
TEC development at an early stage (Blackburn et al. 1996; Anderson and Jenkinson 
2001; Jenkinson et al. 2008).  Interestingly however, FoxN1 does not appear to be 
required for the preliminary stages of thymic organogenesis, in particular the initial 
colonisation and growth of bipotent thymic epithelial progenitors (Anderson and 
Jenkinson 2001; Jenkinson et al. 2008).  It is the subsequent differentiation of these 
progenitor cells into cortical or medullary lineages that is stalled due to the lack of 
FoxN1 (Anderson et al. 2007; Jenkinson et al. 2008).  We therefore sought to 
analyse the pattern of histone modifications across Spt1, Spt2 and Csn1s1 within 
these TEC progenitors from foetal FoxN1-deficient BALB/c nude (Nu/Nu) mice.  The 
development of these FoxN1-deficient nude TEC is blocked and hence expression of 
these genes will not occur.  Comparisons back to the results already obtained in 
bipotent TEC progenitor cells from normal mice, would highlight whether the nude 
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TEC progenitor equivalents lose the predictive pattern of histone modifications.  We 
also chose to examine the housekeeping gene Gapdh, whose expression is 
ubiquitous in the nude cell populations, the non-AIRE-regulated gene Skint1 whose 
expression pattern correlates with TRA, and the cTEC-specific Psmβ11.  The silent 
nature of Spt1, Spt2, Csn1s1, Skint1 and Psmβ11 within the FoxN1-deficient nude 
TEC was first confirmed through expression analysis from FACS sorted nude cells 
(Figure 3.26).  Again, the cell yields following FACS of FoxN1-deficient nude TEC are 
very low and therefore in order to assay histone modifications in this rare population 
of cells, CChIP was required. 
 
3.5.1. Pattern of Histone Modifications for Salivary Protein-1, Salivary Protein-2 
and Casein-α within FoxN1-Deficient Nude Thymic Epithelial Cells 
To allow for comparisons with the distribution of modifications in the equivalent wild-
type bipotent TEC progenitors and also mature cTECs, where these genes are 
silenced, FoxN1-deficient nude TEC results are displayed alongside those from the 
wild-type cells in Figures 3.27 and 3.28.  FoxN1-deficient nude TEC, which lack the 
capacity to express TRA, are marked by divergent histone modifications that differ 
greatly from the equivalent wild-type cells.  Also evident are the distinct variations 
between the gene regions analysed, with each gene responding in an individual way 
to the change in cell fate.  However, some commonalities do present themselves 
such as the predominance of H4K8ac within the nude cells and the correspondingly 
lower levels of H3K4me3 and H3K27me3. 
Expression profile of AIRE-regulated tissue-restricted antigens and control 
genes in athymic FoxN1-deficient nude mice.  Foetal thymic organ culture was 
employed, followed by FACS to isolate Mus musculus EpCAM1+ FoxN1-deficient 
TEC and real-time quantitative PCR was used to compare the relative mRNA 
expression levels of AIRE and three tissue-restricted antigens; casein-α (Csn1s1); 
salivary protein-1 (Spt1); and salivary protein-2 (Spt2), in addition to the mTEC-
specific selection and upkeep of intraepithelial T-cells 1 (Skint1) and the cTEC-
specific proteasome subunit β-type 11 (Psmβ11) as indicated.  For comparison, 
expression levels of these genes within normal bipotent TEC progenitors, mTECs 
and cTECs are displayed.  Data was normalised to β-actin expression levels as 
standard.  Data are the mean ±SEM from technical triplicate reactions, and are 
representative of at least two distinct cDNA preparations.
Figure 3.26 – The Epigenetic Patterning of FoxN1-Deficient Nude Thymic 
Epithelial Cells: Expression of the Autoimmune Regulator and Tissue-
Restricted Antigens upon Disruption of Normal TEC Development
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Comparisons between the bipotent TEC progenitors and the equivalent cells within 
the nude mice across Spt1, revealed an exciting shift in the histone modifications.  
Where the wild-type bipotent TEC progenitors showed a clear bivalency at the 
promoter region of Spt1 (Figure 3.27 B), with equally high levels of H3K4me3 and 
H3K27me3, enrichment of these modifications was much lower in the nude 
population.  Instead, these cells displayed a predominance of H4K8ac and the 
silencing modification H3K9me2.  For the Spt1 coding region (Figure 3.27 C), a 
different pattern of histone marks was seen for the nude mouse cells, with a very 
high level of acetylation at H4K8; at an intensity approximately 2-fold greater than 
the normal progenitors, along with an almost total loss of H3K4me3 and low levels of 
H3K27me3 and H3K9me2.  However, what was common for both the promoter and 
coding region of Spt1 was the subordinance of the bivalent marks in the nude cells.  
These alterations to the histone modifications across Spt1, a gene which could 
potentially be up-regulated in the wild-type cells, but whose expression will never 
occur within the nude mice, were especially exciting as they were more akin to those 
seen in wild-type mature cTECs, where Spt1 is also off (displayed in Figure 3.27 as 
indicated).  This trend is possibly indicative of the fact that Spt1 is more permanently 
silenced in the nude mice due to their halted differentiation.  However, one 
noticeable discrepancy is that the significant enrichment of H3K9me2 seen for the 
mature cTECs is not observed to the same extent in the nude mice, and this may be 
a result of the stunted developmental programme of these cells.  FoxN1-deficient 
nude TEC are fundamentally representative of the undifferentiated bipotent TEC 
progenitors, however, they are effectively ‘in limbo’ as no further differentiation will 

Figure 3.27 – The Epigenetic Patterning of FoxN1-Deficient Nude Thymic 
Epithelial Cells: Quantitation of the Relative Levels of Histone Modifications 




occur.  These cells may therefore retain the acetylation mark, keeping the chromatin 
open at these gene regions, should the developmental pathway continue. 
 
For the promoter region of Spt2 (Figure 3.27 D), the nude bipotent TEC progenitor 
cells again show an altered distribution of marks to the wild-type progenitor cells.  In 
comparison to the normal progenitors, nude cells displayed a reduction of the active 
histone modification H3K4me3, an approximate 3–fold decrease in H4K8ac and 
H3K9me2, but maintenance of the level of H3K27me3.  Thus when the TEC 
developmental pathway is disrupted, a locus-wide depression of acetylation and 
methylation was observed, which, unlike for Spt1, does not reflect the epigenetic 
status of mature cTECs. 
 
The pattern of histone modifications for Csn1s1 (Figure 3.27 E) in the FoxN1-
deficient population, also varied from that seen in the wild-type progenitors.  Despite 
no change to the overall amounts of the active marks H4K8ac and H3K4me3, the 
level of H3K27me3 was 4.6-fold lower in the nude cells, coupled with a small 
increase in the level of H3K9me2.  This resulted in a distribution of histone 
modifications similar to those seen across Spt1 in the nude TEC population (Figure 
3.27 B and C), and also within the mature cTECs for other TRA.  This pattern was 
not however, observed for the mature cTECs at the Csn1s1 promoter region, which 
in fact more closely resembles the pattern at the coding region of Spt1 (Figure 3.27 
C) for the nude mice cells, with high H4K8ac and low methylation. 
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The observed differences between the histone modifications across wild-type 
bipotent and FoxN1-deficient TEC progenitors for three genes under the 
transcriptional control of AIRE, shows how significant these marks are as indicators 
of future transcription.  With the loss of FoxN1, the TEC developmental pathway is 
blocked prior to the critical lineage choice of the progenitor cells into either AIRE- 
cortical or AIRE+ medullary TECs and thus the programme of transcription of these 
TRA is also halted.  These genes will never be expressed, as the nude cells cannot 
progress through to mature mTECs.  From our results it would appear that the future 
of these genes is reflected in the chromatin, with the alterations to the histone marks 
within the nude mice often showing similarities to mature cTECs where the genes 
are most definitely off.  Yet despite this, nude cells do not mirror cTECs entirely, 
showing instead consistently high H4K8ac levels.  This retention of acetylation is 
interesting and possibly suggests a ‘memory’ of the normal programme of 
development, marking these genes for potential expression should normal 
differentiation resume, even though it never will.  The genes are therefore not shut 
down totally, as in the mature cTECs, hence the differences observed between the 
two populations. 
 
3.5.2. Pattern of Histone Modifications for Glyceraldehyde-3-phosphate, 
Selection and Upkeep of Intraepithelial T-cells 1 and Proteasome Subunit β-
Type 11 within FoxN1-Deficient Nude Thymic Epithelial Cells 
When the histone modifications across the three control genes Gapdh, Skint1 and 
Psmβ11 were analysed, we again observed divergence from the wild-type (Figure 
3.28).  This was particularly interesting considering the unchanged active status of 

Figure 3.28 – The Epigenetic Patterning of FoxN1-Deficient Nude Thymic 
Epithelial Cells: Quantitation of the Relative Levels of Histone Modifications 
across Glyceraldehyde-3-phosphate Dehydrogenase, Selection and 
Upkeep of Intraepithelial T-Cells 1 and Proteasome Subunit β-Type 11 Upon 
Disruption of Normal TEC Development
169
 170
Gapdh within the nude cells.  In addition, noticeable contrasts between the findings 
for the TRA Spt1, Spt2 and Csn1s1 and the control genes arose.  For Gapdh, (Figure 
3.28 B) we observed a shift in the histone modifications in the nude cells in 
comparison to the equivalent bipotent TEC progenitors, however the predominance 
of H3K4me3 points to the active status of this gene within the nude cells.  Thus it is 
clear that even the epigenetic status of a ubiquitously-expressed gene is affected by 
the loss of FoxN1. 
 
For the promoter region of the non-AIRE-regulated Skint1 (Figure 3.28 C), the nude 
bipotent TEC progenitor population again showed a remarkable re-distribution of 
marks from the equivalent wild-type cells.  The most obvious change was the 
significant gain in acetylation at H4K8; a trend which has been consistent for the 
majority of genes analysed thus far in the nude cells.  The overall arrangement of 
the three methylation marks (H3K4me3, H3K27me3 and H3K9me2) for Skint1 in the 
nude progenitor cells does not differ greatly from the wild-type, thus the resultant 
distribution of all four modifications surprisingly reflects those seen for Spt1(c) and 
Csn1s1 in nude cells (Figure 3.27 C and E).  Comparisons between Skint1 in nude 
cells and normal mature cTECs showed little correlation, with the significant 
enrichment of H3K9me2 detected in the cTECs, not observed in the nude 
population. 
 
For the FoxN1-deficient nude TEC, the cTEC-specific Psmβ11 promoter (Figure 
3.28 D) is marked with much lower levels of H4K8ac when compared to the wild-
type progenitor population, which was surprising as for the majority of genes 
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analysed, levels of acetylation have generally shown an increase in the nude cells.  
What is also apparent is the almost total loss of H3K4me3 and H3K27me3, resulting 
in an arrangement of modifications similar to that seen for the nude cells at the 
promoter region of Spt1 (Figure 3.27 B), where low levels of these marks were 
detected along with comparatively higher levels of H4K8ac and H3K9me2.  In 
comparison with the mature cTECs, where Psmβ11 is switched on, we observed 
lower levels of the two active marks H4K8ac and H3K4me3, however the patterns 
seemed to resemble each other, despite the contrasting activities of this gene within 
these two populations. 
 
Together, these findings seem to indicate a default epigenetic patterning in the 
FoxN1-deficient nude TECs, with a predominance of acetylation coupled with a 
depletion of H3K4me3 and H3K27me3, which may reflect the blocked differentiation 




The discovery of the transcriptional regulator, AIRE, arguably represents one of the 
most significant milestones in T-cell biology in the past decade.  Its finding 
reintroduced the concept of central tolerance as a major force in the education of the 
T-cell repertoire, highlighting this protein’s essential role in the prevention of 
autoimmunity.  Since the identification of AIRE, many groups set out to characterise 
this protein and its importance in T-cell development, and to date much is known; 
about AIRE’s pattern of expression within thymic stromal cells of the medulla; of the 
ever-increasing list of pathological mutations; genes under the transcriptional control 
of AIRE; and the proteins with which AIRE has shown an interaction with in the 
nucleus (Pitkanen et al. 2000; Derbinski et al. 2001; Anderson et al. 2002; Pitkanen 
et al. 2005; Rossi et al. 2007; Ruan et al. 2007; Koh et al. 2008; Org et al. 2008).  
However, the way in which AIRE functions at a molecular level in the control of 
promiscuous gene expression remains elusive.  We have now demonstrated that 
AIRE is able to bind its individual target genes, triggering a cascade of post-
translational histone modifications, leading to the up-regulation of the loci. 
 
4.1. AIRE FUNCTIONS AS A TRANSCRIPTIONAL REGULATOR IN RETROVIRALLY-
TRANSFECTED TEP AND 3T3 CELLS 
 
Within the thymus, AIRE is limited to a small subset of CD80+ mTECs, making large-
scale analysis of the epigenetic status of tissue-restricted antigens under the 
transcriptional control of AIRE particularly challenging.  Thus, in order to mimic the in 
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vivo situation, we employed a Mus musculus thymic epithelial (TEP) cell model 
system, transfected with MIg virus bicistronic constructs containing both AIRE and 
GFP (TEP-AIRE), or GFP alone as a control (TEP-GFP).  Although induction of AIRE 
in mTECs and its over-expression within a primary mTEC-derived 1C6 cell line is 
reported to lead to apoptosis, we were able to maintain our TEP lines indefinitely, 
with no loss of either AIRE or TRA expression (Gray et al. 2007).  Our data revealed 
that AIRE was able to up-regulate a number of previously identified TRA; casein-α 
(Csn1s1), and salivary protein-1 and -2 (Spt1, Spt2), whose expression was either 
not detected or at a very low level in the control line, with no corresponding impact on 
housekeeping genes (Anderson et al. 2002).  Stable transfection of a non-thymic 3T3 
fibroblast line with MIg-AIRE-GFP also reliably reproduced PGE, suggesting that 
AIRE is able to exert its action regardless of the cellular environment, which has 
been demonstrated in a number of alternative cell lines previously, such as African 
Green Monkey SV40-transfected kidney fibroblast (COS7) cells, human embryonic 
kidney (HEK293) cells, pancreatic islet β cells, rhabdomyosarcoma (RD) cells and 
human leukemic monocyte lymphoma (U937) cells (Halonen et al. 2001; Pitkanen et 
al. 2001; Halonen et al. 2004; Pitkanen et al. 2005; Guerau-de-Arellano et al. 2008; 
Org et al. 2008; Org et al. 2009).  However, what we did find was that the expression 
of TRA within the 3T3 line was at a much lower intensity than that within the TEP 
line, thus it would appear that, although the presence of AIRE alone is sufficient for 
the initiation of PGE, its optimum transcriptional potential is only reached within a 
thymic epithelial background.  This observation could also be due to an alternative 
repertoire of genes under the transcriptional control of AIRE within different cell 
populations, which has been previously reported (Gardner et al. 2008; Guerau-de-
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Arellano et al. 2008; Org et al. 2009).  Guerau-de-Arellano et al (2008) showed 
through transfection of a non-thymic, unrelated epithelial cell line; pancreatic islet β 
cells, that AIRE’s general mode of transcriptional regulation can be replicated in 
tissues other than mTECs, as we saw with the 3T3 line, but that the cellular 
environment and underlying programme of gene expression ultimately defines which 
genes will be influenced by AIRE (Guerau-de-Arellano et al. 2008).  Gardner et al 
(2008) then went on to show that the same is true in vivo, with mTECs and extra-
thymic AIRE-expressing cells within secondary lymphoid organs expressing distinct 
catalogues of TRA (Gardner et al. 2008).  However, this group noted that both the 
total number of genes and fold-change of expression were much greater in mTECs 
than in the periphery (Gardner et al. 2008).  Thus it would appear that cellular 
environmental cues have a major impact upon the plethora of genes regulated by 
AIRE.  Our TEP line efficiently expressed the TRA; Csn1s1, Spt1 and Spt2, all of 
which are also detected in CD80+AIRE+ mTECs in the thymus and was therefore an 
ideal system for modelling AIRE’s mechanism of action within mTECs in vivo 
(Anderson et al. 2002). 
 
4.2. AIRE INDUCES THE ENRICHMENT OF ACTIVE HISTONE MODIFICATIONS ACROSS 
INDIVIDUAL TISSUE-RESTRICTED ANTIGENS 
 
The development of native chromatin immunoprecipitation (NChIP), which takes 
advantage of unfixed chromatin to maximise the efficiency and resolution of analysis, 
has allowed thorough investigation into the distribution of post-translational histone 
modifications across the genome (O'Neill and Turner 2003).  Through the application 
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of NChIP to the TEP model system, we have assayed eight key histone 
modifications, which have demonstrated dynamic roles in transcriptional activation 
and repression.  We found that in the absence of AIRE, individual TRA; Csn1s1, Spt1 
and Spt2, were marked with a relatively consistent pattern of modifications (Figure 
4.1).  In general, the TEP-GFP cells displayed low levels of the archetypal active 
marks, and correspondingly higher levels of silent marks across these non-expressed 
TRA.  In particular, a set pattern of H3K4 methylation was observed in the TEP-GFP 
population, which conformed to a preferential me2 > me1 > me3 distribution, the very 
low levels of H3K4me3 reflecting the silent nature of these genes.  Although 
H3K4me1 and H3K4me3 were depleted in the TEP-GFP cells at TRA, marks which 
are typically found in active genes, H3K4me2 was often enriched, however the 
relationship between H3K4me2 levels and transcription is less well defined and its 
presence within silenced genes has been noted (Orford, et al. 2008).   We 
observed a depletion of H3K9 acetylation across all TRA in the absence of AIRE 
(Figure 4.1), again correlating with their inactive status, and this modification has 
been found specifically within active genes at ‘acetylation islands’, in combination 
with H3K14ac (Roh et al. 2005).  Yet acetylation was not absent in the TEP-GFP 
population at these loci, with fluctuating levels of enrichment detected for acetyl H4 
(Figure 4.1), which is in agreement with previous studies showing that the impact of 
H4K16 and K8 acetylation on the genome is not linked to the control of ongoing 
transcription, but may instead define euchromatic genes as a mark of potential 
expression (O'Neill and Turner 1995; Johnson et al. 1998).  In nucleosomal arrays, 
H4K16ac has been shown to relax the chromatin structure and hence may prime the 
genes for transcription (Luger et al. 1997; Shogren-Knaak et al. 2006).  This may be 
Establishment of the typical epigenetic marking of AIRE-regulated tissue-restricted 
antigens (TRA) in Mus musculus thymic epithelial (TEP) cell lines.  Through 
native chromatin immunoprecipitation, levels of histone modifications at the TRA 
casein-α and salivary protein-1 and -2 were determined.  A relatively stable pattern 
of modifications was observed in the absence of AIRE (TEP-GFP) where these 
genes are silent, with low levels of the archetypal active marks H3K4me3 and 
H3K9ac in combination with higher levels of the silencing marks H3K9me2 and 
H3K27me3.  In the presence of AIRE (TEP-AIRE), TRA were actively transcribed, 
thus concordant rises in the active marks; H3K4 methylation, H3K9ac were 
observed along with a maintenance of H3K27me3, possibly allowing for shut 
down of the genes after transcription.  Although H4 acetylation was present in 
the control cells, upon AIRE-induced gene activation these marks were seen to 
increase.
Figure 4.1 – Model for the Epigenetic Patterning of Tissue-Restricted 




a feature of the TEP background as these genes would never ordinarily be 
expressed outside of their tissue-restricted niche, however within the thymus, they 
have the potential to be transcribed in the presence of AIRE.  The predominant mark 
within TEP-GFP cells was the archetypal silencing modification H3K27me3 (Figure 
4.1), which has been shown to be essential in the repression of developmental 
homeobox (Hox) genes in Drosophila melanogaster, through interactions with 
Polycomb group proteins (PcG), thus its localisation at TRA is indicative of their off 
state and possibly implicates PcG complexes in the silencing of these genes (Breiling 
et al. 2004; Schwartz and Pirrotta 2007; Henikoff 2008).  This was further confirmed 
through our analysis of the binding status of PcG proteins; the H3K27me-specific 
methyltransferase KMT6/Ezh2 and its co-factor Eed at the Spt1 and Spt2 promoters, 
via conventional formaldehyde cross-linked XChIP, showing detectable levels of 
these proteins in TEP-GFP cells.  We also identified the presence of the alternative 
silencing modification H3K9me2 (Figure 4.1), albeit at lower levels that those of 
H3K27me3, suggesting a dominance of PcG-mediated silencing mechanisms in the 
TEP cell line. 
 
The observed distributions of histone modifications in the control TEP-GFP 
population reflect the silent nature of TRA in these cells, and their relatively static 
levels are indicative of a locus-specific chromatin signature, patterning each gene 
with a background of epigenetic signals which could denote these tissue-specific 
genes, acting as a post-code, facilitating the recruitment of AIRE.  Recently, the first 
PHD finger of AIRE has demonstrated the potential to interact with un-modified H3K4 
(me0), an association which was lost upon methylation of this residue (Koh et al. 
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2008; Org et al. 2008; Chignola et al. 2009).  However, from our results, we can 
conclude that the presence of methylation at H3K4 at TRA does not impede AIRE’s 
actions, as detectable levels of me1, me2 and me3 are found across Csn1s1, Spt1 
and Spt2 in the absence of AIRE and that despite this, AIRE is still recruited and 
these genes are switched on, although this does result in substantial increases in 
methylation at this residue.  One possible explanation for these contrasting findings 
could be the different cell lines and techniques utilised for each study, the majority of 
previous work being carried out in HEK293 cells and through in vitro biochemical 
analysis (Koh et al. 2008; Org et al. 2008; Chignola et al. 2009).  Given our 
observation that AIRE’s function is influenced significantly by the cellular background 
within which it is operating, it may be that the different model systems employed 
could account for the discrepancies.  HEK293 cells are an epithelial line derived from 
human embryonic kidney and their continued use as a model system, enabling the 
study of AIRE’s mechanism of action, has provided valuable insight into how AIRE 
functions, however many inconsistencies have also arisen in terms of AIRE’s 
localisation, showing cytoplasmic distributions alongside the in vivo punctate nuclear 
staining, and to the catalogue of genes AIRE influences (Halonen et al. 2001; 
Pitkanen et al. 2005; Org et al. 2008; Org et al. 2009).  We observed similar 
differences with our 3T3 line which, although sorted for 100% transfection efficiency, 
expressed AIRE and the two salivary proteins at a much lower efficiency that the 
TEP line.  Thus as a representation of AIRE activity within its primary niche, 
retrovirally transfected TEP cells are more reliable for the epigenetic analysis of TRA.  
Alternatively, AIRE may require the combinational patterns of histone modifications 
we observed for its recruitment, reading the chromatin environment at its target 
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genes and identifying where in the genome it should bind.  Due to the regular 
spacing of nucleosomes, there will be many copies of each histone protein across a 
single gene and therefore H3K4me0 may serve as a docking site for AIRE, but could 
function in combination with the modified histones we observed to facilitate AIRE’s 
transcriptional activity.  Un-modified H3K4 could be located adjacent to methylated 
H3K4 on a neighbouring histone or nucleosome, providing a crosstalk.  In support of 
this hypothesis, one group noted, through the use of in vitro peptide binding assays, 
that di-methylation of H3R2 abrogated AIRE’s potential to bind H3K4me0 (Chignola 
et al. 2009).  However, the complex language of chromatin, including the enormous 
plethora of post-translational histone modifications and the vast network of histone-
modifying enzymes, is difficult to replicate with in vitro arrays, hence the true impact 
of histone modifications on AIRE-regulated expression can only really be modelled 
through native ChIP analysis of unfixed chromatin in a TEC-like cell line. 
 
In the presence of AIRE we observed highly dynamic chromatin reorganisation with 
dramatic changes to the distribution of histone modifications across the TRA Csn1s1, 
Spt1 and Spt2, signifying the change in transcriptional status of each loci (Figure 
4.1).  The most striking transformations were to the active histone marks, always 
resulting in significantly higher levels of enrichment in the TEP-AIRE cells.  For the 
majority of loci we observed a shift in the balance of H3K4 methylation for the TEP-
AIRE population.  While the background levels of H3K4 methylation were 
predominantly di-methyl, in the TEP-AIRE cells tri-methylation dominated; a mark 
which is found to peak at the promoters of active genes (Barski et al. 2007).  All three 
forms of H3K4 methylation were shown to increase in the presence of AIRE, linking 
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their enrichment to the induction of active transcription.  Through XChIP analysis, we 
observed heightened levels of the H3K4 methyltransferase KMT2A/MLL1 bound to 
the promoters of Spt1 and Spt2 in the presence of AIRE, which could account for the 
increases in H3K4 methylation across TRA.  AIRE also impacts considerably on 
histone acetylation.  Given the near depletion of H3K9ac in the control cells, AIRE-
induced up-regulation of the loci leads to its enrichment in TEP-AIRE cells, in line 
with work showing heightened levels of this modification upon gene activation (Roh 
et al. 2005; Wang et al. 2008).  Furthermore, despite the presence of H4K8ac and 
H4K16ac in the TEP-GFP population, these marks also intensify in the presence of 
AIRE and these modifications are frequently found localised to active loci (Barski et 
al. 2007; Kouzarides 2007).  Interestingly, the activation of the loci did not result in 
dramatic reductions in the silencing modifications H3K27me3 and H3K9me2 from the 
control TEP-GFP cells (Figure 4.1).  However, from our XChIP analysis of the binding 
status of PcG proteins at Spt1 and Spt2, enrichments of KMT6/Ezh2 and Eed were 
observed in the presence of AIRE, which may account for the maintenance of 
H3K27me3 in the TEP-AIRE cells.  The presence of inactive modifications in active 
gene regions has regularly been reported and may point to a system put in place to 
regulate expression, allowing for the shutdown of the loci after transcription (Vakoc et 
al. 2005; Squazzo et al. 2006; Vakoc et al. 2006; Barski et al. 2007; Kouzarides 
2007; Shilatifard 2008).  The marks may also prevent over-expression by AIRE due 
to a lack of normal cellular signalling pathways which would ordinarily operate to 
regulate transcription within each TRA’s natural peripheral environment. 
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Together, these results show that AIRE is able to induce major alterations to the 
distribution of histone modifications across individual TRA.  Active acetylation and 
methylation marks increase significantly from the background signature of 
modifications patterning these genes in the absence of AIRE, whereas silent marks 
often remain unchanged.  Yet these changes are subtly different between TRA, 
which may account for the altering levels of expression of these genes. 
 
4.3. AIRE’S TRANSCRIPTIONAL CONTROL OF A CLUSTER OF GENES INVOLVES DOMAIN-
WIDE ALTERATIONS TO HISTONE MODIFICATIONS 
 
As a transcriptional regulator, AIRE must presumably bind each target gene, or a 
regulatory region of DNA to either activate or repress the loci.  Yet AIRE is faced with 
a number of complexities as it not only controls the expression of many thousands of 
target genes, they are distributed randomly across all chromosomes (Gotter et al. 
2004).  However, the finding that many of these loci are clustered along the 
chromosome arms, points to a more domain-wide regulation by AIRE (Derbinski et al. 
2005; Johnnidis et al. 2005).  Although our Western blot analysis and 
immunofluorescence of metaphase chromosome spreads indicated that AIRE does 
not exert its transcriptional activity through genome-wide acetylation or methylation, 
our observation of AIRE-induced increases in H3K4 methylation and H3 and H4 
acetylation across the housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), with no change to the transcription levels, may support this 
theory; suggesting a general deposition of H3K4 methylation, mediated by AIRE.  
Our analysis of a cluster of genes which show differential expression profiles in the 
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presence and absence of AIRE, does however suggest that AIRE may influence the 
distribution of certain histone modifications in a domain-wide manner. 
 
Previous analysis into AIRE’s control of transcription showed fluctuating levels of 
output from each target gene and that those located in clusters did not respond 
equally, often with neighbouring genes acting in opposing ways (Gotter et al. 2004; 
Derbinski et al. 2005; Johnnidis et al. 2005).  Preliminary studies by Johnnidis et al 
(2005) into the clustering of AIRE-regulated genes, demonstrated that one such 
cluster on Mus musculus chromosome 15 contained three genes which were 
differentially regulated by AIRE (Johnnidis et al. 2005).  They found that keratin 4 
increased in expression, while keratin 18 and eukaryotic translation initiation factor 
4b (Eif4b) showed a decrease in the presence of AIRE (Johnnidis et al. 2005).  We 
extended these studies, to cover the entire keratin cluster, which actually 
encompasses five keratin genes (Krt4, Krt79, Krt78, Krt8 and Krt18), and three 
further genes (Eif4b, tensin-like C1 domain-containing phosphatase (Tenc1) and 
SPRY domain-containing 3 (Spryd3)) within a 217kbp region.  We instead found that 
AIRE exerted a positive influence over all genes, with the exception of keratin 18, 
which did not appear to be affected by AIRE as approximately equal transcript levels 
were detected in TEP-AIRE and TEP-GFP cells.  Our method of analysis and model 
system differed from those of the original study, which may explain the observed 
discrepancies.  While Johnnidis et al (2005) opted for a large-scale bioinformatic 
analysis of published microarray data on medullary RNA transcripts from AIRE-
deficient versus wild-type mice, we performed quantitative real-time PCR (qPCR) 
with our TEP cell lines (Johnnidis et al. 2005).  Validation of the expression of each 
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individual gene following microarray is an arduous and unrealistic task, however, 
qPCR is often a more reliable representation of the true situation, which is why we 
chose to analyse the transcriptional profile across the entire cluster using this 
technique.  The ectopic expression of AIRE-regulated genes within the thymus is 
known to occur at considerably lower levels when compared to their expression in 
the relevant peripheral tissues, hence any fluctuations in transcript levels will also be 
small, and could be lost or misinterpreted following genome-wide analyses (Johnnidis 
et al. 2005).  In addition, as mentioned previously, certain variation can arise 
between different cell types, we therefore wanted to verify the situation in our TEP 
model system. 
 
Through the use of NChIP we were able to, for the first time, assay the distribution of 
histone modifications across each of the genes in the AIRE-regulated keratin cluster, 
in addition to the intergenic regions between the loci.  This gave us a thorough 
analysis of how AIRE influences transcription on a broader scale.  Our results 
provide a direct demonstration that AIRE is able to modulate histone modifications, 
impacting on each individual mark in a distinct way (Figure 4.2).  In general, AIRE-
induced up-regulation of the keratin cluster genes resulted in heightened levels of 
active methylation and acetylation marks, with broad domains of these modifications 
occurring across all genetic regions of the cluster, often irrespective of the ultimate 
level of expression when compared to the basal levels in TEP-GFP cells (Figure 4.2 
A, B).  However, we also observed domains of certain modifications in the control 
cells, reflecting the expression profile of the genes, particularly in the 3` end of the 
cluster where active transcription is occurring.  In particular, TEP-GFP cells harbour 
The impact of AIRE on domain-wide distributions of histone modifications across a 
cluster of AIRE-regulated genes in Mus musculus thymic epithelial (TEP) cell lines. 
Through native chromatin immunoprecipitation, levels of histone modifications 
across the keratin cluster on Mus musculus chromosome 15 were determined. 
Histone modifications investigated included; A, H3K4 methylation (me1, me2, 
me3), B, H3K9, H4K8 and H4K16 acetylation, and C, silencing modifications 
H3K9me2 and H3K27me3.  In the absence of AIRE, genes in the keratin cluster 
showing active expression in TEP-GFP cells were typically marked with peaks 
of the archetypal active modifications H3K4me3 and H3K9ac.  This pattern was 
mirrored in the presence of AIRE, suggesting AIRE has limited influence over 
these marks.  Mono-and di-methylation of H4 however were consistently higher 
in TEP-AIRE cells.  In the presence of AIRE, H4 acetylation occurred in a blanket 
across the cluster, not seen in the active genes in the TEP-GFP cells, suggestive 
of a role for AIRE in the enrichment of these marks.  Silencing modifications were 
seen to peak across silent genes in TEP-GFP cells, however, this patterning was 
not lost in the presence of AIRE despite active gene expression, although overall 
levels were reduced.  Peaks of H3K9me2 were introduced in the TEP-AIRE cells 
at active genes across the cluster and AIRE may play a role in their deposition.
Figure 4.2 – Model for the Domain-Wide Epigenetic Patterning of a Cluster 
of AIRE-Regulated Genes in Thymic Epithelial Cell Lines
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increased levels of the two classical active marks H3K4me3 and H3K9ac at the 
promoters of active genes (Figure 4.2 A, B) (Roh et al. 2005; Shilatifard 2008).  
Interestingly, the enrichment levels of these two histone modifications, show little 
change at these genes in the presence of AIRE, when active expression is occurring 
in both cell populations, despite the approximate 4-fold increases in expression in the 
TEP-AIRE cells.  This may suggest that AIRE does not impact significantly on these 
modifications, and that their presence within the transcriptionally active genes merely 
reflects their active status in both the presence and absence of AIRE.  In contrast, 
some modifications show major changes in response to AIRE (Figure 4.2).  For 
example, AIRE appears to modulate acetylation of H4K8 and H4K16, which both 
appear to show little correlation with transcriptional activity in the control cells in that 
only minor enrichments were observed in the active 3` genes.  Although a small 
domain-wide increase in H4K8ac was observed for the actively-expressed genes and 
their corresponding intergenic regions in TEP-GFP cells, the intensity at each active 
region is heightened in the presence of AIRE.  This may account for the increased 
levels of transcription for the majority of genes in the TEP-AIRE cells.  The same is 
seen for H4K16ac yet to an even greater extent (Figure 4.2 B).  In the control cells, 
there was no correlation between this modification and the expression profile across 
the cluster, with a consistently low level in both the silent and active loci in TEP-GFP 
cells, however a broad domain of acetylation spread across the entire cluster in the 
presence of AIRE.  This observation is in agreement with the seminal report by 
O’Neill and Turner (1995), who discovered that euchromatic coding regions showing 
ongoing transcriptional activity, did not coincide with induced hyperacetylation, but 
instead H4 acetylation marked large euchromatic domains, distinguishing them from 
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the hypoacetylated heterochromatin (O'Neill and Turner 1995).  With this in mind, our 
demonstration of constant background levels of H4 acetylation in TEP-GFP cells and 
AIRE-induced H4 hyperacetylation may suggest a role for AIRE in the direct or 
indirect deposition of these marks.  This may allow an opening of the locus, 
facilitating higher levels of expression across the keratin cluster mediated by AIRE.  
This is particularly interesting considering the co-localisation of AIRE and 
KAT3A/CBP, a ubiquitous transcriptional activator with intrinsic histone and non-
histone acetyltransferase activity, an association shown to enhance AIRE’s 
transactivating potential (Pitkanen et al. 2000; Akiyoshi et al. 2004; Pitkanen et al. 
2005; Ferguson et al. 2007).  Although KAT3A/CBP participates in hundreds of 
different transcriptional programmes, binding transcription factors including members 
of the general transcription machinery such as TFIID, TFIIB and RNA polymerase II, 
its nuclear co-localisation within mTECs has been shown to be specifically 
dependent upon AIRE (Bannister and Kouzarides 1996; Vo and Goodman 2001; 
Ferguson et al. 2007).  Through synchronous AIRE induction by anti-RANK 
stimulation of foetal thymic organ cultures, Ferguson et al (2007) showed that prior to 
the up-regulation of AIRE, KAT3A/CBP remained cytoplasmic, only to translocate to 
the nucleus upon AIRE production, leading to the co-accumulation of AIRE and 
KAT3A/CBP within focal nuclear puncta (Ferguson et al. 2007).  The heightened 
levels of H4 acetylation we see in TEP-AIRE cells across the entire keratin cluster 
may be brought about as a result of this interaction.  Given that depletion of 
KAT3A/CBP suppresses the rate of transcription, as demonstrated for IFNβ gene 
expression, the interaction between AIRE and KAT3A/CBP may facilitate the 
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enhanced levels of transcription across the majority of the genes in the cluster (Yie et 
al. 1999). 
 
Our results also imply that AIRE influences the modifications typically associated with 
silent genes; H3K9me2 and H3K27me3 (Figure 4.2 C).  Both of these marks are 
concentrated towards the 5` end of the cluster and are then lost further downstream 
which, in the control cells, correlates perfectly with the expression profile across the 
cluster.  Interestingly, TEP-AIRE cells also show this domain of silencing 
modifications, despite active expression occurring for every gene.  However, while 
TEP-GFP cells show peaks in silent promoters, TEP-AIRE cells show higher levels in 
the 5` intergenic regions.  Further along the cluster, peaks of H3K9me2 do occur, but 
only in the TEP-AIRE cells, specifically at promoter regions thus, whereas the levels 
of H3K9me2 correlate perfectly with the expression profile in the TEP-GFP cells, in 
the presence of AIRE we see a deposition of this mark at actively expressed genes, 
hence it would appear that AIRE is able to manipulate the levels of H3K9me2.  The 
presence of silent marks in active genes is in agreement with our findings for the 
TRA Csn1s1, Spt1 and Spt2 and also with published data, strengthening the idea 
that these marks could be indicative of an internal safety feature for AIRE-regulated 
transcription; preventing aberrant expression (Vakoc et al. 2005; Squazzo et al. 
2006; Vakoc et al. 2006; Kouzarides 2007; Shilatifard 2008).  The fact that the levels 
of these marks fluctuate frequently in the presence and absence of AIRE shows how 
there is no strict rule for the functional outcome of each individual modification, but 
that it is the overall combination of marks that dictates a genes activity. 
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Collectively, these results show that, in its role as a transcriptional regulator, AIRE is 
able to command both subtle and domain-wide changes in the epigenetic status of its 
target genes.  Our data also highlight the significant bearing post-translational 
histone modifications impart upon the control of gene expression and of chromatin in 
general. 
 
4.4. TISSUE-RESTRICTED ANTIGENS ARE MARKED WITH DYNAMIC HISTONE MODIFICATIONS 
WHICH RAPIDLY REARRANGE UPON DIFFERENTIATION THROUGHOUT THE TEC 
DEVELOPMENTAL PATHWAY 
 
The use of cultured cell lines as model systems of the in vivo situation are however 
limited in their application.  In the case of the TEP line, the transfected cells ultimately 
represent the end points of a well established developmental pathway which begins 
in the embryo and continues throughout adulthood, with mature CD80+AIRE+ mTECs 
constantly turning over and replenishing the population (Gray et al. 2007; Ferguson 
et al. 2008).  Although our TEP system replicated AIRE’s role with regards to its 
expression, subcellular localisation, and its control of PGE, we have already 
demonstrated AIRE’s requirement for a thymic cell background to function optimally.  
The perfect scenario would therefore be to look within the embryonic thymus, in the 
cells in which AIRE is expressed in vivo, ideally immediately following AIRE’s up-
regulation, thus giving a snapshot into the epigenetic state of the cells prior to the 
onset of AIRE-induced replicative cell death.  The major steps in the pathway of TEC 
development have recently been uncovered in two influential reports by Rossi et al 
(2006, 2007), showing that cortical and medullary TECs stem from a common 
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bipotent TEC progenitor (Rossi et al. 2006; Rossi et al. 2007).  They also defined an 
additional layer of differentiation, which exists for the mTEC lineage, with mature 
CD80+AIRE+ mTECs passing through an immature CD80-AIRE- phase, only 
completing development upon stimulation with RANK ligand (Rossi et al. 2007).  
These important findings provided an insight into how thymic development is 
controlled; finally resolving the long-standing issue of whether cortical and medullary 
TECs derive from individual stem cell lineages or a single progenitor.  However, this 
work also clarified how and when AIRE is switched on in the thymus, thus offering 
evidence in support of the terminal differentiation model; assuming PGE to be an 
autonomous trait of mTECs, with the number and complexity of genes expressed 
increasing as the cells mature (Farr et al. 2002; Kyewski et al. 2002; Gotter and 
Kyewski 2004; Devoss and Anderson 2007). 
 
Foetal thymic organ culture preserves the three-dimensional architecture of the 
developing thymus, and the phenotype of each stromal cell subset (Jenkinson and 
Anderson 1994).  Thus regular programmes of cell development, in particular that of 
TECs, can occur as normal (Jenkinson and Anderson 1994; Anderson and Jenkinson 
1995; Anderson and Jenkinson 2008).  Through FACS sorting, pure populations of 
each of the four phases in the TEC developmental pathway (bipotent TEC 
progenitors, immature and mature mTECs and mature cTECs) can be isolated.  Due 
to the limited cell numbers in each population, we were unable to analyse the 
distribution of histone modifications across TRA by native ChIP, which requires a 
minimum of 1x107 cells, thus we turned to the novel technique of carrier ChIP, 
developed within our lab for the detailed analysis of small numbers of cells (O'Neill et 
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al. 2006).  This procedure takes advantage of the high efficiency of native ChIP with 
unfixed chromatin and, by reducing wash volumes and keeping losses at each stage 
to a minimum, results in immunoprecipitation recoveries of up to 28%, although the 
number of possible PCR assays is severely limited. 
 
We have successfully employed CChIP to assess the patterns of four histone 
modifications (H4K8ac, H3K4me3, H3K27me3 and H3K9me2) across TRA and 
control genes throughout the four main stages of the embryonic TEC developmental 
pathway (Figure 4.3).  Within the TEC developmental pathway, bipotent TEC 
progenitors essentially represent an undifferentiated population and we therefore 
chose to analyse the bivalent modifications H3K4me3 and H3K27me3, which have 
been shown to prime key developmental genes in pluripotent embryonic stem cells 
for future transcription (Azuara et al. 2006; Bernstein et al. 2006).  Although we 
repeatedly saw a co-localisation of active and silent marks for TRA in the 
undifferentiated cells, this was not always the traditional H3K4me3 / H3K27me3 
bivalency (Figure 4.3).  For example, across Spt1 we observed conventional 
bivalency at the promoter region, however the Spt2 promoter showed a 
predominance of H4K8ac and H3K9me2 and the Csn1s1 promoter displayed an 
H4K8ac / H3K27me3 patterning.  Thus it would appear that the established 
H3K4me3 / H3K27me3 bivalency does not always play an essential role in the 
priming of TRA throughout the TEC developmental pathway, which may be due to 
the more developed nature of these progenitor cells, being bipotent rather than 
pluripotent embryonic stem cells.  However, what is apparent is that these TRA are 




















































































combination of an active and a silent mark (Figure 4.3).  The presence of an active 
mark such as H4K8ac or H3K4me3 marking the genes for expression should these 
bipotent TEC progenitors receive signals to differentiate into mTECs, would maintain 
a relaxed chromatin structure to allow for future transcription, whilst the silent marks 
present keep the genes off during development and would enable rapid shutdown of 
the loci upon differentiation into cTECs.  This epigenetic priming is highlighted when 
the distribution of marks are evaluated across the entire developmental pathway, 
particularly when comparisons are made to the mature cTEC population where TRA 
expression is switched off more permanently.  Typically mature cTEC TRA were 
marked with very high levels of H3K9me2, signifying the silent nature of these genes 
in the cortex.  Interestingly, even when H3K27me3 was the predominant silencing 
mark in the bipotent TEC progenitor population, cTECs still presented with higher 
H3K9me2 than H3K27me3, suggesting that H3K9me2 is possibly a stronger 
silencing signal on these genes.  Mature cTECs also showed low levels of H3K4me3 
and H3K27me3 along with moderate H4K8ac and this pattern of modifications was 
repeated in the majority of TRA.  This distribution was also mirrored in the cTECs at 
the mTEC-specific, but AIRE-independent selection and upkeep of intraepithelial T-
cells 1 (Skint1), whose expression profile matches that of the AIRE-regulated TRA.  
This may suggest that this combination of marks is essential for the more permanent 
silencing of these genes in the mature cTECs, possibly reflecting a default or stable 
chromatin state, as opposed to the poised nature of these genes throughout the 
mTEC lineage, hence their more dynamic histone modifications.  This pattern did not 
always follow however, as Csn1s1 was instead marked with high levels of H4K8ac in 
the mature cTEC population (Figure 4.3).  This was interesting given our observation 
 193
of AIRE-induced domain-wide H4 hyperacetylation and the presence of H4 
acetylation across TRA within the control TEP-GFP cells, indicating that these marks 
show little correlation with active, on-going transcription.  This high H4 acetylation 
could be due to an alternative repertoire of histone acetyltransferases or 
deacetylases at the different loci, leading to diverse turnover rates of acetylation.  
However, what is obvious is that this high H4K8ac is not able to override the 
silencing signals.  This is also reflected in the mTEC lineage where again large and 
highly dynamic chromatin re-organisations are observed as the cells develop (Figure 
4.3).  Typically, upon lineage commitment to immature mTECs, we saw a fall in the 
levels of all four modifications.  But again this was not ubiquitous as Csn1s1 showed 
higher levels of H4K8ac, H3K4me3 and H3K9me2.  This re-distribution of marks 
within the immature mTECs reflects the change in phenotype and development, with 
the TRA epigenetic patterning altering as these genes move one step closer to their 
ultimate expression, despite remaining in a poised state.  Maturation of the cells and 
the initiation of AIRE-induced TRA expression sees further interesting shifts in 
histone modifications, which again are unique for each gene region analysed.  In 
general however, we often recorded increases or maintenance of the levels of the 
active marks H4K8ac and H3K4me3 from the immature mTECs, with only Csn1s1 
showing a decrease in H4K8ac.  We frequently observed increases in H3K27me3 
and H3K9me2, again with the exception of Csn1s1 where H3K9me2 levels fell in the 
mature mTECs.  The presence of the silencing marks within the mTEC lineage and 
bipotent progenitors, and frequent predominance of H3K9me2, may imply a more 
strict regulation of gene expression within the embryo, maintaining a high level of the 
mark across the progenitors and immature mTECs to prevent aberrant gene 
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expression, and within the mature mTECs to allow for rapid shut down of the locus 
when required.  Alternatively, H3K9me2 could be acting as a signal for the 
recruitment of AIRE, marking its target genes as transcriptionally silent and working 
in combination with the active marks present across the loci to permit transcription.  
These findings emphasize how individual genes respond in different ways throughout 
a developmental pathway, supporting the hypothesis that combinations of marks act 
in synergy to direct transcriptional programmes.  Our results have also highlighted 
the importance of in vivo investigations, which could not have been possible without 
the development of the CChIP technique.  We often observed contrasting findings 
between the primary TEC developmental pathway and the TEP model system, for 
example, the clear cut and recurring enrichment of active marks in combination with 
lower levels of silent marks seen in the TEP line, were less obvious across the four 
TEC populations.  Instead, high levels of silencing marks, in particular H3K9me2 
were observed for the majority of TRA across all four cell populations in vivo, often 
predominating over the active marks even when gene expression was occurring.  
Although enrichment of silencing modifications was also seen in the TEP lines in 
active loci, the dominant mark was typically H3K27me3, which may imply a less strict 
regulation of expression within the cell lines. 
 
Interestingly, the control gene Gapdh exhibited fluctuating levels of histone 
modifications, although the common theme throughout each stage of the 
developmental pathway for this gene was the enrichment of active modifications.  
However these were frequently matched by equally high levels of silencing marks as 
observed for the TRA.  In the study by Vakoc et al (2005), which showed H3K9me2 
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and me3, along with HP1γ, within the transcribed regions of active mammalian 
genes, Gapdh was also found to display these marks (Vakoc et al. 2005).  The 
authors concluded that the presence of these silencing modifications at the 
ubiquitously expressed Gapdh, in addition to the increases they observed within 
genes which were up-regulated in their model system, reflected more steady-state 
transcription rates, rather than genes undergoing dynamic fluctuations in expression 
(Vakoc et al. 2005).  They proposed that the specific location of H3K9 methylation 
may determine its functional outcome; associating with transcriptional repressors at 
the promoter region, yet aiding transcriptional elongation within transcribed regions 
(Vakoc et al. 2005).  Our results however, do not support this theory as we observed 
high levels at both the promoter and coding regions of Spt1 throughout all stages of 
the developmental pathway when the gene is both on and off.  Instead our findings 
substantiate this group’s alternative theory of H3K9 methylation, in combination with 
HP1γ, exerting an attenuating effect on elongation by RNA pol II, thus preventing 
aberrant expression (Vakoc et al. 2005). 
 
Analysis of the distribution of modifications across each stage of the TEC 
developmental pathway has allowed an insight into how these marks contribute to 
PGE prior to, and immediately following AIRE’s up-regulation.  In a recent report by 
Org et al (2009), cross-linked ChIP was used to analyse H3K4me3, bulk acetylated 
(Ac)H3 and H3K27me3 in AIRE-transfected and control HEK293 cells, and in CD80-
AIRE- and CD80+AIRE+ mTEC populations (Org et al. 2009).  This group, who also 
reported on AIRE’s ability to bind H3K4me0, showed that in the absence of AIRE 
within cultured cells, the TRA GHR and LPL showed low levels of active marks 
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H3K4me3 and AcH3, which increased in the AIRE-transfected cells, from which they 
concluded that the absence of these marks is a signal for AIRE-recruitment and 
binding to H3K4me0 (Org et al. 2009).  This was not always the case however as 
they also found high levels of H3K4me3 in the AIRE-regulated TRA INV, INS and 
S100A8 in their AIRE-negative control line, which were maintained when AIRE was 
present (Org et al. 2009).  When they looked in vivo in the mouse, they saw low 
levels of H3K4me3 in CD80-AIRE- mTECs across S100a8 and Ins2 in comparison to 
the levels of this mark in the corresponding peripheral tissues, which contrasted with 
their cell line data for these genes (Org et al. 2009).  Upon maturation of the cells to 
CD80+AIRE+ mTECs, levels of H3K4me3 increased for S100a8, but remained low for 
Ins2, again contrasting with the high levels of this mark seen in their HEK293 lines for 
this gene (Org et al. 2009).  They do not address these discrepancies in their report, 
however this is in agreement with our data, showing that histone modifications can 
fluctuate between model systems and between individual genes.  Given that their 
data is generated from non-thymic HEK293 cells, this may account for their 
contrasting findings.  In our observations the two salivary proteins for example 
displayed a substantial decrease in all four modifications we assayed as the cells 
progressed from bipotent TEC progenitors to immature CD80-AIRE- mTECs, levels of 
which then rose as the cells matured.  However, for Csn1s1, we observed a 
contrasting scenario, with high levels of enrichment of H4K8ac, H3K4me3 and 
H3K9me2 in the immature cells, that were either maintained (H3K4me3), or fell 
(H4K8ac and H3K9me2) as AIRE was switched on.  These dynamic fluctuations 
throughout each stage of the TEC developmental pathway were not addressed by 
Org et al (2009) as their analysis did not stretch to the four definable TEC 
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populations and their range of marks assayed was limited, therefore our findings offer 
a more comprehensive view of the role of histone modifications in the control of 
promiscuous gene expression in vivo. 
 
Throughout the TEC developmental pathway, we observed considerable changes to 
the distribution of histone modifications at each phase of differentiation that varied for 
every gene analysed, highlighting the dynamic nature of these epigenetic 
phenomena.  Our data suggest that instead of individual marks working as static 
on/off switches, histone modifications act in concert to direct gene expression and 
that combinatorial patterns dictate whether a gene is on or off. 
 
4.5. THE EPIGENETIC PRIMING OF AIRE-REGULATED GENES IS LOST UPON DISRUPTION TO 
THE PATHWAY OF TEC DEVELOPMENT 
 
For the first time, a comprehensive analysis of histone modifications throughout a 
cellular developmental pathway, covering a population of bipotent progenitors, along 
with their two end points of differentiation, has been made possible through the 
application of the novel and complex CChIP technique.  This has allowed an insight 
into the roles these modifications play in priming genes for future expression, in 
addition to the ultimate outcomes when the genes are either expressed or silenced.  
Yet it does not answer the question of whether these marks are essential for 
development.  The only way to address this is to disrupt or block the pathway of 
development and then analyse the distribution of modifications once normal 
differentiation is prevented.  To this end, the athymic nude mouse model which is 
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deficient in the forkhead transcription factor FoxN1, provides an invaluable tool for 
these investigations.  The lack of FoxN1 leads to the generation of a non-functional 
cystic thymic rudiment due to an early block in normal TEC development (Blackburn 
et al. 1996; Anderson and Jenkinson 2001; Jenkinson et al. 2008).  Both medullary 
and cortical lineages cannot develop, however the preliminary stages of thymic 
organogenesis in which bipotent TEC progenitors are generated, does occur 
(Anderson and Jenkinson 2001; Anderson et al. 2007; Chen et al. 2008; Jenkinson et 
al. 2008).  These small numbers of FoxN1-deficient nude TEC, representing the wild-
type bipotent TEC population, were FACS sorted and used subsequently in CChIP to 
analyse the epigenetic status of TRA when normal thymus embryogenesis is 
blocked. 
 
Our investigation into the patterns of histone modifications across the TRA Spt1, 
Spt2 and Csn1s1 within these TEC progenitors from foetal FoxN1-deficient nude 
mice has provided direct evidence for their importance in the establishment of future 
gene expression profiles.  Due to the disruption to FoxN1-deficient nude TEC 
development, these genes lose the potential to be expressed within mature mTECs, 
and this was reflected in the chromatin, with often major shifts in the distribution of 
modifications (Figure 4.4).  While the normal bipotent TEC progenitors occasionally 
displayed a bivalent chromatin signature, not necessarily with the classic bivalent 
marks H3K4me3 and H3K27me3, but a mixture of active and silent marks, the 
FoxN1-deficient nude TEC displayed particularly low levels of H3K4me3 and 
H3K27me3.  Thus it would appear that the nude TEC progenitor equivalents lose the 
pattern of histone modifications set up in the wild-type bipotent TEC population to 
Model of the typical epigenetic marking of AIRE-regulated tissue-restricted 
antigens (TRA) within Mus musculus FoxN1-deficient nude thymic epithelial 
cells (TEC), following disruption to normal TEC development.  The nude mouse 
model, athymic due to a deficiency in the forkhead transcription factor FoxN1, 
can generate FoxN1-deficient TEC progenitors, but medullary and cortical 
TECs cannot develop (Blackburn et al. 1996; Anderson and Jenkinson 2001; 
Anderson et al. 2007; Chen et al. 2008; Jenkinson et al. 2008).  Through carrier 
chromatin immunoprecipitation of FACS sorted primary cell populations from 
foetal thymic organ culture, levels of histone modifications at the TRA casein-α 
and salivary protein-1 and -2 were determined.  Although FoxN1-deficient nude 
TEC represent bipotent TEC progenitors, the poised status of TRA within these 
cells is lost as mTECs can never develop and this was reflected in the chromatin. 
FoxN1-deficient nude TEC were instead marked with a relatively stable pattern of 
modifications, typically with low H3K4me3 and H3K27me3, moderate H3K9me2 
keeping the loci silent and very high H4K8ac, possible representing a ‘memory’ 
of normal development.  This pattern was similar to that seen in mature cTECs 
where the loci are permanently silenced, however the level of H3K9me2 was 
not as high in the nude cells, indicating that the loci may not be switched off as 
strictly.
Figure 4.4 – Model for the Epigenetic Patterning of Tissue-Restricted 




prime the genes for future transcription.  Instead, these cells were marked 
predominantly with high levels of H4K8ac, along with modest H3K9me2 for the 
majority of TRA and control genes (Figure 4.4).  Although subtle differences did 
present themselves between individual genes, what was consistent was the 
significant divergence between the patterns seen in the nude cells when compared to 
the equivalent wild-type cells, suggesting that because of the halt in development, 
these genes are instead marked for an alternative fate of permanent silencing.  In 
support of this, the patterns observed in the FoxN1-deficient nude TEC often 
reflected those seen in mature cTECs, where these genes are off (Figure 4.4).  
However, one major difference distinguishing the nude cells from the cTECs is the 
dominance of H4K8ac over H3K9me2; the mark which was pronounced in the 
cTECs, denoting the silencing of the TRA in these cells.  The retention of a mark of 
active transcription in the nude TEC may represent the preservation of an open 
chromatin structure, as a ‘memory’ of the developmental pathway.  Prior to the block 
in differentiation, these cells could have been ‘unaware’ of their fate, hence beginning 
the process of establishing the epigenetic status of the TRA.  Of the four 
modifications we investigated, H4K8ac may be deposited across these genes early in 
development as a predictive mark, allowing an opening of the domain and preventing 
the formation of repressive heterochromatin across the TRA that would ordinarily be 
expressed further along the differentiation pathway.  It is known that the presence of 
H3K4me3 and H3K27me3 across certain genes in pluripotent embryonic stem cells 
renders them in a poised state (Azuara et al. 2006; Bernstein et al. 2006).  Cui et al 
(2009) have added to this story, showing that those genes which go on to become 
active, losing the repressive H3K27me3 mark, uniquely carried high levels of 
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H3K4me1, H3K9me1, H4K20me1 and RNA pol II in the undifferentiated cells, not 
observed in the genes which subsequently remained silent (Cui et al. 2009).  
Alternatively, Golebiewska et al (2009) have demonstrated that, rather than 
H3K27me3, H3K9me2 in combination with H3K4me3, could play a more dominant 
role in the poising of certain embryonic stem cell genes (Golebiewska et al. 2009).  
They did observe heightened H3K27me3, but not until the first stages of lineage 
commitment had been completed (Golebiewska et al. 2009).  Thus some genes are 
often ‘conscious’ of their futures, which is reflected in their chromatin.  Our findings, 
showing a default epigenetic patterning in the FoxN1-deficient nude TECs with 
enrichment of H4K8ac and low H3K4me3 and H3K27me3 across TRA and the 
control genes Skint1 and proteasome subunit β-type 11 (Psmβ11), may also 
represent a ‘knowledge’ of the destiny of these genes.  They will never be expressed, 
however, the retention of acetylation keeps the chromatin in an open and accessible 
form, so that should AIRE and other transcriptional regulators be switched on, the 
genes would be prepared and not completely shut down as is the case for TRA within 
the cTEC lineage.  In support of Golebiewska et al (2009), we observed higher levels 
of H3K9me2 than H3K27me3, however, this was matched with consistently low 
levels of H3K4me3 (Golebiewska et al. 2009).  This could suggest that the active 
mark H3K4me3, which is known to peak at active gene promoters, may be a more 
dynamic modification, being rapidly removed in response to the block in the 
developmental pathway, thus preventing aberrant expression due to the loss of 






Histone modifications are notoriously complicated in both their regulation and their 
functional outcomes.  The preliminary data that we have demonstrated here gives an 
insight into the role these marks play in the control of PGE, and how AIRE may be 
able to manipulate their positioning and intensity.  We have shown how simply the 
introduction of AIRE into an AIRE-negative background is sufficient for the onset of 
PGE, suggesting that AIRE is able to function as a transcriptional regulator without 
the need for additional mTEC-specific factors, but that this activity is dependent upon 
the cellular environment.  Our results indicate that AIRE is recruited to the loci of TRA 
along with RNA pol II and chromatin modifying complexes including KMT2A/MLL1 
and KMT6/Ezh2 with its co-factor Eed, which leads to the redistribution of histone 
modification and the induction of expression.  We saw how AIRE was able to 
increase the levels of active acetylation and methylation marks, in particular gene-
specific H3K4 methylation, yet silencing modifications were often maintained as a 
theoretical safety net, preventing unnecessary or un-regulated expression.  AIRE 
was also able to mediate domain-wide changes to histone modifications across the 
keratin cluster to allow for the heightened levels of expression seen for the majority of 
loci, with hyperacetylated H4 potentially relaxing the chromatin structure, facilitating 
AIRE’s actions.  Through FTOC and CChIP we have been able to track the 
epigenetic control of PGE throughout the recently defined TEC developmental 
pathway in vivo which has provided further clues into the function of post-
translational histone modifications in the management of developmental programmes 
of gene expression.  This has revealed how AIRE-regulated TRA are marked or 
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primed for future transcription with both active and silent modifications co-existing 
throughout TEC development in bipotent TEC progenitors and immature mTECs, 
although typically not the traditional H3K4me3 / H3K27me3 bivalent marks.  
Furthermore the pattern of modifications changes dramatically as the cells progress 
through differentiation, highlighting the dynamic nature of post-translational histone 
marks.  However, a more stable epigenetic signature is required for the permanent 
silencing of the loci in mature cTECs, where expression would be detrimental.  The 
importance of these unique, gene-specific patterns of modifications were confirmed 
through disruption to normal TEC development, when the alternative transcriptional 
fate of the TRA was reflected in the chromatin. 
 
Collectively our results show how significant epigenetic patterning is to the control of 
expression of individual genes throughout a developmental pathway, and how these 
patterns can differ between model systems both on a gene-by-gene basis and on a 
more broad domain-wide scale.  CChIP has made the investigation of post-
translational histone modifications finally applicable to small numbers of primary cells, 
however because of this the scope of analysis is always restricted.  We chose to 
study four key histone modifications throughout TEC development which has given 
invaluable insight onto the control of PGE in vivo, yet from our preliminary results in 
cultured TEP cells it is clear that a great plethora of modifications act in concert to 
direct transcriptional programmes.  Thus, determining the definitive contribution 
epigenetic marks have in the regulation of PGE will require further analysis with 
additional modifications.  Clarification of the direct impact of AIRE and chromatin-
modifying complexes on the expression of these genes in vivo would provide insight 
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into how PGE is directed on an epigenetic level, however at present a protocol for 
miniaturised XChIP has not been developed.  Alternatively, a model system in which 
AIRE expression is inducible, such as a thymic epithelial line stably transfected with 
RANK whereby anti-RANK stimulation would switch on biologically relevant levels of 
AIRE, could allow a more accurate reproduction of the mTEC lineage.  Through 
inhibition of certain histone modifying enzymes such as histone deacetylase 
enzymes, the significance of the chromatin signature of each TRA could be 
determined, bringing us one step closer to a clarification of the roles of the various 
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